Title: Inhibition of estrogen receptor reduces connexin 43 expression in breast cancers.
Journal: Toxicology and applied pharmacology 20180101
Title: Ginkgo biloba extract EGb 761-mediated inhibition of aromatase for the treatment of hormone-dependent breast cancer.
Journal: Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20160101
Title: Testotoxicosis: Report of Two Cases, One with a Novel Mutation in LHCGR Gene.
Journal: Journal of clinical research in pediatric endocrinology 20150901
Title: Rapid fluorescent detection of (anti)androgens with spiggin-gfp medaka.
Journal: Environmental science & technology 20140916
Title: Genomic models of short-term exposure accurately predict long-term chemical carcinogenicity and identify putative mechanisms of action.
Journal: PloS one 20140101
Title: Extra virgin olive oil potentiates the effects of aromatase inhibitors via glutathione depletion in estrogen receptor-positive human breast cancer (MCF-7) cells.
Journal: Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20131201
Title: Preventive therapy for breast cancer.
Journal: Current oncology reports 20121201
Title: The synergistic effect of EGFR tyrosine kinase inhibitor gefitinib in combination with aromatase inhibitor anastrozole in non-small cell lung cancer cell lines.
Journal: Lung cancer (Amsterdam, Netherlands) 20121201
Title: Prevention of tobacco carcinogen-induced lung cancer in female mice using antiestrogens.
Journal: Carcinogenesis 20121101
Title: Fulvestrant 500 mg versus anastrozole 1 mg for the first-line treatment of advanced breast cancer: follow-up analysis from the randomized 'FIRST' study.
Journal: Breast cancer research and treatment 20121101
Title: Soy products in the management of breast cancer.
Journal: Current opinion in clinical nutrition and metabolic care 20121101
Title: Anastrozole and fulvestrant in metastatic breast cancer.
Journal: The New England journal of medicine 20121025
Title: Anastrozole and fulvestrant in metastatic breast cancer.
Journal: The New England journal of medicine 20121025
Title: Anastrozole and fulvestrant in metastatic breast cancer.
Journal: The New England journal of medicine 20121025
Title: Breast cancer: Anastrozole and fulvestrant--combination to unlock efficacy.
Journal: Nature reviews. Clinical oncology 20121001
Title: The development, application and limitations of breast cancer cell lines to study tamoxifen and aromatase inhibitor resistance.
Journal: The Journal of steroid biochemistry and molecular biology 20120901
Title: Ovarian function suppression and fulvestrant as endocrine therapy in premenopausal women with metastatic breast cancer.
Journal: European journal of cancer (Oxford, England : 1990) 20120901
Title: Age effect on bone mineral density changes in breast cancer patients receiving anastrozole: results from the ARBI prospective clinical trial.
Journal: Journal of cancer research and clinical oncology 20120901
Title: Aromatase inhibitors and mood disturbances.
Journal: Palliative & supportive care 20120901
Title: Cellular actions of testosterone in vascular cells: mechanism independent of aromatization to estradiol.
Journal: Steroids 20120901
Title: Effect of aromatase inhibitors on background parenchymal enhancement and amount of fibroglandular tissue at breast MR imaging.
Journal: Radiology 20120901
Title: Uncommon metastatic site from breast cancer.
Journal: Vojnosanitetski pregled 20120901
Title: Suppression of plasma estrogen levels by letrozole and anastrozole is related to body mass index in patients with breast cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120820
Title: Aromatase inhibition in obese women: how much is enough?
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120820
Title: Combination anastrozole and fulvestrant in metastatic breast cancer.
Journal: The New England journal of medicine 20120802
Title: Impact of Aromatase protein variants and drug interactions in breast cancer: a molecular docking approach.
Journal: Journal of receptor and signal transduction research 20120801
Title: Systematic review of lapatinib in combination with letrozole compared with other first-line treatments for hormone receptor positive(HR+) and HER2+ advanced or metastatic breast cancer(MBC).
Journal: Current medical research and opinion 20120801
Title: Lipid profiles within the SABRE trial of anastrozole with and without risedronate.
Journal: Breast cancer research and treatment 20120801
Title: Differentially expressed genes in window trials are influenced by the wound-healing process: lessons learned from a pilot study with anastrozole.
Journal: The Journal of surgical research 20120701
Title: Effect of the aromatase inhibitor anastrozole on uterine and leiomyoma Doppler blood flow in patients scheduled for hysterectomy: a pilot study.
Journal: Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 20120701
Title: Preventive effect of risedronate on bone loss and frailty fractures in elderly women treated with anastrozole for early breast cancer.
Journal: Journal of bone and mineral metabolism 20120701
Title: Aromatase inhibitors and calcium absorption in early stage breast cancer.
Journal: Breast cancer research and treatment 20120701
Title: In vitro evaluation of the interaction potential of irosustat with drug-metabolizing enzymes.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20120701
Title: Changes in hormonal profile and seminal parameters with use of aromatase inhibitors in management of infertile men with low testosterone to estradiol ratios.
Journal: Fertility and sterility 20120701
Title: Weight change associated with anastrozole and tamoxifen treatment in postmenopausal women with or at high risk of developing breast cancer.
Journal: Breast cancer research and treatment 20120701
Title: A priming role of local estrogen on exogenous estrogen-mediated synaptic plasticity and neuroprotection.
Journal: Experimental & molecular medicine 20120630
Title: Whole-genome analysis informs breast cancer response to aromatase inhibition.
Journal: Nature 20120621
Title: Spectral characterization of the binding and conformational changes of serum albumins upon interaction with an anticancer drug, anastrozole.
Journal: Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20120615
Title: FACT: an open-label randomized phase III study of fulvestrant and anastrozole in combination compared with anastrozole alone as first-line therapy for patients with receptor-positive postmenopausal breast cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120601
Title: A randomized trial of combination anastrozole plus gefitinib and of combination fulvestrant plus gefitinib in the treatment of postmenopausal women with hormone receptor positive metastatic breast cancer.
Journal: Breast cancer research and treatment 20120601
Title: Combined treatment with GH and anastrozole in a pubertal boy with Cushing's disease and postsurgical GH deficiency.
Journal: European journal of endocrinology 20120601
Title: Polyendocrine treatment in estrogen receptor-positive breast cancer: a 'FACT' yet to be proven.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120601
Title: Pharmacogenomics of third-generation aromatase inhibitors.
Journal: Expert opinion on pharmacotherapy 20120601
Title: Short-term and low-dose prednisolone administration reduces aromatase inhibitor-induced arthralgia in patients with breast cancer.
Journal: Anticancer research 20120601
Title: Pathological complete response in younger and older breast cancer patients.
Journal: Archives of medical science : AMS 20120509
Title: Sex differences in the effectiveness of treadmill training in enhancing axon regeneration in injured peripheral nerves.
Journal: Developmental neurobiology 20120501
Title: Health-related quality of life, psychological distress, and adverse events in postmenopausal women with breast cancer who receive tamoxifen, exemestane, or anastrozole as adjuvant endocrine therapy: National Surgical Adjuvant Study of Breast Cancer 04 (N-SAS BC 04).
Journal: Breast cancer research and treatment 20120501
Title: Combined inhibition of aromatase activity and dihydrotestosterone supplementation attenuates renal injury in male streptozotocin (STZ)-induced diabetic rats.
Journal: American journal of physiology. Renal physiology 20120501
Title: Aromatase inhibitors--a viable option for recurrent granulosa cell tumour of ovary: overview and case report.
Journal: JPMA. The Journal of the Pakistan Medical Association 20120501
Title: Development of a new class of aromatase inhibitors: design, synthesis and inhibitory activity of 3-phenylchroman-4-one (isoflavanone) derivatives.
Journal: Bioorganic & medicinal chemistry 20120415
Title: Does trauma or an intercurrent surgical intervention lead to a short-term increase in breast cancer recurrence rates?
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20120401
Title: Hormone treatment without surgery for patients aged 75 years or older with operable breast cancer.
Journal: Annals of surgical oncology 20120401
Title: Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review.
Journal: Breast cancer research and treatment 20120401
Title: Effect of baseline serum vitamin D levels on aromatase inhibitors induced musculoskeletal symptoms: results from the IBIS-II, chemoprevention study using anastrozole.
Journal: Breast cancer research and treatment 20120401
Title: Aromatase inhibitors in premenopausal breast cancer.
Journal: The Lancet. Oncology 20120401
Title: Neoadjuvant anastrozole versus tamoxifen in patients receiving goserelin for premenopausal breast cancer (STAGE): a double-blind, randomised phase 3 trial.
Journal: The Lancet. Oncology 20120401
Title: Acute sex steroid withdrawal increases cholesterol efflux capacity and HDL-associated clusterin in men.
Journal: Steroids 20120401
Title: Impact of testosterone on the expression of organic anion transporting polypeptides (OATP-1A2, OATP-2B1, OATP-3A1) in malignant and non-malignant human breast cells in vitro.
Journal: Maturitas 20120401
Title: Genesis and outcome of a breast cancer trial to develop the aromatase inhibitor anastrozole.
Journal: Clinical chemistry 20120401
Title: Optimization of the aromatase inhibitory activities of pyridylthiazole analogues of resveratrol.
Journal: Bioorganic & medicinal chemistry 20120401
Title: CYP2D6 and UGT2B7 genotype and risk of recurrence in tamoxifen-treated breast cancer patients.
Journal: Journal of the National Cancer Institute 20120321
Title: [The effect of diet induced obesity on testicular tissue and serum oxidative stress parameters].
Journal: Actas urologicas espanolas 20120301
Title: Outcomes of Japanese breast cancer patients treated with pre-operative and post-operative anastrozole or tamoxifen.
Journal: Cancer science 20120301
Title: Empirical medical therapy for idiopathic male infertility: a survey of the American Urological Association.
Journal: The Journal of urology 20120301
Title: Deep time: the long and the short of adjuvant endocrine therapy for breast cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120301
Title: Tamoxifen and anastrozole as a sequencing strategy: a randomized controlled trial in postmenopausal patients with endocrine-responsive early breast cancer from the Austrian Breast and Colorectal Cancer Study Group.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120301
Title: [A case of recurrent breast cancer with brain metastases successfully treated with vinorelbine and anastrozole after multiple chemo-endocrine therapies].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20120301
Title: Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer.
Journal: The New England journal of medicine 20120209
Title: Breast cancer: Anastrozole sets the STAGE for premenopausal women.
Journal: Nature reviews. Clinical oncology 20120207
Title: Hydrophilic interaction chromatography-electrospray ionization tandem mass spectrometric analysis of anastrozole in human plasma and its application to a pharmacokinetic study.
Journal: Biomedical chromatography : BMC 20120201
Title: Acute testosterone deprivation reduces insulin sensitivity in men.
Journal: Clinical endocrinology 20120201
Title: Relationship between body mass index and preoperative treatment response to aromatase inhibitor exemestane in postmenopausal patients with primary breast cancer.
Journal: Breast (Edinburgh, Scotland) 20120201
Title: Bone health in a prospective cohort of postmenopausal women receiving aromatase inhibitors for early breast cancer.
Journal: Breast (Edinburgh, Scotland) 20120201
Title: Short-term biomarker modulation prevention study of anastrozole in women at increased risk for second primary breast cancer.
Journal: Cancer prevention research (Philadelphia, Pa.) 20120201
Title: Effects of aromatase inhibitor on menopausal hyperplasia in a case of obesity.
Journal: Climacteric : the journal of the International Menopause Society 20120201
Title: International consensus and practical guidelines on the gynecologic and obstetric management of female patients with hereditary angioedema caused by C1 inhibitor deficiency.
Journal: The Journal of allergy and clinical immunology 20120201
Title: Human steroid biosynthesis for the oncologist.
Journal: Journal of investigative medicine : the official publication of the American Federation for Clinical Research 20120201
Title: Pharmacokinetic comparison of 2 formulations of anastrozole (1 mg) in healthy Korean male volunteers: a randomized, single-dose, 2-period, 2-sequence, crossover study.
Journal: Clinical therapeutics 20120201
Title: Exemestane versus anastrozole as front-line endocrine therapy in postmenopausal patients with hormone receptor-positive, advanced breast cancer: final results from the Spanish Breast Cancer Group 2001-03 phase 2 randomized trial.
Journal: Cancer 20120101
Title: Effects of aromatase inhibition versus gonadectomy on hippocampal complex amyloid pathology in triple transgenic mice.
Journal: Neurobiology of disease 20120101
Title: Adherence to adjuvant therapy in post-menopausal breast cancer patients: a review.
Journal: European journal of cancer care 20120101
Title: 5α-reductase inhibitors, antiviral and anti-tumor activities of some steroidal cyanopyridinone derivatives.
Journal: International journal of biological macromolecules 20120101
Title: Combined treatment with bicalutamide and anastrozole in a young boy with peripheral precocious puberty due to McCune-Albright Syndrome.
Journal: Endocrine journal 20120101
Title: Effect of simvastatin on the pharmacokinetics of anastrozole.
Journal: Breast cancer research and treatment 20120101
Title: Clitoral metastasis from ductal breast cancer revealing metastases in multiple sites and review of the literature.
Journal: Journal of lower genital tract disease 20120101
Title: Hydroxybenzothiazoles as new nonsteroidal inhibitors of 17β-hydroxysteroid dehydrogenase type 1 (17β-HSD1).
Journal: PloS one 20120101
Title: Reviewing the cost-effectiveness of endocrine early breast cancer therapies: influence of differences in modeling methods on outcomes.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20120101
Title: Molecular bases and phenotypic determinants of aromatase excess syndrome.
Journal: International journal of endocrinology 20120101
Title: Aromatase inhibitors for PCOS: a systematic review and meta-analysis.
Journal: Human reproduction update 20120101
Title: Hypogonadism in the aging male diagnosis, potential benefits, and risks of testosterone replacement therapy.
Journal: International journal of endocrinology 20120101
Title: Trastuzumab for HER2-Positive Metastatic Breast Cancer: Clinical and Economic Considerations.
Journal: Clinical Medicine Insights. Oncology 20120101
Title: Innovative oral treatments of uterine leiomyoma.
Journal: Obstetrics and gynecology international 20120101
Title: Bilateral de quervain syndrome after aromatase inhibitor administration: a case report and review of the literature.
Journal: Case reports in medicine 20120101
Title: Managing arthralgia in a postmenopausal woman taking an aromatase inhibitor for hormonesensitive early breast cancer: a case study.
Journal: Cancer management and research 20120101
Title: Preclinical and clinical studies of estrogen deprivation support the PDGF/Abl pathway as a novel therapeutic target for overcoming endocrine resistance in breast cancer.
Journal: Breast cancer research : BCR 20120101
Title: McCune-Albright syndrome and the extraskeletal manifestations of fibrous dysplasia.
Journal: Orphanet journal of rare diseases 20120101
Title: Carcinomatous pericarditis in 3 breast cancer patients with long-term survival.
Journal: Case reports in oncology 20120101
Title: Ductal carcinoma in situ: what can we learn from clinical trials?
Journal: International journal of surgical oncology 20120101
Title: Leiomyomatosis peritonealis disseminata associated with endometriosis and multiple uterus-like mass: report of two cases.
Journal: Clinical medicine insights. Case reports 20120101
Title: Physiologically Based Pharmacokinetic Modeling of Tamoxifen and its Metabolites in Women of Different CYP2D6 Phenotypes Provides New Insight into the Tamoxifen Mass Balance.
Journal: Frontiers in pharmacology 20120101
Title: Bioactive dietary supplements reactivate ER expression in ER-negative breast cancer cells by active chromatin modifications.
Journal: PloS one 20120101
Title: Postmenopausal women with DCIS post-mastectomy: a potential role for aromatase inhibitors.
Journal: The breast journal 20120101
Title: Partial benefit of anastrozole in the long-term treatment of precocious puberty in McCune-Albright syndrome.
Journal: Journal of pediatric endocrinology & metabolism : JPEM 20120101
Title: Aromatase inhibition attenuates desflurane-induced preconditioning against acute myocardial infarction in male mouse heart in vivo.
Journal: PloS one 20120101
Title: Tamoxifen for the management of breast events induced by non-steroidal antiandrogens in patients with prostate cancer: a systematic review.
Journal: BMC medicine 20120101
Title: Determination and characterization of degradation products of anastrozole by LC-MS/MS and NMR spectroscopy.
Journal: Journal of pharmaceutical and biomedical analysis 20111215
Title: Adjuvant sequencing of tamoxifen and anastrozole is superior to tamoxifen alone in postmenopausal women with low proliferating breast cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20111215
Title: Selective estrogen receptor modulators and aromatase inhibitors for breast cancer chemoprevention.
Journal: Current drug targets 20111201
Title: Identifying potential adverse effects using the web: a new approach to medical hypothesis generation.
Journal: Journal of biomedical informatics 20111201
Title: Effects of zoledronic acid on bone mineral density during aromatase inhibitor treatment of Korean postmenopausal breast cancer patients.
Journal: Breast cancer research and treatment 20111201
Title: Changes in breast density and circulating estrogens in postmenopausal women receiving adjuvant anastrozole.
Journal: Cancer prevention research (Philadelphia, Pa.) 20111201
Title: Progress in endocrine approaches to the treatment and prevention of breast cancer.
Journal: Maturitas 20111201
Title: An overview of letrozole in postmenopausal women with hormone-responsive breast cancer.
Journal: Advances in therapy 20111201
Title: [Role of medical treatment for symptomatic leiomyoma management in premenopausal women].
Journal: Journal de gynecologie, obstetrique et biologie de la reproduction 20111201
Title: Putting the cardiovascular safety of aromatase inhibitors in patients with early breast cancer into perspective: a systematic review of the literature.
Journal: Drug safety 20111201
Title: Nursing perspectives on fulvestrant for the treatment of postmenopausal women with metastatic breast cancer.
Journal: Clinical journal of oncology nursing 20111201
Title: Prioritizing pharmacogenetic research: a value of information analysis of CYP2D6 testing to guide breast cancer treatment.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20111201
Title: Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
Journal: PLoS computational biology 20111201
Title: Prognostic Implications of MicroRNA-21 Overexpression in Invasive Ductal Carcinomas of the Breast.
Journal: Journal of breast cancer 20111201
Title: Locoregional recurrence of breast conserving surgery after preoperative chemotherapy in korean women with locally advanced breast cancer.
Journal: Journal of breast cancer 20111201
Title: Risk of recurrence and chemotherapy benefit for patients with node-negative, estrogen receptor-positive breast cancer: recurrence score alone and integrated with pathologic and clinical factors.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20111120
Title: The breast cancer chemoprevention debate.
Journal: Journal of the National Cancer Institute 20111116
Title: Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials.
Journal: Lancet (London, England) 20111112
Title: Embracing the complexity of comorbidity.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20111110
Title: Influence of comorbidities and age on risk of death without recurrence: a retrospective analysis of the Arimidex, Tamoxifen Alone or in Combination trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20111110
Title: Prognostic value of a combined estrogen receptor, progesterone receptor, Ki-67, and human epidermal growth factor receptor 2 immunohistochemical score and comparison with the Genomic Health recurrence score in early breast cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20111110
Title: Androgens and musculoskeletal symptoms among breast cancer patients on aromatase inhibitor therapy.
Journal: Breast cancer research and treatment 20111101
Title: A case of aromatase inhibitor (anastrozole)-induced side-effects successfully treated with Kampo medicines.
Journal: Journal of alternative and complementary medicine (New York, N.Y.) 20111101
Title: 4-({(E)-[2-(But-3-en-1-yl)-1-(prop-2-en-1-yl)-4-sulfanyl-1H-imidazol-5-yl]methyl-idene}amino)-3-phenyl-1H-1,2,4-triazole-5(4H)-thione.
Journal: Acta crystallographica. Section E, Structure reports online 20111101
Title: [Determination of 6 antiestrogens in fish tissues by ultra performance liquid chromatography-tandem mass spectrometry].
Journal: Se pu = Chinese journal of chromatography 20111101
Title: Direct spectroscopic evidence for binding of anastrozole to the iron heme of human aromatase. Peering into the mechanism of aromatase inhibition.
Journal: Chemical communications (Cambridge, England) 20111014
Title: A phase II neoadjuvant trial of anastrozole, fulvestrant, and gefitinib in patients with newly diagnosed estrogen receptor positive breast cancer.
Journal: Breast cancer research and treatment 20111001
Title: Breast cancer medications and vision: effects of treatments for early-stage disease.
Journal: Current eye research 20111001
Title: Strategies for maximizing growth in puberty in children with short stature.
Journal: Pediatric clinics of North America 20111001
Title: Grover disease (transient acantholytic dermatosis) induced by anastrozole.
Journal: Cutis 20111001
Title: Clinical and economic benefits of aromatase inhibitor therapy in early-stage breast cancer.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20110915
Title: Aromatase inhibitor anastrozole as a second-line hormonal treatment to a recurrent low-grade endometrial stromal sarcoma: a case report.
Journal: Medical oncology (Northwood, London, England) 20110901
Title: Evaluation of the psychometric properties of the BCPT Symptom Checklist with a sample of breast cancer patients before and after adjuvant therapy.
Journal: Psycho-oncology 20110901
Title: Inhibition of estradiol synthesis attenuates renal injury in male streptozotocin-induced diabetic rats.
Journal: American journal of physiology. Renal physiology 20110901
Title: Post-marketing safety evaluation of S-1 in patients with inoperable or recurrent breast cancer: especially in patients treated with S-1 + trastuzumab.
Journal: Japanese journal of clinical oncology 20110901
Title: Update on adjuvant hormonal treatment of early breast cancer.
Journal: Advances in therapy 20110901
Title: Management of patients with metastatic breast cancer.
Journal: Advances in therapy 20110901
Title: Initialization of adjuvant hormonal treatment for breast cancer.
Journal: Advances in therapy 20110901
Title: Contemporary issues in precocious puberty.
Journal: Indian journal of endocrinology and metabolism 20110901
Title: Invasive lobular breast cancer presenting an unusual metastatic pattern in the form of peritoneal and rectal metastases: a case report.
Journal: Journal of breast cancer 20110901
Title: 3-(4-Nitro-phen-yl)-1H-1,2,4-triazole-5(4H)-thione.
Journal: Acta crystallographica. Section E, Structure reports online 20110901
Title: Aromatase inhibitor-induced loss of grip strength is body mass index dependent: hypothesis-generating findings for its pathogenesis.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20110801
Title: The effect of exemestane, anastrozole, and tamoxifen on lipid profiles in Japanese postmenopausal early breast cancer patients: final results of National Surgical Adjuvant Study BC 04, the TEAM Japan sub-study.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20110801
Title: Aromatase and dual aromatase-steroid sulfatase inhibitors from the letrozole and vorozole templates.
Journal: ChemMedChem 20110801
Title: Killing the second messenger: targeting loss of cell cycle control in endocrine-resistant breast cancer.
Journal: Endocrine-related cancer 20110801
Title: Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20110801
Title: Effects of toremifene and anastrozole on serum lipids and bone metabolism in postmenopausal females with estrogen receptor-positive breast cancer: the results of a 2-year multicenter open randomized study.
Journal: Breast cancer research and treatment 20110801
Title: Five-day anastrozole group in infertility needs supplemental human chorionic gonadotropin.
Journal: Fertility and sterility 20110801
Title: Vitamin D and aromatase inhibitor-induced musculoskeletal symptoms (AIMSS): a phase II, double-blind, placebo-controlled, randomized trial.
Journal: Breast cancer research and treatment 20110801
Title: Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20110801
Title: Fulvestrant revisited: efficacy and safety of the 500-mg dose.
Journal: Clinical breast cancer 20110801
Title: Current role and safety profile of aromatase inhibitors in early breast cancer.
Journal: Expert review of anticancer therapy 20110801
Title: Autophagy and endocrine resistance in breast cancer.
Journal: Expert review of anticancer therapy 20110801
Title: Use of Oncotype DX in Women with Node-Positive Breast Cancer.
Journal: PLoS currents 20110721
Title: Profiling of a prescription drug library for potential renal drug-drug interactions mediated by the organic cation transporter 2.
Journal: Journal of medicinal chemistry 20110714
Title: Molecular effects of oestrogen deprivation in breast cancer.
Journal: Molecular and cellular endocrinology 20110704
Title: Oral fluoropyrimidine may augment the efficacy of aromatase inhibitor via the down-regulation of estrogen receptor in estrogen-responsive breast cancer xenografts.
Journal: Breast cancer research and treatment 20110701
Title: Overview of adjuvant trials of aromatase inhibitors in early breast cancer.
Journal: Steroids 20110701
Title: Binding features of steroidal and nonsteroidal inhibitors.
Journal: Steroids 20110701
Title: Examination of the use of Exemestane in patients with metastatic breast cancer.
Journal: Breast cancer (Tokyo, Japan) 20110701
Title: Association between breast cancer subtypes and response to neoadjuvant anastrozole.
Journal: Steroids 20110701
Title: Predictive algorithms for adjuvant therapy: TransATAC.
Journal: Steroids 20110701
Title: An in vitro model showing adaptation to long-term oestrogen deprivation highlights the clinical potential for targeting kinase pathways in combination with aromatase inhibition.
Journal: Steroids 20110701
Title: Impact of body mass index on the efficacy of endocrine therapy in premenopausal patients with breast cancer: an analysis of the prospective ABCSG-12 trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110701
Title: Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial.
Journal: The Lancet. Oncology 20110701
Title: Development and validation of a sensitive liquid chromatography/tandem mass spectrometry method for the determination of exemestane in human plasma.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20110701
Title: [Effects of anastrozole on lipid metabolism in Chinese postmenopausal women with breast cancer].
Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology] 20110701
Title: Randomized phase II neoadjuvant comparison between letrozole, anastrozole, and exemestane for postmenopausal women with estrogen receptor-rich stage 2 to 3 breast cancer: clinical and biomarker outcomes and predictive value of the baseline PAM50-based intrinsic subtype--ACOSOG Z1031.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110610
Title: A phase II study of the histone deacetylase inhibitor vorinostat combined with tamoxifen for the treatment of patients with hormone therapy-resistant breast cancer.
Journal: British journal of cancer 20110607
Title: Influence of concurrent anastrozole on acute and late side effects of whole breast radiotherapy.
Journal: American journal of clinical oncology 20110601
Title: The efficacy of HER2-targeted agents in metastatic breast cancer: a meta-analysis.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20110601
Title: Prognostic value of lymph node micrometastases in breast cancer: a multicenter cohort study.
Journal: Annals of surgical oncology 20110601
Title: An 'omics' approach to determine the mechanisms of acquired aromatase inhibitor resistance.
Journal: Omics : a journal of integrative biology 20110601
Title: When to start an aromatase inhibitor: now or later?
Journal: Journal of surgical oncology 20110601
Title: Ovarian hyperstimulation syndrome in a patient treated with tamoxifen for breast cancer.
Journal: Fertility and sterility 20110601
Title: Lead optimization of 4-imidazolylflavans: new promising aromatase inhibitors.
Journal: European journal of medicinal chemistry 20110601
Title: Hormonal therapy plus bevacizumab in postmenopausal patients who have hormone receptor-positive metastatic breast cancer: a phase II Trial of the Sarah Cannon Oncology Research Consortium.
Journal: Clinical breast cancer 20110601
Title: Inhibitory effects of calcitriol on the growth of MCF-7 breast cancer xenografts in nude mice: selective modulation of aromatase expression in vivo.
Journal: Hormones & cancer 20110601
Title: Efficacy of fulvestrant in heavily pretreated postmenopausal women with advanced breast cancer: a preliminary report.
Journal: Journal of breast cancer 20110601
Title: Use of tamoxifen and aromatase inhibitors in a large population-based cohort of women with breast cancer.
Journal: British journal of cancer 20110510
Title: Synthesis of α-aryl nitriles through palladium-catalyzed decarboxylative coupling of cyanoacetate salts with aryl halides and triflates.
Journal: Angewandte Chemie (International ed. in English) 20110502
Title: Assessing the efficacy of targeted therapy using circulating epithelial tumor cells (CETC): the example of SERM therapy monitoring as a unique tool to individualize therapy.
Journal: Journal of cancer research and clinical oncology 20110501
Title: Short-term anastrozole therapy reduces Ki-67 and progesterone receptor expression in invasive breast cancer: a prospective, placebo-controlled, double-blind trial.
Journal: Journal of cancer research and clinical oncology 20110501
Title: Close and stable relationship between proliferation and a hypoxia metagene in aromatase inhibitor-treated ER-positive breast cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20110501
Title: Health-related quality of life and psychological distress of breast cancer patients after surgery during a phase III randomized trial comparing continuation of tamoxifen with switching to anastrozole after adjuvant tamoxifen for 1-4 years: N-SAS BC 03.
Journal: Breast cancer research and treatment 20110501
Title: Drug safety evaluation of exemestane.
Journal: Expert opinion on drug safety 20110501
Title: Preventive therapy for breast cancer: a consensus statement.
Journal: The Lancet. Oncology 20110501
Title: Aromatase inhibitor-induced skin adverse reactions: exemestane-related cutaneous vasculitis.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV 20110501
Title: 7-(4-Chloro-benzyl-idene)-3-[(4-chloro-phen-oxy)meth-yl]-6-(4-nitro-thio-phen-2-yl)-7H-1,2,4-triazolo[3,4-b][1,3,4]thia-diazine.
Journal: Acta crystallographica. Section E, Structure reports online 20110501
Title: Is primary endocrine therapy effective in treating the elderly, unfit patient with breast cancer?
Journal: Annals of the Royal College of Surgeons of England 20110501
Title: Long-term clinical outcome of oestrogen receptor-positive operable primary breast cancer in older women: a large series from a single centre.
Journal: British journal of cancer 20110426
Title: An ultraperformance liquid chromatography-tandem mass spectrometry method for determination of anastrozole in human plasma and its application to a pharmacokinetic study.
Journal: Biomedical chromatography : BMC 20110401
Title: Long-term effects of anastrozole on bone mineral density: 7-year results from the ATAC trial.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20110401
Title: A qualitative systematic review of the evidence base for non-cross-resistance between steroidal and non-steroidal aromatase inhibitors in metastatic breast cancer.
Journal: Clinical oncology (Royal College of Radiologists (Great Britain)) 20110401
Title: Anastrozole vs. clomiphene citrate in infertile women with ovulatory dysfunction: a phase II, randomized, dose-finding study.
Journal: Fertility and sterility 20110401
Title: Anastrozole single-dose protocol in women with oligo- or anovulatory infertility: results of a randomized phase II dose-response study.
Journal: Fertility and sterility 20110401
Title: Combination of trastuzumab and letrozole after resistance to sequential trastuzumab and aromatase inhibitor monotherapies in patients with estrogen receptor-positive, HER-2-positive advanced breast cancer: a proof-of-concept trial (SAKK 23/03).
Journal: Endocrine-related cancer 20110401
Title: A gene expression signature from human breast cancer cells with acquired hormone independence identifies MYC as a mediator of antiestrogen resistance.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20110401
Title: Anastrozole versus clomiphene citrate: which is better for ovulation induction?
Journal: Fertility and sterility 20110401
Title: Sustained release optimized formulation of anastrozole-loaded chitosan microspheres: in vitro and in vivo evaluation.
Journal: Journal of materials science. Materials in medicine 20110401
Title: Effect of tamoxifen or anastrozole on steroid sulfatase activity and serum androgen concentrations in postmenopausal women with breast cancer.
Journal: Anticancer research 20110401
Title: ESR1 is co-expressed with closely adjacent uncharacterised genes spanning a breast cancer susceptibility locus at 6q25.1.
Journal: PLoS genetics 20110401
Title: [Neoadjuvant endocrine therapy for postmenopausal estrogen receptor-positive patients with breast cancer].
Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology] 20110401
Title: Differences between the non-steroidal aromatase inhibitors anastrozole and letrozole--of clinical importance?
Journal: British journal of cancer 20110329
Title: Design, synthesis, and biological evaluation of imidazolyl derivatives of 4,7-disubstituted coumarins as aromatase inhibitors selective over 17-α-hydroxylase/C17-20 lyase.
Journal: Journal of medicinal chemistry 20110324
Title: Time dependent effects of adjuvant tamoxifen therapy on cerebrovascular disease: results from a randomised trial.
Journal: British journal of cancer 20110315
Title: A case of ectopic breast cancer with a literature review.
Journal: Surgical oncology 20110301
Title: The potency and clinical efficacy of aromatase inhibitors across the breast cancer continuum.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20110301
Title: Does anastrozole affect bone resorption similarly in early and late postmenopausal women?
Journal: Calcified tissue international 20110301
Title: 10-year analysis of the ATAC trial: wrong conclusion?
Journal: The Lancet. Oncology 20110301
Title: [A case of possible retroperitoneal metastasis of breast cancer successfully treated with oral S-1 and cyclophosphamide therapy after TC therapy].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20110301
Title: Eight-year follow-up of a girl with McCune-Albright syndrome.
Journal: Journal of clinical research in pediatric endocrinology 20110301
Title: Depressogenic effects of medications: a review.
Journal: Dialogues in clinical neuroscience 20110301
Title: [Aromatase inhibitors and arthralgia].
Journal: Magyar onkologia 20110301
Title: A novel approach for long-term oral drug administration in animal research.
Journal: Journal of neuroscience methods 20110215
Title: Fulvestrant: a review of its use in the management of hormone receptor-positive metastatic breast cancer in postmenopausal women.
Journal: Drugs 20110212
Title: Adjuvant endocrine therapy in postmenopausal breast cancer patients: does hormone receptor status influence decision-making?
Journal: Critical reviews in oncology/hematology 20110201
Title: Time and geographical variations in utilization of endocrine therapy for breast cancer in Australia.
Journal: Internal medicine journal 20110201
Title: Anastrozole and letrozole: an investigation and comparison of quality of life and tolerability.
Journal: Breast cancer research and treatment 20110201
Title: Cortical and trabecular bone at the radius and tibia in postmenopausal breast cancer patients: a Peripheral Quantitative Computed Tomography (pQCT) study.
Journal: Bone 20110201
Title: Uterine and quality of life changes in postmenopausal women with an asymptomatic tamoxifen-thickened endometrium randomized to continuation of tamoxifen or switching to anastrozole.
Journal: Menopause (New York, N.Y.) 20110201
Title: Cancer therapy associated bone loss: implications for hip fractures in mid-life women with breast cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20110201
Title: Chemotherapy: Anastrozole superiority to tamoxifen for early breast cancer confirmed.
Journal: Nature reviews. Clinical oncology 20110201
Title: Premenopausal hormone-responsive breast cancer with extensive axillary nodes involvement: total estrogen blockade and chemotherapy.
Journal: Anticancer research 20110201
Title: Evaluation of management of desmoid tumours associated with familial adenomatous polyposis in Dutch patients.
Journal: British journal of cancer 20110104
Title: Effectiveness of Traditional Chinese Medicine for Liver Protection and Chemotherapy Completion among Cancer Patients.
Journal: Evidence-based complementary and alternative medicine : eCAM 20110101
Title: Successful use of biweekly gemcitabine plus nab-paclitaxel in two male patients with stage iv breast cancer: case reports and review of the literature.
Journal: American journal of therapeutics 20110101
Title: Failure to perceive increased risk of fracture in women 55 years and older: the Global Longitudinal Study of Osteoporosis in Women (GLOW).
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20110101
Title: Predictors of non-adherence to aromatase inhibitors among commercially insured women with breast cancer.
Journal: Breast cancer research and treatment 20110101
Title: Rheumatoid arthritis and aromatase inhibitors.
Journal: Joint, bone, spine : revue du rhumatisme 20110101
Title: In vivo treatments with fulvestrant and anastrozole differentially affect gene expression in the rat efferent ductules.
Journal: Biology of reproduction 20110101
Title: Fulvestrant 250 mg versus anastrozole for Chinese patients with advanced breast cancer: results of a multicentre, double-blind, randomised phase III trial.
Journal: Cancer chemotherapy and pharmacology 20110101
Title: Phase I/II study of sorafenib with anastrozole in patients with hormone receptor positive aromatase inhibitor resistant metastatic breast cancer.
Journal: Breast cancer research and treatment 20110101
Title: Manipulating protein acetylation in breast cancer: a promising approach in combination with hormonal therapies?
Journal: Journal of biomedicine & biotechnology 20110101
Title: Association of functional polymorphisms in CYP19A1 with aromatase inhibitor associated arthralgia in breast cancer survivors.
Journal: Breast cancer research : BCR 20110101
Title: Chemoprevention of hormone receptor-negative breast cancer: new approaches needed.
Journal: Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer 20110101
Title: Risk of Ipsilateral breast tumor recurrence in patients treated with Tamoxifen or Anastrozole following breast-conserving surgery with or without radiotherapy.
Journal: Anticancer research 20110101
Title: Prolactin-induced mouse mammary carcinomas model estrogen resistant luminal breast cancer.
Journal: Breast cancer research : BCR 20110101
Title: Intervening on the side effects of hormone-dependent cancer treatment: the role of strength training.
Journal: Journal of aging research 20110101
Title: Prepubertal gynecomastia in two monozygotic twins with Peutz-Jeghers syndrome: two years' treatment with anastrozole and genetic study.
Journal: Hormone research in paediatrics 20110101
Title: Treatment options for polycystic ovary syndrome.
Journal: International journal of women's health 20110101
Title: [A case of aromatase inhibitor-tolerant metastatic breast cancer revealing complete remission with high-dose toremifene therapy].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20110101
Title: Do aromatase inhibitors have adverse effects on cognitive function?
Journal: Breast cancer research : BCR 20110101
Title: Significant survival improvement of patients with recurrent breast cancer in the periods 2001-2008 vs. 1992-2000.
Journal: BMC cancer 20110101
Title: Anastrozole-related acute hepatitis with autoimmune features: a case report.
Journal: BMC gastroenterology 20110101
Title: Aromatase inhibitor-associated bone and musculoskeletal effects: new evidence defining etiology and strategies for management.
Journal: Breast cancer research : BCR 20110101
Title: Honey induces apoptosis in renal cell carcinoma.
Journal: Pharmacognosy magazine 20110101
Title: Gynecomastia - evaluation and current treatment options.
Journal: Therapeutics and clinical risk management 20110101
Title: Cerebellar degeneration as presenting symptom of recurrent endometrial stromal sarcoma with sex-cord elements.
Journal: Case reports in neurology 20110101
Title: Goserelin plus letrozole as first- or second-line hormonal treatment in premenopausal patients with advanced breast cancer.
Journal: Endocrine journal 20110101
Title: Tamoxifen in early-stage estrogen receptor-positive breast cancer: overview of clinical use and molecular biomarkers for patient selection.
Journal: OncoTargets and therapy 20110101
Title: Gonadotropin-dependent precocious puberty: neoplastic causes and endocrine considerations.
Journal: International journal of pediatric endocrinology 20110101
Title: Interpreting clinical assays for histone deacetylase inhibitors.
Journal: Cancer management and research 20110101
Title: Interpreting Breast International Group (BIG) 1-98: a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with hormone receptor-positive, early breast cancer.
Journal: Breast cancer research : BCR 20110101
Title: Malignancy-associated dyslipidemia.
Journal: The open cardiovascular medicine journal 20110101
Title: Evaluation of cell cycle arrest in estrogen responsive MCF-7 breast cancer cells: pitfalls of the MTS assay.
Journal: PloS one 20110101
Title: Anti-inflammatory and antinociceptive evaluation of newly synthesized 4-(substituted ethanoyl) amino-3-mercapto-5-(4-methoxy) phenyl-1,2,4-triazoles.
Journal: Journal of pharmacy & bioallied sciences 20110101
Title: Extended letrozole regimen versus clomiphene citrate for superovulation in patients with unexplained infertility undergoing intrauterine insemination: a randomized controlled trial.
Journal: Reproductive biology and endocrinology : RB&E 20110101
Title: Aromatase inhibitors in stimulated IVF cycles.
Journal: Reproductive biology and endocrinology : RB&E 20110101
Title: Letrozole or clomiphene citrate as first line for anovulatory infertility: a debate.
Journal: Reproductive biology and endocrinology : RB&E 20110101
Title: The emerging use of aromatase inhibitors for endometriosis treatment.
Journal: Reproductive biology and endocrinology : RB&E 20110101
Title: Letrozole and norethisterone acetate versus letrozole and triptorelin in the treatment of endometriosis related pain symptoms: a randomized controlled trial.
Journal: Reproductive biology and endocrinology : RB&E 20110101
Title: Use of aromatase inhibitors to treat endometriosis-related pain symptoms: a systematic review.
Journal: Reproductive biology and endocrinology : RB&E 20110101
Title: Aromatase inhibitors in post-menopausal endometriosis.
Journal: Reproductive biology and endocrinology : RB&E 20110101
Title: Aromatase inhibitors and antiepileptic drugs: a computational systems biology analysis.
Journal: Reproductive biology and endocrinology : RB&E 20110101
Title: Aromatase inhibitors in men: effects and therapeutic options.
Journal: Reproductive biology and endocrinology : RB&E 20110101
Title: Trastuzumab in the adjuvant treatment of HER2-positive early breast cancer patients: a meta-analysis of published randomized controlled trials.
Journal: PloS one 20110101
Title: Promising molecular targeted therapies in breast cancer.
Journal: Indian journal of pharmacology 20110101
Title: Surviving metastatic breast cancer for 18 years: a case report and review of the literature.
Journal: The breast journal 20110101
Title: Dose and polymorphic genes xrcc1, xrcc3, gst play a role in the risk of articledeveloping erythema in breast cancer patients following single shot partial breast irradiation after conservative surgery.
Journal: BMC cancer 20110101
Title: TP53 status and response to treatment in breast cancers.
Journal: Journal of biomedicine & biotechnology 20110101
Title: Aromatase activity and bone loss in men.
Journal: Journal of osteoporosis 20110101
Title: Microarrays in the 2010s: the contribution of microarray-based gene expression profiling to breast cancer classification, prognostication and prediction.
Journal: Breast cancer research : BCR 20110101
Title: Microarray-based oncogenic pathway profiling in advanced serous papillary ovarian carcinoma.
Journal: PloS one 20110101
Title: Serum estradiol levels associated with specific gene expression patterns in normal breast tissue and in breast carcinomas.
Journal: BMC cancer 20110101
Title: Innegligible musculoskeletal disorders caused by zoledronic acid in adjuvant breast cancer treatment: a meta-analysis.
Journal: Journal of experimental & clinical cancer research : CR 20110101
Title: Ki67 proliferation in core biopsies versus surgical samples - a model for neo-adjuvant breast cancer studies.
Journal: BMC cancer 20110101
Title: Managing the personal side of health: how patient expertise differs from the expertise of clinicians.
Journal: Journal of medical Internet research 20110101
Title: Orbital metastases as first sign of metastatic spread in breast cancer: case report and review of the literature.
Journal: Head & neck oncology 20110101
Title: Increased fracture rate in women with breast cancer: a review of the hidden risk.
Journal: BMC cancer 20110101
Title: Choosing the right cell line for breast cancer research.
Journal: Breast cancer research : BCR 20110101
Title: Discovering biological connections between experimental conditions based on common patterns of differential gene expression.
Journal: BMC bioinformatics 20110101
Title: Platinum resistance in breast and ovarian cancer cell lines.
Journal: Journal of experimental & clinical cancer research : CR 20110101
Title: Pharmacogenetic testing affects choice of therapy among women considering tamoxifen treatment.
Journal: Genome medicine 20110101
Title: The time since last menstrual period is important as a clinical predictor for non-steroidal aromatase inhibitor-related arthralgia.
Journal: BMC cancer 20110101
Title: Prognostic utility of the breast cancer index and comparison to Adjuvant! Online in a clinical case series of early breast cancer.
Journal: Breast cancer research : BCR 20110101
Title: Male breast carcinoma: increased awareness needed.
Journal: Breast cancer research : BCR 20110101
Title: Endocrine therapy, new biologicals, and new study designs for presurgical studies in breast cancer.
Journal: Journal of the National Cancer Institute. Monographs 20110101
Title: Toxicity and cosmesis outcomes after single fraction partial breast irradiation in early stage breast cancer.
Journal: Radiation oncology (London, England) 20110101
Title: Exemestane in the adjuvant treatment of breast cancer in postmenopausal women.
Journal: Breast cancer : basic and clinical research 20110101
Title: Protein biomarkers for the early detection of breast cancer.
Journal: International journal of proteomics 20110101
Title: Study of Estrogen Receptor and Progesterone Receptor Expression in Breast Ductal Carcinoma In Situ by Immunohistochemical Staining in ER/PgR-Negative Invasive Breast Cancer.
Journal: ISRN oncology 20110101
Title: Versican G3 domain modulates breast cancer cell apoptosis: a mechanism for breast cancer cell response to chemotherapy and EGFR therapy.
Journal: PloS one 20110101
Title: Breast cancer in the lower jaw after reconstructive surgery with a pectoralis major myocutaneous flap (PMMC) -- a case report.
Journal: European journal of medical research 20110101
Title: Mutations in the phosphatidylinositol 3-kinase pathway: role in tumor progression and therapeutic implications in breast cancer.
Journal: Breast cancer research : BCR 20110101
Title: Obesity, inflammation, and postmenopausal breast cancer: therapeutic implications.
Journal: TheScientificWorldJournal 20110101
Title: Lapatinib and trastuzumab in combination with an aromatase inhibitor for the first-line treatment of metastatic hormone receptor-positive breast cancer which over-expresses human epidermal growth factor 2 (HER2): a systematic review and economic analysis.
Journal: Health technology assessment (Winchester, England) 20110101
Title: Efficacy and safety of ultra-low-dose Vagifem (10 mcg).
Journal: Patient preference and adherence 20110101
Title: The use of high dose letrozole in ovulation induction and controlled ovarian hyperstimulation.
Journal: ISRN obstetrics and gynecology 20110101
Title: Regression of late onset choroidal metastasis from a breast carcinoma with letrozole.
Journal: Case reports in ophthalmology 20110101
Title: Rosiglitazone and pioglitazone alter aromatase kinetic properties in human granulosa cells.
Journal: PPAR research 20110101
Title: Review of breast conservation therapy: then and now.
Journal: ISRN oncology 20110101
Title: The state of research into children with cancer across Europe: new policies for a new decade.
Journal: Ecancermedicalscience 20110101
Title: Role of HER2-Targeted Agents in Adjuvant Treatment for Breast Cancer.
Journal: Chemotherapy research and practice 20110101
Title: Breast conservation surgery: state of the art.
Journal: International journal of breast cancer 20110101
Title: The Role of Interferon Regulatory Factor-1 (IRF1) in Overcoming Antiestrogen Resistance in the Treatment of Breast Cancer.
Journal: International journal of breast cancer 20110101
Title: Joint symptoms, aromatase inhibitor-related adverse reactions, are indirectly associated with decreased serum estradiol.
Journal: International journal of surgical oncology 20110101
Title: 17α-ethynyl-5α-androstane-3α, 17β-diol treatment of MNU-induced mammary cancer in rats.
Journal: International journal of breast cancer 20110101
Title: [Effectiveness of aromatase inhibitors in comparison with metformin for neoadjuvant treatment in patients with endometrial cancer].
Journal: Voprosy onkologii 20110101
Title: Expression of aromatase and estrogen receptor alpha in chondrosarcoma, but no beneficial effect of inhibiting estrogen signaling both in vitro and in vivo.
Journal: Clinical sarcoma research 20110101
Title: Peripheral vs. Central Sex Steroid Hormones in Experimental Parkinson's Disease.
Journal: Frontiers in endocrinology 20110101
Title: Cancer and renal insufficiency results of the BIRMA study.
Journal: British journal of cancer 20101207
Title: Impact of the estrus cycle and reduction in estrogen levels with aromatase inhibition, on renal function and nitric oxide activity in female rats.
Journal: Steroids 20101201
Title: Minimizing early relapse and maximizing treatment outcomes in hormone-sensitive postmenopausal breast cancer: efficacy review of AI trials.
Journal: Cancer metastasis reviews 20101201
Title: Antimicrobial, antitumor and 5α-reductase inhibitor activities of some hydrazonoyl substituted pyrimidinones.
Journal: European journal of medicinal chemistry 20101201
Title: Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial.
Journal: The Lancet. Oncology 20101201
Title: 10 years of ATAC: one question answered, many others unresolved.
Journal: The Lancet. Oncology 20101201
Title: [Advanced breast cancer in a patient achieving long-term SD after letrozole administration for liver metastasis developing during anastrozole therapy].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20101201
Title: In vitro and in vivo oxidative metabolism and glucuronidation of anastrozole.
Journal: British journal of clinical pharmacology 20101201
Title: Effect of soy isoflavones on breast cancer recurrence and death for patients receiving adjuvant endocrine therapy.
Journal: CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20101123
Title: Cognitive changes associated with endocrine therapy for breast cancer.
Journal: Maturitas 20101101
Title: Synthesis of bioactive polyheterocyclic ring systems as 5α-reductase inhibitors.
Journal: European journal of medicinal chemistry 20101101
Title: Suppression of ovarian function in combination with an aromatase inhibitor as treatment for advanced breast cancer in pre-menopausal women.
Journal: European journal of cancer (Oxford, England : 1990) 20101101
Title: Genome-wide associations and functional genomic studies of musculoskeletal adverse events in women receiving aromatase inhibitors.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20101101
Title: What is the value of the 21 gene recurrence score in HER2-negative patients?
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20101101
Title: Combining luteinising hormone releasing hormone agonists and aromatase inhibitors in breast cancer.
Journal: European journal of cancer (Oxford, England : 1990) 20101101
Title: Anastrozole.
Journal: Expert opinion on drug safety 20101101
Title: Optimizing clinical benefits of bisphosphonates in cancer patients with bone metastases.
Journal: The oncologist 20101101
Title: [A case of stage IV breast cancer with bone metastases that responded well for long-term to hormonal therapy].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20101101
Title: 3-Ethyl-4-[3-(1H-imidazol-1-yl)prop-yl]-5-phenyl-4H-1,2,4-triazole dihydrate.
Journal: Acta crystallographica. Section E, Structure reports online 20101101
Title: Clinical usefulness of high-dose toremifene in patients relapsed on treatment with an aromatase inhibitor.
Journal: Breast cancer (Tokyo, Japan) 20101001
Title: Concurrent administration of chemo-endocrine therapy for postmenopausal breast cancer patients.
Journal: Breast cancer (Tokyo, Japan) 20101001
Title: Antiproliferative effects of anastrozole, methotrexate, and 5-fluorouracil on endometriosis in vitro and in vivo.
Journal: Fertility and sterility 20101001
Title: Endocrine therapy is associated with low performance on some estrogen-sensitive cognitive tasks in postmenopausal women with breast cancer.
Journal: Journal of clinical and experimental neuropsychology 20101001
Title: Development and validation of a liquid chromatography-tandem mass spectrometry method for the simultaneous quantification of tamoxifen, anastrozole, and letrozole in human plasma and its application to a clinical study.
Journal: Analytical and bioanalytical chemistry 20101001
Title: Cost effectiveness of letrozole versus anastrozole in postmenopausal women with HR+ early-stage breast cancer.
Journal: Current medical research and opinion 20101001
Title: Prevention and treatment of side-effects of systemic treatment: bone loss.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20101001
Title: Endocrine therapy for male breast cancer: rates of toxicity and adherence.
Journal: Current oncology (Toronto, Ont.) 20101001
Title: Bicalutamide plus anastrozole for the treatment of gonadotropin-independent precocious puberty in boys with testotoxicosis: a phase II, open-label pilot study (BATT).
Journal: Journal of pediatric endocrinology & metabolism : JPEM 20101001
Title: N-[(4-Amino-5-sulfanyl-idene-4,5-dihydro-1H-1,2,4-triazol-3-yl)meth-yl]-4-methyl-benzamide.
Journal: Acta crystallographica. Section E, Structure reports online 20101001
Title: 3,3'-Dimethyl-4,4'-(hexane-1,6-di-yl)bis-[1H-1,2,4-triazol-5(4H)-one].
Journal: Acta crystallographica. Section E, Structure reports online 20101001
Title: Neoadjuvant endocrine therapy in primary breast cancer: indications and use as a research tool.
Journal: British journal of cancer 20100907
Title: ETAR antagonist ZD4054 exhibits additive effects with aromatase inhibitors and fulvestrant in breast cancer therapy, and improves in vivo efficacy of anastrozole.
Journal: Breast cancer research and treatment 20100901
Title: Amelioration of sexual adverse effects in the early breast cancer patient.
Journal: Journal of cancer survivorship : research and practice 20100901
Title: Phase II trial of anastrozole plus goserelin in the treatment of hormone receptor-positive, metastatic carcinoma of the breast in premenopausal women.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100901
Title: Bicalutamide and third-generation aromatase inhibitors in testotoxicosis.
Journal: Pediatrics 20100901
Title: Quality of life in hormone receptor-positive HER-2+ metastatic breast cancer patients during treatment with letrozole alone or in combination with lapatinib.
Journal: The oncologist 20100901
Title: Optimal adjuvant hormonal therapy in postmenopausal women with hormone-receptor-positive early breast cancer: have we answered the question?
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20100901
Title: Use of aromatase inhibitors in children and adolescents: what's new?
Journal: Current opinion in pediatrics 20100801
Title: Systematic review of aromatase inhibitors in the first-line treatment for hormone sensitive advanced or metastatic breast cancer.
Journal: Breast cancer research and treatment 20100801
Title: Cost-effectiveness of zoledronic acid plus endocrine therapy in premenopausal women with hormone-responsive early breast cancer.
Journal: Clinical breast cancer 20100801
Title: [An elderly advanced breast cancer with a good response to anastrozole].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20100801
Title: [A case of breast meningeal carcinomatosis caused by trastuzumab treatment as adjuvant chemotherapy].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20100801
Title: Early recurrence risk: aromatase inhibitors versus tamoxifen.
Journal: Expert review of anticancer therapy 20100801
Title: Predictors of recurrence in breast cancer patients with a pathologic complete response after neoadjuvant chemotherapy.
Journal: British journal of cancer 20100727
Title: Inflammatory cytokines and aromatase inhibitor-associated musculoskeletal syndrome: a case-control study.
Journal: British journal of cancer 20100727
Title: Effect of body mass index on recurrences in tamoxifen and anastrozole treated women: an exploratory analysis from the ATAC trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100720
Title: Obesity and hormone therapy in breast cancer: an unfinished puzzle.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100720
Title: Adverse events and bone health during anastrozole therapy in postmenopausal Japanese breast cancer patients.
Journal: Breast cancer (Tokyo, Japan) 20100701
Title: A simple, selective and rapid validated method for estimation of anastrazole in human plasma by liquid chromatography-tandem mass spectrometry and its application to bioequivalence study.
Journal: Biomedical chromatography : BMC 20100701
Title: Vitamin D deficiency and bone mineral density in postmenopausal women receiving aromatase inhibitors for early breast cancer.
Journal: Maturitas 20100701
Title: Mean platelet volume increase after tamoxifen, but not after anastrazole in adjuvant therapy of breast cancer.
Journal: Medical oncology (Northwood, London, England) 20100601
Title: Exemestane as first-line therapy in postmenopausal women with recurrent or metastatic breast cancer.
Journal: American journal of clinical oncology 20100601
Title: Aromatase inhibition in male breast cancer patients: biological and clinical implications.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20100601
Title: Secretagogue type, sex-steroid milieu, and abdominal visceral adiposity individually determine secretagogue-stimulated cortisol secretion.
Journal: European journal of endocrinology 20100601
Title: Phase III randomized adjuvant study of tamoxifen alone versus sequential tamoxifen and anastrozole in Japanese postmenopausal women with hormone-responsive breast cancer: N-SAS BC03 study.
Journal: Breast cancer research and treatment 20100601
Title: Gene expression profiling and prediction of response to hormonal neoadjuvant treatment with anastrozole in surgically resectable breast cancer.
Journal: Breast cancer research and treatment 20100601
Title: Rectal metastasis from lobular carcinoma of the breast: a case report.
Journal: Collegium antropologicum 20100601
Title: [Inhibitory effect on estrogen production and its influence on invasive ability of human endometrial cells of endometriosis by medicated serum of SLW].
Journal: Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica 20100601
Title: Ethyl 4-(3-ethyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-4-yl)benzoate.
Journal: Acta crystallographica. Section E, Structure reports online 20100601
Title: Transdermal patches for site-specific delivery of anastrozole: In vitro and local tissue disposition evaluation.
Journal: International journal of pharmaceutics 20100531
Title: Effect of aromatase inhibitors on ectopic endometrial growth and peritoneal environment in a mouse model of endometriosis.
Journal: Fertility and sterility 20100515
Title: Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19).
Journal: Bioorganic & medicinal chemistry letters 20100515
Title: Adjuvant aromatase inhibitor therapy: outcomes and safety.
Journal: Cancer treatment reviews 20100501
Title: Concordance between semiquantitative immunohistochemical assay and oncotype DX RT-PCR assay for estrogen and progesterone receptors.
Journal: Applied immunohistochemistry & molecular morphology : AIMM 20100501
Title: Comparison of the effects of raloxifene and anastrozole on experimental endometriosis.
Journal: European journal of obstetrics, gynecology, and reproductive biology 20100501
Title: Breast cancer risk assessment in a mammography screening program and participation in the IBIS-II chemoprevention trial.
Journal: Breast cancer research and treatment 20100501
Title: Adjuvant endocrine therapy for early breast cancer: the story so far.
Journal: Cancer investigation 20100501
Title: [A case of recurrence of breast cancer 36 years after mastectomy treated with endocrine and chemotherapy].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20100501
Title: Breast cancer in the personal genomics era.
Journal: Current genomics 20100501
Title: Phosphorylation of the mutant K303R estrogen receptor alpha at serine 305 affects aromatase inhibitor sensitivity.
Journal: Oncogene 20100422
Title: Variation in anastrozole metabolism and pharmacodynamics in women with early breast cancer.
Journal: Cancer research 20100415
Title: Epidemiology and pathophysiology of cancer-associated thrombosis.
Journal: British journal of cancer 20100413
Title: Prediction of risk of distant recurrence using the 21-gene recurrence score in node-negative and node-positive postmenopausal patients with breast cancer treated with anastrozole or tamoxifen: a TransATAC study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100410
Title: Analysis of hormone antagonists in clinical and municipal wastewater by isotopic dilution liquid chromatography tandem mass spectrometry.
Journal: Analytical and bioanalytical chemistry 20100401
Title: Nationwide drug-dispensing data reveal important differences in adherence to drug label recommendations on CYP2D6-dependent drug interactions.
Journal: British journal of clinical pharmacology 20100401
Title: [Clinical significance and pathological evaluation of neoadjuvant chemotherapy in breast cancer].
Journal: Zhonghua bing li xue za zhi = Chinese journal of pathology 20100401
Title: The effects of adding zoledronic acid to neoadjuvant chemotherapy on tumour response: exploratory evidence for direct anti-tumour activity in breast cancer.
Journal: British journal of cancer 20100330
Title: Phase II, randomized trial to compare anastrozole combined with gefitinib or placebo in postmenopausal women with hormone receptor-positive metastatic breast cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20100315
Title: Highly potent first examples of dual aromatase-steroid sulfatase inhibitors based on a biphenyl template.
Journal: Journal of medicinal chemistry 20100311
Title: [Goserelin plus anastrozole in the treatment of premenopausal patients with metastatic breast cancer].
Journal: Zhonghua yi xue za zhi 20100302
Title: Long-term endometrial effects in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES)--a randomised controlled trial of exemestane versus continued tamoxifen after 2-3 years tamoxifen.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20100301
Title: Treatment of advanced uterine leiomyosarcoma with aromatase inhibitors.
Journal: Gynecologic oncology 20100301
Title: Relationship between plasma estradiol levels and estrogen-responsive gene expression in estrogen receptor-positive breast cancer in postmenopausal women.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100301
Title: [Management of metastatic HER2-positive breast cancer: present and future].
Journal: Bulletin du cancer 20100301
Title: Targeting signal transduction pathways in metastatic breast cancer: a comprehensive review.
Journal: The oncologist 20100301
Title: Question 2. Which medications effectively reduce pubertal gynaecomastia?
Journal: Archives of disease in childhood 20100301
Title: [Inhibitory effect of Jiawei Sanleng pill medicated serum on estrogen production and its influence on apoptosis of human endometrial cells of endometriosis].
Journal: Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials 20100301
Title: Evaluation of plasma and tissue estrogen suppression with third-generation aromatase inhibitors: of relevance to clinical understanding?
Journal: The Journal of steroid biochemistry and molecular biology 20100227
Title: Impact of aromatase inhibitors on bone health in breast cancer patients.
Journal: The Journal of steroid biochemistry and molecular biology 20100227
Title: Molecular characterization of aromatase inhibitor-resistant, tamoxifen-resistant and LTEDaro cell lines.
Journal: The Journal of steroid biochemistry and molecular biology 20100227
Title: Prevention of aromatase inhibitor-induced bone loss using risedronate: the SABRE trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100220
Title: Assessment of fracture risk in women with breast cancer using current vs emerging guidelines.
Journal: British journal of cancer 20100216
Title: Low-molecular-weight cyclin E can bypass letrozole-induced G1 arrest in human breast cancer cells and tumors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20100215
Title: Potential role of UGT pharmacogenetics in cancer treatment and prevention: focus on tamoxifen and aromatase inhibitors.
Journal: Drug metabolism reviews 20100201
Title: Musculoskeletal manifestations in patients with malignant disease.
Journal: Clinical rheumatology 20100201
Title: A study of the effects of the aromatase inhibitors anastrozole and letrozole on bone metabolism in postmenopausal women with estrogen receptor-positive breast cancer.
Journal: Breast cancer research and treatment 20100201
Title: Switching from tamoxifen to aromatase inhibitors for adjuvant endocrine therapy in postmenopausal patients with early breast cancer.
Journal: Cancer treatment reviews 20100201
Title: [A negative first-line work-up of Raynaud's phenomenon: And what if it were cancer?].
Journal: Journal des maladies vasculaires 20100201
Title: Effect of a switch of aromatase inhibitors on musculoskeletal symptoms in postmenopausal women with hormone-receptor-positive breast cancer: the ATOLL (articular tolerance of letrozole) study.
Journal: Breast cancer research and treatment 20100201
Title: A comparison of anastrozole and testosterone versus placebo and testosterone for treatment of sexual dysfunction in men with epilepsy and hypogonadism.
Journal: Epilepsy & behavior : E&B 20100201
Title: Tamoxifen malabsorption after Roux-en-Y gastric bypass surgery: case series and review of the literature.
Journal: Pharmacotherapy 20100201
Title: Understanding resistance to endocrine agents: molecular mechanisms and potential for intervention.
Journal: Clinical breast cancer 20100201
Title: Lapatinib plus letrozole as first-line therapy for HER-2+ hormone receptor-positive metastatic breast cancer.
Journal: The oncologist 20100201
Title: Management of hot flashes in women with breast cancer.
Journal: Current oncology (Toronto, Ont.) 20100201
Title: Management of aromatase inhibitor-induced arthralgia.
Journal: Current oncology (Toronto, Ont.) 20100201
Title: Endometriosis: in search of optimal treatment.
Journal: Minerva ginecologica 20100201
Title: 1-Benzoyl-methyl-3-(2-thienylmeth-yl)-4-(2-thienylmethyl-eneamino)-1H-1,2,4-triazol-5(4H)-one.
Journal: Acta crystallographica. Section E, Structure reports online 20100201
Title: Lack of association between oestrogen receptor polymorphisms and change in bone mineral density with tamoxifen therapy.
Journal: British journal of cancer 20100119
Title: A randomized trial exploring the biomarker effects of neoadjuvant sequential treatment with exemestane and anastrozole in post-menopausal women with hormone receptor-positive breast cancer.
Journal: Breast cancer research and treatment 20100101
Title: Functional genetic polymorphisms in the aromatase gene CYP19 vary the response of breast cancer patients to neoadjuvant therapy with aromatase inhibitors.
Journal: Cancer research 20100101
Title: Co-inhibition of BCL-W and BCL2 restores antiestrogen sensitivity through BECN1 and promotes an autophagy-associated necrosis.
Journal: PloS one 20100101
Title: Accelerated hypofractionated radiotherapy as adjuvant regimen after conserving surgery for early breast cancer: interim report of toxicity after a minimum follow up of 3 years.
Journal: Journal of experimental & clinical cancer research : CR 20100101
Title: A polymorphism at the 3'-UTR region of the aromatase gene defines a subgroup of postmenopausal breast cancer patients with poor response to neoadjuvant letrozole.
Journal: BMC cancer 20100101
Title: [Endometrial stromal sarcoma: complete response to therapy with aromatase-inhibitor, anastrozole].
Journal: Voprosy onkologii 20100101
Title: Cost-effectiveness analysis of anastrozole versus tamoxifen in adjuvant therapy for early-stage breast cancer - a health-economic analysis based on the 100-month analysis of the ATAC trial and the German health system.
Journal: Onkologie 20100101
Title: Management of anastrozole-induced bone loss in breast cancer patients with oral risedronate: results from the ARBI prospective clinical trial.
Journal: Breast cancer research : BCR 20100101
Title: Adding zoledronic acid to endocrine therapy in the adjuvant treatment of hormone-sensitive breast cancer in premenopausal women: a new care standard or a provocative idea?
Journal: Current oncology reports 20100101
Title: Gynaecomastia: the anastrozole paradox.
Journal: Journal of pediatric endocrinology & metabolism : JPEM 20100101
Title: Responsiveness to PI3K and MEK inhibitors in breast cancer. Use of a 3D culture system to study pathways related to hormone independence in mice.
Journal: PloS one 20100101
Title: Classical and Novel Prognostic Markers for Breast Cancer and their Clinical Significance.
Journal: Clinical Medicine Insights. Oncology 20100101
Title: Dynamic changes in gene expression in vivo predict prognosis of tamoxifen-treated patients with breast cancer.
Journal: Breast cancer research : BCR 20100101
Title: Managing bone mineral density with oral bisphosphonate therapy in women with breast cancer receiving adjuvant aromatase inhibition.
Journal: Breast cancer research : BCR 20100101
Title: Small cell neuroendocrine tumor of the breast in a 40 year-old woman: a case report.
Journal: Journal of medical case reports 20100101
Title: Results of the Zometa cost-utility model for the german healthcare system based on the results of the ABCSG-12 study.
Journal: Onkologie 20100101
Title: A rare case of breast cancer metastasis.
Journal: Breast disease 20100101
Title: Changes in expression of oestrogen regulated and proliferation genes with neoadjuvant treatment highlight heterogeneity of clinical resistance to the aromatase inhibitor, letrozole.
Journal: Breast cancer research : BCR 20100101
Title: Alternative strategies for the treatment of classical congenital adrenal hyperplasia: pitfalls and promises.
Journal: International journal of pediatric endocrinology 20100101
Title: The differences in outcome between ATAC and BIG 1-98 suggest efficacy differences between these two nonsteroidal AIs.
Journal: Cancer investigation 20100101
Title: Clinical practice decisions in endocrine therapy.
Journal: Cancer investigation 20100101
Title: The ATAC adjuvant breast-cancer trial: six-year results of the endometrial subprotocol.
Journal: Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology 20100101
Title: Managing bone health in women with breast cancer under adjuvant treatment with aromatase inhibitors: pretreatment bone mineral density is important.
Journal: Breast cancer research : BCR 20100101
Title: Constitutively nuclear FOXO3a localization predicts poor survival and promotes Akt phosphorylation in breast cancer.
Journal: PloS one 20100101
Title: Musculoskeletal adverse events associated with adjuvant aromatase inhibitors.
Journal: Journal of oncology 20100101
Title: [Cost-benefit analysis of anastrazol and tamoxifen in adjuvant treatment of hormone receptor-positive, post-menopausal breast cancer].
Journal: Biomedica : revista del Instituto Nacional de Salud 20100101
Title: ExaCT: automatic extraction of clinical trial characteristics from journal publications.
Journal: BMC medical informatics and decision making 20100101
Title: Finasteride and Male Breast Cancer: Does the MHRA Report Show a Link?
Journal: Journal of cutaneous and aesthetic surgery 20100101
Title: Reduction of radiation pneumonitis by V20-constraints in breast cancer.
Journal: Radiation oncology (London, England) 20100101
Title: Present and future evolution of advanced breast cancer therapy.
Journal: Breast cancer research : BCR 20100101
Title: Women and bone health: maximizing the benefits of aromatase inhibitor therapy.
Journal: Oncology 20100101
Title: Antiangiogenic therapy for breast cancer.
Journal: Breast cancer research : BCR 20100101
Title: Expression of estrogen receptor beta and phosphorylation of estrogen receptor alpha serine 167 correlate with progression-free survival in patients with metastatic breast cancer treated with aromatase inhibitors.
Journal: Oncology 20100101
Title: The Brustkrebs-Studien.de website for breast cancer patients: User acceptance of a German internet portal offering information on the disease and treatment options, and a clinical trials matching service.
Journal: BMC cancer 20100101
Title: Ligands specify estrogen receptor alpha nuclear localization and degradation.
Journal: BMC cell biology 20100101
Title: Hot flashes in breast cancer survivors and an association with calcium supplement use.
Journal: International journal of women's health 20100101
Title: Quality of life of breast cancer patients medicated with anti-estrogens, 2 years after acupuncture treatment: a qualitative study.
Journal: International journal of women's health 20100101
Title: Prevention of bone metastases and management of bone health in early breast cancer.
Journal: Breast cancer research : BCR 20100101
Title: Designing adjuvant treatment based on biological measurements in the neoadjuvant setting.
Journal: Breast cancer research : BCR 20100101
Title: Genome-wide case-control study of musculoskeletal adverse events and functional genomics in women receiving aromatase inhibitors: going beyond associations.
Journal: Breast cancer research : BCR 20100101
Title: Evaluation of ketorolac tromethamine microspheres by chitosan/gelatin B complex coacervation.
Journal: Scientia pharmaceutica 20100101
Title: Tailoring adjuvant endocrine therapy for postmenopausal breast cancer: a CYP2D6 multiple-genotype-based modeling analysis and validation.
Journal: PloS one 20100101
Title: Role of lapatinib in the first-line treatment of patients with metastatic breast cancer.
Journal: Cancer management and research 20100101
Title: FACE: the barefaced facts of AI potency.
Journal: Cancer management and research 20100101
Title: Effects of exemestane, anastrozole and tamoxifen on bone mineral density and bone turnover markers in postmenopausal early breast cancer patients: results of N-SAS BC 04, the TEAM Japan substudy.
Journal: Oncology 20100101
Title: Safety and tolerability of zoledronic acid and other bisphosphonates in osteoporosis management.
Journal: Drug, healthcare and patient safety 20100101
Title: Endometrial adenocarcinoma in a 27-year-old woman.
Journal: Clinical medicine insights. Case reports 20100101
Title: Pharmacoeconomic considerations in the treatment of breast cancer.
Journal: ClinicoEconomics and outcomes research : CEOR 20100101
Title: The role of funding and policies on innovation in cancer drug development.
Journal: Ecancermedicalscience 20100101
Title: Safe practice and nursing care of patients receiving oral anti-cancer medicines: a position statement from UKONS.
Journal: Ecancermedicalscience 20100101
Title: Inflammatory osteoarthritis which was precipitated by Arimidex and resolved with tamoxifen.
Journal: BMJ case reports 20100101
Title: Role of aromatase inhibitors in the upfront adjuvant hormonal therapy of postmenopausal patients with breast cancer.
Journal: Indian journal of surgical oncology 20100101
Title: Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis.
Journal: Ontario health technology assessment series 20100101
Title: Potent and selective steroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 7, an enzyme that catalyzes the reduction of the key hormones estrone and dihydrotestosterone.
Journal: Journal of medicinal chemistry 20091210
Title: Effects of aromatase inhibition on bone mineral density and bone turnover in older men with low testosterone levels.
Journal: The Journal of clinical endocrinology and metabolism 20091201
Title: CITED2 and NCOR2 in anti-oestrogen resistance and progression of breast cancer.
Journal: British journal of cancer 20091201
Title: CYP2C8 and CYP2C9 polymorphisms in relation to tumour characteristics and early breast cancer related events among 652 breast cancer patients.
Journal: British journal of cancer 20091201
Title: Clinical use of selective estrogen receptor modulators and down regulators with the main focus on breast cancer.
Journal: Minerva ginecologica 20091201
Title: Hormonal deprivation therapy-induced osteoporosis in postmenopausal women with breast cancer.
Journal: Best practice & research. Clinical rheumatology 20091201
Title: Testosterone: more is not always better.
Journal: The Journal of clinical endocrinology and metabolism 20091201
Title: [A case of advanced breast cancer with multiple bone metastases responding to docetaxel and high-dose toremifene as fourth-line chemo-endocrine therapy].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20091201
Title: Treatment of familial male-limited precocious puberty (testotoxicosis) with anastrozole and bicalutamide in a boy with a novel mutation in the luteinizing hormone receptor.
Journal: Journal of pediatric endocrinology & metabolism : JPEM 20091201
Title: Aromatase inhibitors to augment height: continued caution and study required.
Journal: Journal of clinical research in pediatric endocrinology 20091201
Title: How to treat hormone receptor-positive, human epidermal growth factor receptor 2-amplified breast cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20091120
Title: Trastuzumab plus anastrozole versus anastrozole alone for the treatment of postmenopausal women with human epidermal growth factor receptor 2-positive, hormone receptor-positive metastatic breast cancer: results from the randomized phase III TAnDEM study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20091120
Title: Randomized biomarker trial of anastrozole or low-dose tamoxifen or their combination in subjects with breast intraepithelial neoplasia.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20091115
Title: Effect of testosterone on E1S-sulfatase activity in non-malignant and cancerous breast cells in vitro.
Journal: The Journal of steroid biochemistry and molecular biology 20091101
Title: Retrospective analysis of concurrent vs. sequential administration of radiotherapy and hormone therapy using aromatase inhibitor for hormone receptor-positive postmenopausal breast cancer.
Journal: Anticancer research 20091101
Title: [A case of inflammatory breast cancer responding to anastrozole].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20091101
Title: [A successful case of advanced breast cancer of the elderly treated with the only breast-hormone therapy as PST].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20091101
Title: Aromatase inhibitor-induced carpal tunnel syndrome: results from the ATAC trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20091020
Title: Nuclear receptor co-activators and HER-2/neu are upregulated in breast cancer patients during neo-adjuvant treatment with aromatase inhibitors.
Journal: British journal of cancer 20091020
Title: LC and LC-MS/MS study of forced decomposition behavior of anastrozole and establishment of validated stability-indicating analytical method for impurities estimation in low dose anastrozole tablets.
Journal: Journal of pharmaceutical and biomedical analysis 20091015
Title: Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women.
Journal: The Cochrane database of systematic reviews 20091007
Title: Alternating electric fields (TTFields) inhibit metastatic spread of solid tumors to the lungs.
Journal: Clinical & experimental metastasis 20091001
Title: Effects of morphine on testosterone levels in rat C6 glioma cells: modulation by anastrozole.
Journal: Journal of cellular physiology 20091001
Title: Biological profile of oestrogen receptor positive primary breast cancers in the elderly and response to primary endocrine therapy.
Journal: Critical reviews in oncology/hematology 20091001
Title: Medical treatment for rectovaginal endometriosis: what is the evidence?
Journal: Human reproduction (Oxford, England) 20091001
Title: Aromatase inhibitors for female infertility: a systematic review of the literature.
Journal: Reproductive biomedicine online 20091001
Title: Activity of fulvestrant 500 mg versus anastrozole 1 mg as first-line treatment for advanced breast cancer: results from the FIRST study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090920
Title: Tamoxifen: the drug that came in from the cold.
Journal: British journal of cancer 20090915
Title: Clomiphene citrate or anastrozole for ovulation induction in women with polycystic ovary syndrome? A prospective controlled trial.
Journal: Fertility and sterility 20090901
Title: Vitreo-retinal traction and anastrozole use.
Journal: Breast cancer research and treatment 20090901
Title: Comparing the cost of adjuvant anastrozole with the benefits of managing less patients with relapsed breast cancer.
Journal: Breast cancer research and treatment 20090901
Title: Does confirmatory tumor biopsy alter the management of breast cancer patients with distant metastases?
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20090901
Title: Breast cancer chemoprevention - a vision not yet realized.
Journal: European journal of cancer care 20090901
Title: Strategies for maximizing growth in puberty in children with short stature.
Journal: Endocrinology and metabolism clinics of North America 20090901
Title: [Efficacy and safety of high-dose toremifene for hormone-responsive advanced or metastatic breast cancer patients with failed prior treatment by aromatase inhibitors].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20090901
Title: [Safety and compliance with UFT (tegafur and uracil) alone and in combination with hormone therapy in patients with breast cancer].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20090901
Title: A case of uterine tumour resembling ovarian sex cord tumour responding to second-line, single agent anastrazole.
Journal: Internal medicine journal 20090901
Title: Treatment of autonomous ovarian follicular cyst with long-term anastrozole therapy.
Journal: Indian journal of pediatrics 20090901
Title: Letrozole: a review of its use in the treatment of postmenopausal women with hormone-responsive early breast cancer.
Journal: Drugs 20090820
Title: Detection of cytokeratin-19 mRNA-positive cells in the peripheral blood and bone marrow of patients with operable breast cancer.
Journal: British journal of cancer 20090818
Title: A suite of activity-based probes for human cytochrome P450 enzymes.
Journal: Journal of the American Chemical Society 20090805
Title: Characterization of the weak estrogen receptor alpha agonistic activity of exemestane.
Journal: Breast cancer research and treatment 20090801
Title: Cognitive effects of hormonal therapy in early stage breast cancer patients: a prospective study.
Journal: Psycho-oncology 20090801
Title: Improved survival in patients with breast rhabdoid tumors with multi-agent adjuvant chemotherapy combined with irradiation.
Journal: Cancer chemotherapy and pharmacology 20090801
Title: Pharmacokinetics and pharmacodynamics of anastrozole in pubertal boys with recent-onset gynecomastia.
Journal: The Journal of clinical endocrinology and metabolism 20090801
Title: Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20090801
Title: Fulvestrant treatment is associated with cholesterol plasma level reduction in hormone-receptor-positive metastatic breast cancer patients.
Journal: Cancer biology & therapy 20090801
Title: Clinical perspectives on the utility of aromatase inhibitors for the adjuvant treatment of breast cancer.
Journal: Breast (Edinburgh, Scotland) 20090801
Title: A remarkable case of cutaneous metastatic breast carcinoma.
Journal: Dermatology online journal 20090715
Title: Drug-induced pruritic micropapular eruption: anastrozole, a commonly used aromatase inhibitor.
Journal: Dermatology online journal 20090715
Title: The Global Longitudinal Study of Osteoporosis in Women (GLOW): rationale and study design.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20090701
Title: Hemicentral retinal artery occlusion in a breast cancer patient using anastrozole.
Journal: Onkologie 20090701
Title: Metastasis of lobular breast carcinoma to the uterus in a patient under anastrozole therapy.
Journal: Onkologie 20090701
Title: Promising effect of aromatase inhibitors on recurrent granulosa cell tumors.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20090701
Title: Aromatase inhibitors for ovulation and pregnancy in polycystic ovary syndrome.
Journal: The Annals of pharmacotherapy 20090701
Title: An updated review on the efficacy of adjuvant endocrine therapies in hormone receptor-positive early breast cancer.
Journal: Current oncology (Toronto, Ont.) 20090701
Title: Safety of adjuvant endocrine therapies in hormone receptor-positive early breast cancer.
Journal: Current oncology (Toronto, Ont.) 20090701
Title: Comparison of the effect of the aromatase inhibitor, anastrazole, to the antioestrogen, tamoxifen citrate, on canine prostate and semen.
Journal: Reproduction in domestic animals = Zuchthygiene 20090701
Title: Incidence of joint symptoms and bone fractures in Japanese postmenopausal breast cancer patients treated with adjuvant anastrozole.
Journal: Journal of cancer research and clinical oncology 20090601
Title: History of aromatase: saga of an important biological mediator and therapeutic target.
Journal: Endocrine reviews 20090601
Title: 21-Gene expression profile assay on core needle biopsies predicts responses to neoadjuvant endocrine therapy in breast cancer patients.
Journal: Breast (Edinburgh, Scotland) 20090601
Title: Comparative review of anastrozole, letrozole and exemestane in the management of early breast cancer.
Journal: Expert opinion on pharmacotherapy 20090601
Title: Expression of the K303R estrogen receptor-alpha breast cancer mutation induces resistance to an aromatase inhibitor via addiction to the PI3K/Akt kinase pathway.
Journal: Cancer research 20090601
Title: Differential effects of aromatase inhibitors and antiestrogens on estrogen receptor expression in breast cancer cells.
Journal: Anticancer research 20090601
Title: Enhancing the efficacy of hormonal agents with selected targeted agents.
Journal: Clinical breast cancer 20090601
Title: Endocrine therapy plus zoledronic acid in premenopausal breast cancer.
Journal: The New England journal of medicine 20090528
Title: Endocrine therapy plus zoledronic acid in premenopausal breast cancer.
Journal: The New England journal of medicine 20090528
Title: Endocrine therapy plus zoledronic acid in premenopausal breast cancer.
Journal: The New England journal of medicine 20090528
Title: Endocrine therapy plus zoledronic acid in premenopausal breast cancer.
Journal: The New England journal of medicine 20090528
Title: Endocrine therapy plus zoledronic acid in premenopausal breast cancer.
Journal: The New England journal of medicine 20090528
Title: Endocrine therapy plus zoledronic acid in premenopausal breast cancer.
Journal: The New England journal of medicine 20090528
Title: Combined Src and aromatase inhibition impairs human breast cancer growth in vivo and bypass pathways are activated in AZD0530-resistant tumors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20090515
Title: Follicular and endocrine response to anastrozole versus clomiphene citrate administered in follicular phase to normoovulatory women: a randomized comparison.
Journal: Fertility and sterility 20090501
Title: Fulvestrant for systemic therapy of locally advanced or metastatic breast cancer in postmenopausal women: a systematic review.
Journal: Breast cancer research and treatment 20090501
Title: A woman's heart: the impact of adjuvant endocrine therapy on cardiovascular health.
Journal: Cancer 20090501
Title: Combined down-regulation by aromatase inhibitor and GnRH-agonist in IVF patients with endometriomas-A pilot study.
Journal: European journal of obstetrics, gynecology, and reproductive biology 20090501
Title: Sustained effect of the aromatase inhibitors anastrozole and letrozole on endometrial thickness in patients with endometrial hyperplasia and endometrial carcinoma.
Journal: Current medical research and opinion 20090501
Title: [Nineteen years postoperatively, anastrozole, UFT and cyclophosphamide combination therapy remained effective against recurrent hormone responsive breast cancer with intraabdominal lymphnode, pleural, skin and bone metastases in old age following sixteen-year tamoxifen treatment - a case report].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20090501
Title: [Inhibitory effect of Sanlengwan on expression of adhesion molecules ICAM-1, CD44 in rats of endometriosis].
Journal: Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica 20090501
Title: 2-Benzoylmethyl-4-[(2-benzylidene-ethylidene)amino]-5-(2-thienylmethyl)-2H-1,2,4-triazol-3(4H)-one.
Journal: Acta crystallographica. Section E, Structure reports online 20090501
Title: 4-[(E)-4-Methoxy-benzyl-ideneamino]-3-{1-[4-(2-methyl-prop-yl)phen-yl]eth-yl}-1H-1,2,4-triazole-5(4H)-thione.
Journal: Acta crystallographica. Section E, Structure reports online 20090501
Title: A randomised study of the effects of letrozole and anastrozole on oestrogen receptor positive breast cancers in postmenopausal women.
Journal: Breast cancer research and treatment 20090401
Title: Successful treatment of refractory endometriosis-related chronic pelvic pain with aromatase inhibitors in premenopausal patients.
Journal: European journal of obstetrics, gynecology, and reproductive biology 20090401
Title: Initial treatment and changes in adjuvant endocrine therapy for early stage breast cancer.
Journal: Breast (Edinburgh, Scotland) 20090401
Title: [A case of metastatic breast cancer resistant to anastrozole treatment responding to high-dose toremifene].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20090401
Title: By the way, doctor. I'm 78. I had breast cancer nine years ago and have been taking Arimidex for six years. I have pain and some bleeding after intercourse, despite using Astroglide. My gynecologist prescribed vaginal estrogen cream. Is that safe for me?
Journal: Harvard women's health watch 20090401
Title: Anastrozole Use in Early Stage Breast Cancer of Post-Menopausal Women.
Journal: Clinical medicine. Therapeutics 20090331
Title: Poor survival outcomes in HER2-positive breast cancer patients with low-grade, node-negative tumours.
Journal: British journal of cancer 20090310
Title: Long-term effectiveness of adjuvant goserelin in premenopausal women with early breast cancer.
Journal: Journal of the National Cancer Institute 20090304
Title: Lack of complete cross-resistance between different aromatase inhibitors; a real finding in search for an explanation?
Journal: European journal of cancer (Oxford, England : 1990) 20090301
Title: Aromatase and 5alpha-reductase inhibition during an exogenous testosterone clamp unveils selective sex steroid modulation of somatostatin and growth hormone secretagogue actions in healthy older men.
Journal: The Journal of clinical endocrinology and metabolism 20090301
Title: Adherence to adjuvant endocrine therapy in postmenopausal women with breast cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20090301
Title: Future targets in endometriosis treatment: targeting the endometriotic implant.
Journal: Mini reviews in medicinal chemistry 20090301
Title: [Adjuvant breast cancer treatment with hormono-radiotherapy].
Journal: Bulletin du cancer 20090301
Title: 3-[1-(4-Isobutyl-phen-yl)eth-yl]-1H-1,2,4-triazole-5(4H)-thione.
Journal: Acta crystallographica. Section E, Structure reports online 20090301
Title: The total hospital and community UK costs of managing patients with relapsed breast cancer.
Journal: British journal of cancer 20090224
Title: Endocrine therapy plus zoledronic acid in premenopausal breast cancer.
Journal: The New England journal of medicine 20090212
Title: Exemestane as primary treatment of oestrogen receptor-positive breast cancer in postmenopausal women: a phase II trial.
Journal: British journal of cancer 20090210
Title: A case of benign metastasizing leiomyoma treated by surgical castration followed by an aromatase inhibitor, anastrozole.
Journal: Archives of gynecology and obstetrics 20090201
Title: Treating elderly patients with hormone sensitive breast cancer: what do the data show?
Journal: Cancer treatment reviews 20090201
Title: Aromatase inhibitors and bone health.
Journal: Current opinion in obstetrics & gynecology 20090201
Title: Predictors and temporal trends of adjuvant aromatase inhibitor use in breast cancer.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN 20090201
Title: [A case of metastatic breast cancer with liver metastasis effectively treated with capecitabine and vinorelbine].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20090201
Title: Phase 3 trials of aromatase inhibitors for breast cancer prevention: following in the path of the selective estrogen receptor modulators.
Journal: Annals of the New York Academy of Sciences 20090201
Title: Aromatase inhibitors and breast cancer.
Journal: Annals of the New York Academy of Sciences 20090201
Title: A comparative study of exemestane versus anastrozole in patients with postmenopausal breast cancer with visceral metastases.
Journal: Clinical breast cancer 20090201
Title: Action of aromatase inhibitor for treatment of uterine leiomyoma in perimenopausal patients.
Journal: Fertility and sterility 20090101
Title: Long-term disease-free survival after hormonal therapy of a patient with recurrent low grade endometrial stromal sarcoma: a case report.
Journal: Archives of gynecology and obstetrics 20090101
Title: Start strong or switch? Adjuvant endocrine strategies for postmenopausal women with hormone-sensitive breast cancer.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20090101
Title: A lower incidence of gynecologic adverse events and interventions with anastrozole than with tamoxifen in the ATAC trial.
Journal: American journal of obstetrics and gynecology 20090101
Title: Effects of 17beta-estradiol on rat urinary bladder: gender differences in anoxia-glucopenia and reperfusion damage.
Journal: Neurourology and urodynamics 20090101
Title: Pregnancy outcome after ovulation induction with aromatase inhibitors or clomiphene citrate in unexplained infertility.
Journal: Acta obstetricia et gynecologica Scandinavica 20090101
Title: The Coffey Lecture: steroidogenic enzyme inhibitors and hormone dependent cancer.
Journal: Urologic oncology 20090101
Title: Vitamin D insufficiency and musculoskeletal symptoms in breast cancer survivors on aromatase inhibitor therapy.
Journal: Cancer nursing 20090101
Title: Hypothesis: primary antiangiogenic method proposed to treat early stage breast cancer.
Journal: BMC cancer 20090101
Title: Update on the role of aromatase inhibitors in growth disorders.
Journal: Hormone research 20090101
Title: Prevalence, sources, and predictors of soy consumption in breast cancer.
Journal: Nutrition journal 20090101
Title: [Clinical course of multiple sclerosis in patients treated with cytostatic drugs for cancer].
Journal: Revista de neurologia 20090101
Title: Breast cancer in young women and its impact on reproductive function.
Journal: Human reproduction update 20090101
Title: Are we HER-ting for innovation in neoadjuvant breast cancer trial design?
Journal: Breast cancer research : BCR 20090101
Title: Gynecomastia: what the surgeon needs to know.
Journal: Eplasty 20090101
Title: Side effects of anastrozole in the experimental pre-menopausal mammary carcinogenesis.
Journal: Neoplasma 20090101
Title: Diagnosis and treatment of early breast cancer, including locally advanced disease--summary of NICE guidance.
Journal: BMJ (Clinical research ed.) 20090101
Title: Risk reduction of distant metastasis in hormone-sensitive postmenopausal breast cancer.
Journal: Breast cancer (Tokyo, Japan) 20090101
Title: Collaborative work on evaluation of ovarian toxicity. 8) Two- or four-week repeated-dose studies and fertility study of Anastrozole in female rats.
Journal: The Journal of toxicological sciences 20090101
Title: Successful desensitisation to Anastrozole.
Journal: Allergologia et immunopathologia 20090101
Title: Lapatinib plus capecitabine resolved human epidermal growth factor receptor 2-positive brain metastases.
Journal: American journal of therapeutics 20090101
Title: Enhancing the adjuvant treatment of hormone receptor positive breast cancer.
Journal: The breast journal 20090101
Title: Immoderate inhibition of estrogen by anastrozole enhances the severity of experimental polyarthritis.
Journal: Experimental gerontology 20090101
Title: Quantitative real-time RT-PCR and chromogenic in situ hybridization: precise methods to detect HER-2 status in breast carcinoma.
Journal: BMC cancer 20090101
Title: Internal auditory canal metastasis mimicking a vestibular schwannoma at presentation - a case report and review of the literature.
Journal: International seminars in surgical oncology : ISSO 20090101
Title: Amplitude-modulated electromagnetic fields for the treatment of cancer: discovery of tumor-specific frequencies and assessment of a novel therapeutic approach.
Journal: Journal of experimental & clinical cancer research : CR 20090101
Title: The effects of endogenous and exogenous androgens on cardiovascular disease risk factors and progression.
Journal: Reproductive biology and endocrinology : RB&E 20090101
Title: A review of the use of exemestane in early breast cancer.
Journal: Therapeutics and clinical risk management 20090101
Title: Characterization of a novel small molecule subtype specific estrogen-related receptor alpha antagonist in MCF-7 breast cancer cells.
Journal: PloS one 20090101
Title: A case of brain metastases from breast cancer that responded to anastrozole monotherapy.
Journal: The breast journal 20090101
Title: Ruptured gallbladder as the first presentation of breast cancer.
Journal: World journal of surgical oncology 20090101
Title: Issues in applying multi-arm multi-stage methodology to a clinical trial in prostate cancer: the MRC STAMPEDE trial.
Journal: Trials 20090101
Title: Henoch-Schönlein purpura and aromatase inhibitors.
Journal: European journal of dermatology : EJD 20090101
Title: In situ aromatase expression in primary tumor is associated with estrogen receptor expression but is not predictive of response to endocrine therapy in advanced breast cancer.
Journal: BMC cancer 20090101
Title: Extended adjuvant hormonal therapy with exemestane has no detrimental effect on the lipid profile of postmenopausal breast cancer patients: final results of the ATENA lipid substudy.
Journal: Breast cancer research : BCR 20090101
Title: Current trends in the treatment of polycystic ovary syndrome with desire for children.
Journal: Therapeutics and clinical risk management 20090101
Title: The Gene expression Grade Index: a potential predictor of relapse for endocrine-treated breast cancer patients in the BIG 1-98 trial.
Journal: BMC medical genomics 20090101
Title: Alternative use of multiple exons 1 of aromatase gene in cancerous and normal breast tissues from women over the age of 80 years.
Journal: Breast cancer research : BCR 20090101
Title: [Criteria for evaluating the effectiveness of aromatase inhibitors in the neoadjuvant treatment of patients with endometrial carcinoma].
Journal: Voprosy onkologii 20090101
Title: Pathologic and biologic response to preoperative endocrine therapy in patients with ER-positive ductal carcinoma in situ.
Journal: BMC cancer 20090101
Title: The benefits and risks of testosterone replacement therapy: a review.
Journal: Therapeutics and clinical risk management 20090101
Title: HER2 breast cancer therapies: a review.
Journal: Biologics : targets & therapy 20090101
Title: Recent advances in systemic therapy. When HER2 is not the target: advances in the treatment of HER2-negative metastatic breast cancer.
Journal: Breast cancer research : BCR 20090101
Title: Cost-effectiveness of anastrozole, in comparison with tamoxifen, in the adjuvant treatment of early breast cancer in Brazil.
Journal: Revista da Associacao Medica Brasileira (1992) 20090101
Title: Long-term efficacy and safety of anastrozole for adjuvant treatment of early breast cancer in postmenopausal women.
Journal: Therapeutics and clinical risk management 20090101
Title: Long-term efficacy and safety of letrozole for the adjuvant treatment of early breast cancer in postmenopausal women: a review.
Journal: Therapeutics and clinical risk management 20090101
Title: A system for computerised retinal haemorrhage analysis.
Journal: BMC research notes 20090101
Title: Drugs associated with more suicidal ideations are also associated with more suicide attempts.
Journal: PloS one 20090101
Title: Can survival prediction be improved by merging gene expression data sets?
Journal: PloS one 20090101
Title: Targeting tumorigenesis: development and use of mTOR inhibitors in cancer therapy.
Journal: Journal of hematology & oncology 20090101
Title: Update on the use of aromatase inhibitors in early-stage breast cancer.
Journal: Breast cancer research : BCR 20090101
Title: Serum estradiol should be monitored not only during the peri-menopausal period but also the post-menopausal period at the time of aromatase inhibitor administration.
Journal: World journal of surgical oncology 20090101
Title: [Cost-effectiveness analysis of adjuvant anastrozol in post-menopausal women with breast cancer].
Journal: Revista da Associacao Medica Brasileira (1992) 20090101
Title: Antiproliferative effect of exemestane in lung cancer cells.
Journal: Molecular cancer 20090101
Title: Role of testosterone/estradiol ratio in predicting the efficacy of tamoxifen citrate treatment in idiopathic oligoasthenoteratozoospermic men.
Journal: Urologia internationalis 20090101
Title: Who would have thought a single Ki67 measurement would predict long-term outcome?
Journal: Breast cancer research : BCR 20090101
Title: Do BIG1-98 and ZOFAST demand a change in guidelines for endocrine therapy?
Journal: Breast cancer research : BCR 20090101
Title: Are current drug development programmes realising the full potential of new agents? The scenario.
Journal: Breast cancer research : BCR 20090101
Title: Foundation clinical trials.
Journal: Breast cancer research : BCR 20090101
Title: Are current drug development programmes realising the full potential of new agents? Tyrosine kinase inhibitors.
Journal: Breast cancer research : BCR 20090101
Title: Tailored targeted therapy for all: a realistic and worthwhile objective against.
Journal: Breast cancer research : BCR 20090101
Title: Role of neo-adjuvant hormonal therapy in the treatment of breast cancer: a review of clinical trials.
Journal: International journal of general medicine 20090101
Title: The evolving role of zoledronic acid in early breast cancer.
Journal: OncoTargets and therapy 20090101
Title: Aromatase inhibitor strategies in metastatic breast cancer.
Journal: International journal of women's health 20090101
Title: Growth factor receptors and apoptosis regulators: signaling pathways, prognosis, chemosensitivity and treatment outcomes of breast cancer.
Journal: Breast cancer : basic and clinical research 20090101
Title: Osteoporosis after breast cancer chemotherapy: a case report.
Journal: The Ochsner journal 20090101
Title: The evolution of treatment for early breast cancer: what's next?
Journal: Ecancermedicalscience 20090101
Title: Role of traditional and new biomarkers in breast carcinogenesis.
Journal: Ecancermedicalscience 20090101
Title: Economic evaluation of fulvestrant as an extra step in the treatment sequence for ER-positive advanced breast cancer.
Journal: British journal of cancer 20081209
Title: Evaluation of endometrial thickness in hormone receptor positive early stage breast cancer postmenopausal women switching from adjuvant tamoxifen treatment to anastrozole.
Journal: Breast (Edinburgh, Scotland) 20081201
Title: Never too late: reducing late breast cancer relapse risk.
Journal: Current medical research and opinion 20081201
Title: Treatment-emergent endocrine symptoms and the risk of breast cancer recurrence: a retrospective analysis of the ATAC trial.
Journal: The Lancet. Oncology 20081201
Title: Review of the ATAC study: tamoxifen versus anastrozole in early-stage breast cancer.
Journal: Expert review of anticancer therapy 20081201
Title: Optimizing aromatase inhibitor integration into initial treatment strategies in postmenopausal women with hormone-receptor-positive early breast cancer.
Journal: Breast cancer research and treatment 20081201
Title: Are all aromatase inhibitors alike?
Journal: Breast cancer research and treatment 20081201
Title: Aromatase inhibitors, efficacy and metabolic risk in the treatment of postmenopausal women with early breast cancer.
Journal: Clinical interventions in aging 20081201
Title: Exemestane in early breast cancer: a review.
Journal: Therapeutics and clinical risk management 20081201
Title: The effect of adjuvant hormonal therapy on the endometrium and ovary of breast cancer patients.
Journal: Journal of gynecologic oncology 20081201
Title: 3-[1-(4-Isobutyl-phen-yl)eth-yl]-4-[(E)-4-methyl-benzyl-ideneamino]-1H-1,2,4-triazole-5(4H)-thione.
Journal: Acta crystallographica. Section E, Structure reports online 20081201
Title: Development and validation of an improved high-throughput method for the determination of anastrozole in human plasma by LC-MS/MS and atmospheric pressure chemical ionization.
Journal: Journal of pharmaceutical and biomedical analysis 20081104
Title: Preoperative bevacizumab combined with letrozole and chemotherapy in locally advanced ER- and/or PgR-positive breast cancer: clinical and biological activity.
Journal: British journal of cancer 20081104
Title: Aromatase inhibitors in the management of early breast cancer.
Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20081101
Title: Persistent bilateral ureteral obstruction secondary to endometriosis despite treatment with an aromatase inhibitor.
Journal: Fertility and sterility 20081101
Title: Cutaneous vasculitis in breast cancer treated with chemotherapy.
Journal: Clinical immunology (Orlando, Fla.) 20081001
Title: Effects of anastrozole on cognitive performance in postmenopausal women: a randomised, double-blind chemoprevention trial (IBIS II).
Journal: The Lancet. Oncology 20081001
Title: Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics.
Journal: Journal of the National Cancer Institute 20081001
Title: Estrogen, testosterone, and sequential movement in men.
Journal: Behavioral neuroscience 20081001
Title: Letrozole is superior to anastrozole in suppressing breast cancer tissue and plasma estrogen levels.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20081001
Title: Prevention of anastrozole-induced bone loss with monthly oral ibandronate during adjuvant aromatase inhibitor therapy for breast cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20081001
Title: [A case of recurrent breast cancer with multiple lung metastases responding to anastrozole monotherapy].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20081001
Title: Safety profiles of aromatase inhibitors and selective estrogen-receptor modulators in the treatment of early breast cancer.
Journal: International journal of clinical oncology 20081001
Title: Anastrozole: brain draining or sparing?
Journal: The Lancet. Oncology 20081001
Title: Effectiveness of anastrozole and cyproterone acetate in two brothers with familial male precocious puberty.
Journal: Journal of pediatric endocrinology & metabolism : JPEM 20081001
Title: Re: Pharmacogenomic variation of CYP2D6 and the choice of optimal adjuvant endocrine therapy for postmenopausal breast cancer: a modeling analysis.
Journal: Journal of the National Cancer Institute 20080917
Title: Re: Pharmacogenomic variation of CYP2D6 and the choice of optimal adjuvant endocrine therapy for postmenopausal breast cancer: a modeling analysis.
Journal: Journal of the National Cancer Institute 20080917
Title: Recurrent endometrial carcinoma regression with the use of the aromatase inhibitor anastrozole.
Journal: American journal of obstetrics and gynecology 20080901
Title: Skeletal effects of drugs to treat cancer.
Journal: Current drug safety 20080901
Title: Risk factors for joint symptoms in patients enrolled in the ATAC trial: a retrospective, exploratory analysis.
Journal: The Lancet. Oncology 20080901
Title: Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy.
Journal: The Lancet. Oncology 20080901
Title: Screening and management of osteoporosis in breast cancer patients on aromatase inhibitors.
Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20080901
Title: IBIS II: a breast cancer prevention trial in postmenopausal women using the aromatase inhibitor anastrozole.
Journal: Expert review of anticancer therapy 20080901
Title: Improving informed consent: pilot of a decision aid for women invited to participate in a breast cancer prevention trial (IBIS-II DCIS).
Journal: Health expectations : an international journal of public participation in health care and health policy 20080901
Title: Fulvestrant--a novel estrogen receptor antagonist for the treatment of advanced breast cancer.
Journal: Drugs of today (Barcelona, Spain : 1998) 20080901
Title: tAnGo: a randomised phase III trial of gemcitabine in paclitaxel-containing, epirubicin/cyclophosphamide-based, adjuvant chemotherapy for early breast cancer: a prospective pulmonary, cardiac and hepatic function evaluation.
Journal: British journal of cancer 20080819
Title: Synthesis of 6- or 4-functionalized indoles via a reductive cyclization approach and evaluation as aromatase inhibitors.
Journal: Bioorganic & medicinal chemistry letters 20080815
Title: Target and reality of adjuvant endocrine therapy in postmenopausal patients with invasive breast cancer.
Journal: British journal of cancer 20080805
Title: Safely promoting breast-conserving surgery and preventing early relapses with an aromatase inhibitor.
Journal: Surgical oncology 20080801
Title: Short-term androgen priming by use of aromatase inhibitor and hCG before controlled ovarian stimulation for IVF. A randomized controlled trial.
Journal: Human reproduction (Oxford, England) 20080801
Title: Reducing early recurrence with adjuvant aromatase inhibitors: what is the evidence?
Journal: Breast (Edinburgh, Scotland) 20080801
Title: Successful management of a leiomyomatosis peritonealis disseminata with an aromatase inhibitor.
Journal: Obstetrics and gynecology 20080801
Title: Clinical trial presentations, agency guidelines, and oncology practice: findings from the arimidex, tamoxifen, alone or in combination trial.
Journal: Clinical breast cancer 20080801
Title: Pharmacokinetic profile of the fulvestrant loading dose regimen in postmenopausal women with hormone receptor-positive advanced breast cancer.
Journal: Clinical breast cancer 20080801
Title: Primary uterine rhabdomyosarcoma in a patient with a history of breast cancer and gastrointestinal stromal tumor.
Journal: The journal of obstetrics and gynaecology research 20080801
Title: The endocrine prevention of breast cancer.
Journal: Best practice & research. Clinical endocrinology & metabolism 20080801
Title: 4-[(E)-2-Furylmethyl-eneamino]-3-phenyl-1H-1,2,4-triazole-5(4H)-thione.
Journal: Acta crystallographica. Section E, Structure reports online 20080801
Title: MCF-7aro/ERE, a novel cell line for rapid screening of aromatase inhibitors, ERalpha ligands and ERRalpha ligands.
Journal: Biochemical pharmacology 20080715
Title: The impact of adjuvant therapy on contralateral breast cancer risk and the prognostic significance of contralateral breast cancer: a population based study in the Netherlands.
Journal: Breast cancer research and treatment 20080701
Title: Choosing early adjuvant therapy for postmenopausal women with hormone-sensitive breast cancer: aromatase inhibitors versus tamoxifen.
Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20080701
Title: The role of endocrine therapies in reducing risk of recurrence in postmenopausal women with hormone receptor-positive breast cancer.
Journal: European journal of oncology nursing : the official journal of European Oncology Nursing Society 20080701
Title: The aromatase inhibitor anastrozole is ineffective in the treatment of precocious puberty in girls with McCune-Albright syndrome.
Journal: The Journal of clinical endocrinology and metabolism 20080701
Title: Treatment of male infertility secondary to morbid obesity.
Journal: Nature clinical practice. Endocrinology & metabolism 20080701
Title: Experience with exemestane in the treatment of early and advanced breast cancer.
Journal: Expert opinion on drug metabolism & toxicology 20080701
Title: A novel method for assessing sex-specific and genotype-specific response to injury in astrocyte culture.
Journal: Journal of neuroscience methods 20080630
Title: Genome-wide analysis of aromatase inhibitor-resistant, tamoxifen-resistant, and long-term estrogen-deprived cells reveals a role for estrogen receptor.
Journal: Cancer research 20080615
Title: Risks and benefits of bisphosphonates.
Journal: British journal of cancer 20080603
Title: The in- or exclusion of non-breast cancer related death and contralateral breast cancer significantly affects estimated outcome probability in early breast cancer.
Journal: Breast cancer research and treatment 20080601
Title: Histopathological assessment of anastrozole and tamoxifen as preoperative (neoadjuvant) treatment in postmenopausal Japanese women with hormone receptor-positive breast cancer in the PROACT trial.
Journal: Journal of cancer research and clinical oncology 20080601
Title: Effectively nursing patients receiving aromatase inhibitor therapy.
Journal: Breast (Edinburgh, Scotland) 20080601
Title: Is long-term adjuvant treatment of breast cancer with anastrozole indicated?
Journal: Expert opinion on pharmacotherapy 20080601
Title: Reducing the risk of distant metastases: a better end point in adjuvant aromatase inhibitor breast cancer trials?
Journal: Cancer investigation 20080601
Title: [Adjuvant endocrine therapy in postmenopausal hormone-sensitive breast cancer: to start, to switch or to extend?].
Journal: Magyar onkologia 20080601
Title: [Extended adjuvant hormone therapy (in breast cancer): Why? To whom? What? How long?].
Journal: Magyar onkologia 20080601
Title: Encapsulation and extended release of anti-cancer anastrozole by stealth nanoparticles.
Journal: Drug delivery 20080601
Title: [Inhibitory effects of Sanlengwan on aromatase and cyclooxygenase-2 in rats of endometriosis].
Journal: Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica 20080601
Title: Switching to letrozole or exemestane improves hot flushes, mood and quality of life in tamoxifen intolerant women.
Journal: British journal of cancer 20080506
Title: Cost utility analysis of early adjuvant letrozole or anastrozole versus tamoxifen in postmenopausal women with early invasive breast cancer: the UK perspective.
Journal: The European journal of health economics : HEPAC : health economics in prevention and care 20080501
Title: Anastrozole or letrozole for ovulation induction in clomiphene-resistant women with polycystic ovarian syndrome: a prospective randomized trial.
Journal: Fertility and sterility 20080501
Title: CYP1B1 is not a major determinant of the disposition of aromatase inhibitors in epithelial cells of invasive ductal carcinoma.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20080501
Title: Process analytical technology: non-destructive assessment of anastrozole entrapment within PLGA microparticles by near infrared spectroscopy and chemical imaging.
Journal: Journal of microencapsulation 20080501
Title: Combination of anastrozole with fulvestrant in the intratumoral aromatase xenograft model.
Journal: Cancer research 20080501
Title: The effects of neoadjuvant anastrozole and tamoxifen on circulating vascular endothelial growth factor and soluble vascular endothelial growth factor receptor 1 in breast cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20080501
Title: Retinal hemorrhages in anastrozole users.
Journal: Optometry and vision science : official publication of the American Academy of Optometry 20080501
Title: Targeting breast cancer with hormonal treatment options.
Journal: The Nurse practitioner 20080501
Title: Aromatase inhibitors in adjuvant therapy for hormone receptor positive breast cancer: a systematic review.
Journal: Cancer treatment reviews 20080401
Title: Aromatase inhibitors in early breast-cancer treatment: The story so far.
Journal: Breast (Edinburgh, Scotland) 20080401
Title: Inappropriate ATAC on tamoxifen.
Journal: The Lancet. Oncology 20080401
Title: Inappropriate ATAC on tamoxifen.
Journal: The Lancet. Oncology 20080401
Title: Letrozole suppresses plasma estradiol and estrone sulphate more completely than anastrozole in postmenopausal women with breast cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080401
Title: [A case of elderly breast cancer achieving partial response by letrozole with stable disease to anastrozole as neoadjuvant endocrine therapy].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20080401
Title: Neoadjuvant endocrine therapy for breast cancer: past, present and future.
Journal: Anti-cancer drugs 20080401
Title: Anastrozole-induced subacute cutaneous lupus erythematosus.
Journal: The British journal of dermatology 20080301
Title: Anastrozole increases predicted adult height of short adolescent males treated with growth hormone: a randomized, placebo-controlled, multicenter trial for one to three years.
Journal: The Journal of clinical endocrinology and metabolism 20080301
Title: Facilitating breast-conserving surgery and preventing recurrence: aromatase inhibitors in the neoadjuvant and adjuvant settings.
Journal: Annals of surgical oncology 20080301
Title: Relationship between quantitative estrogen and progesterone receptor expression and human epidermal growth factor receptor 2 (HER-2) status with recurrence in the Arimidex, Tamoxifen, Alone or in Combination trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080301
Title: Effect of anastrozole on bone mineral density: 5-year results from the anastrozole, tamoxifen, alone or in combination trial 18233230.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080301
Title: Menopausal symptoms and adjuvant therapy-associated adverse events.
Journal: Endocrine-related cancer 20080301
Title: Anticancer therapy in patients with porphyrias: evidence today.
Journal: Expert opinion on drug safety 20080301
Title: Controversies in endocrine treatment: effective utilization of steroidal and nonsteroidal aromatase inhibitors: now and in the future. Forward.
Journal: Anti-cancer drugs 20080301
Title: Exploring the lack of cross-resistance between aromatase inhibitors: evidence for a difference?
Journal: Anti-cancer drugs 20080301
Title: [The effect of hormone therapy on cognitive function in patients with breast cancer].
Journal: Nederlands tijdschrift voor geneeskunde 20080301
Title: [Intensification of a diffuse chronic pain syndrome by the introduction of an aromatase inhibitor].
Journal: Praxis 20080206
Title: Switching to anastrozole after tamoxifen improves survival in postmenopausal women with breast cancer.
Journal: Nature clinical practice. Oncology 20080201
Title: New 7,8-benzoflavanones as potent aromatase inhibitors: synthesis and biological evaluation.
Journal: Bioorganic & medicinal chemistry 20080201
Title: Endocrine and targeted manipulation of breast cancer: summary statement for the Sixth Cambridge Conference.
Journal: Cancer 20080201
Title: Summary of aromatase inhibitor clinical trials in postmenopausal women with early breast cancer.
Journal: Cancer 20080201
Title: Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080201
Title: [Efficacy of sequential treatment with anastrozole following exemestane compared with exemestane following anastrozole in patients with metastatic breast cancer].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20080201
Title: [A 23-year delayed locoregional recurrence of breast carcinoma following mastectomy].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20080201
Title: European oncologists' preferences for the management of breast cancer: case presentations and expert commentary.
Journal: Breast (Edinburgh, Scotland) 20080201
Title: Aromatase inhibitors for breast cancer: proven efficacy across the spectrum of disease.
Journal: Clinical breast cancer 20080201
Title: Long-term safety of aromatase inhibitors in the treatment of breast cancer.
Journal: Therapeutics and clinical risk management 20080201
Title: The breast cancer continuum in hormone-receptor-positive breast cancer in postmenopausal women: evolving management options focusing on aromatase inhibitors.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20080101
Title: Increasing protection after tamoxifen: insights from the extended adjuvant aromatase inhibitor trials.
Journal: Journal of cancer research and clinical oncology 20080101
Title: Aromatase inhibitors: past, present and future in breast cancer therapy.
Journal: Medical oncology (Northwood, London, England) 20080101
Title: Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial.
Journal: The Lancet. Oncology 20080101
Title: ERBB2 status and outcome of endocrine treatment.
Journal: The Lancet. Oncology 20080101
Title: Long-term outcomes of aromatase inhibition for breast cancer.
Journal: The Lancet. Oncology 20080101
Title: Chemoprevention of breast cancer.
Journal: Breast cancer (Tokyo, Japan) 20080101
Title: Aromatase inhibitors: from bench to bedside and back.
Journal: Breast cancer (Tokyo, Japan) 20080101
Title: Matters of the heart: cardiac toxicity of adjuvant systemic therapy for early-stage breast cancer.
Journal: Current oncology (Toronto, Ont.) 20080101
Title: Cancer treatment-related bone loss: a review and synthesis of the literature.
Journal: Current oncology (Toronto, Ont.) 20080101
Title: Erythema multiforme after radiotherapy with aromatase inhibitor administration in breast-conservation treatment for breast cancer.
Journal: Breast cancer (Tokyo, Japan) 20080101
Title: The impact of adjuvant endocrine therapy on reducing the risk of distant metastases in hormone-responsive breast cancer.
Journal: Breast (Edinburgh, Scotland) 20080101
Title: Neoadjuvant letrozole in postmenopausal estrogen and/or progesterone receptor positive breast cancer: a phase IIb/III trial to investigate optimal duration of preoperative endocrine therapy.
Journal: BMC cancer 20080101
Title: [Adjuvant treatment of operable breast cancer].
Journal: Anales de medicina interna (Madrid, Spain : 1984) 20080101
Title: Caecal metastasis from breast cancer presenting as intestinal obstruction.
Journal: World journal of surgical oncology 20080101
Title: Cancer and fertility preservation: fertility preservation in breast cancer patients.
Journal: Breast cancer research : BCR 20080101
Title: Evaluation of the quality and accuracy of information regarding aromatase inhibitors available on the internet.
Journal: The breast journal 20080101
Title: Anastrozole: a review of its use in postmenopausal women with early-stage breast cancer.
Journal: Drugs 20080101
Title: What do perceived cognitive problems reflect?
Journal: The journal of supportive oncology 20080101
Title: Genes responsive to both oxidant stress and loss of estrogen receptor function identify a poor prognosis group of estrogen receptor positive primary breast cancers.
Journal: Breast cancer research : BCR 20080101
Title: New steroidal aromatase inhibitors: suppression of estrogen-dependent breast cancer cell proliferation and induction of cell death.
Journal: BMC cell biology 20080101
Title: Conjugated linoleic acid induces apoptosis through estrogen receptor alpha in human breast tissue.
Journal: BMC cancer 20080101
Title: Meta-analysis of trials comparing anastrozole and tamoxifen for adjuvant treatment of postmenopausal women with early breast cancer.
Journal: Trials 20080101
Title: HER2 oncogenic function escapes EGFR tyrosine kinase inhibitors via activation of alternative HER receptors in breast cancer cells.
Journal: PloS one 20080101
Title: Identification of functional networks of estrogen- and c-Myc-responsive genes and their relationship to response to tamoxifen therapy in breast cancer.
Journal: PloS one 20080101
Title: The growth-promoting action of individual women's sera on mammary carcinoma cells.
Journal: Anticancer research 20080101
Title: Health-related quality of life in breast cancer patients: a bibliographic review of the literature from 1974 to 2007.
Journal: Journal of experimental & clinical cancer research : CR 20080101
Title: Current topics and perspectives on the use of aromatase inhibitors in the treatment of breast cancer.
Journal: Breast cancer (Tokyo, Japan) 20080101
Title: Use of letrozole in assisted reproduction: a systematic review and meta-analysis.
Journal: Human reproduction update 20080101
Title: Infertility and the provision of infertility medical services in developing countries.
Journal: Human reproduction update 20080101
Title: Novel therapies in breast cancer: what is new from ASCO 2008.
Journal: Journal of hematology & oncology 20080101
Title: Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes.
Journal: Breast cancer research : BCR 20080101
Title: Breast cancer in men: should aromatase inhibitors become first-line hormonal treatment?
Journal: The breast journal 20080101
Title: Chemopreventive effects of anastrozole in a premenopausal breast cancer model.
Journal: Anticancer research 20080101
Title: The use of fulvestrant, a parenteral endocrine agent, in intestinal obstruction due to metastatic lobular breast carcinoma.
Journal: World journal of surgical oncology 20080101
Title: Anti-oestrogens but not oestrogen deprivation promote cellular invasion in intercellular adhesion-deficient breast cancer cells.
Journal: Breast cancer research : BCR 20080101
Title: A paraneoplastic manifestation of metastatic breast cancer responding to endocrine therapy: a case report.
Journal: World journal of surgical oncology 20080101
Title: By looking back we can see the way forward: enhancing the gains achieved with antihormone therapy.
Journal: Breast cancer research : BCR 20080101
Title: Pharmacogenetics and pharmacogenomics of endocrine agents for breast cancer.
Journal: Breast cancer research : BCR 20080101
Title: Markers of endocrine sensitivity.
Journal: Breast cancer research : BCR 20080101
Title: Identification and mechanisms of endocrine resistance.
Journal: Breast cancer research : BCR 20080101
Title: Integration of endocrine therapy with targeted agents.
Journal: Breast cancer research : BCR 20080101
Title: Strength and weakness of phase I to IV trials, with an emphasis on translational aspects.
Journal: Breast cancer research : BCR 20080101
Title: Neoadjuvant/presurgical treatments.
Journal: Breast cancer research : BCR 20080101
Title: Evaluation of biological agents targeted at early-stage disease.
Journal: Breast cancer research : BCR 20080101
Title: Optimizing the implementation of future treatment using surrogate end-points.
Journal: Breast cancer research : BCR 20080101
Title: Extended follow-up of breast cancer patients in clinic wastes time for both patients and doctors: the case against.
Journal: Breast cancer research : BCR 20080101
Title: Roles of prohibitin in growth control and tumor suppression in human cancers.
Journal: Translational oncogenomics 20080101
Title: Cancer care in Singapore.
Journal: Biomedical imaging and intervention journal 20080101
Title: Innovations in chemotherapy and radiation therapy: Implications and opportunities for the Asia-Pacific Rim.
Journal: Biomedical imaging and intervention journal 20080101
Title: Response of cutaneous metastases from breast cancer to capecitabine.
Journal: Clinical medicine. Oncology 20080101
Title: Co-existence of breast and ovarian cancers in BRCA germ-line mutation carriers.
Journal: Ecancermedicalscience 20080101
Title: Extended adjuvant therapy for breast cancer--how much is enough?
Journal: Journal of the National Cancer Institute 20071219
Title: Extended adjuvant therapy with anastrozole among postmenopausal breast cancer patients: results from the randomized Austrian Breast and Colorectal Cancer Study Group Trial 6a.
Journal: Journal of the National Cancer Institute 20071219
Title: Cost-effectiveness analysis of anastrozole versus tamoxifen as primary adjuvant therapy for postmenopausal women with early breast cancer: a US healthcare system perspective. The 5-year completed treatment analysis of the ATAC ('Arimidex', Tamoxifen Alone or in Combination) trial.
Journal: Breast cancer research and treatment 20071201
Title: Differential effects of tamoxifen and anastrozole on optic cup size in breast cancer survivors.
Journal: Breast cancer research and treatment 20071201
Title: Treatment strategies that effectively reduce early recurrence risk in postmenopausal women with endocrine-sensitive breast cancer: AIs upfront vs. switching.
Journal: Journal of cancer research and clinical oncology 20071201
Title: Reducing the risk of distant metastases in breast cancer patients: role of aromatase inhibitors.
Journal: Cancer treatment reviews 20071201
Title: The what, why and how of aromatase inhibitors: hormonal agents for treatment and prevention of breast cancer.
Journal: International journal of clinical practice 20071201
Title: Aromatase inhibitor-associated arthralgias: Pathogenesis, frequency and management.
Journal: Joint, bone, spine : revue du rhumatisme 20071201
Title: Responses to concurrent radiotherapy and hormone-therapy and outcome for large breast cancers in post-menopausal women.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20071201
Title: Erythema nodosum secondary to aromatase inhibitor use in breast cancer patients: case reports and review of the literature.
Journal: Breast cancer research and treatment 20071201
Title: Efficacy of anastrozole on local recurrence in patients with favorable early breast cancer.
Journal: International journal of radiation oncology, biology, physics 20071201
Title: Adjuvant and extended adjuvant use of aromatase inhibitors: reducing the risk of recurrence and distant metastasis.
Journal: Breast (Edinburgh, Scotland) 20071201
Title: Treatment of bicalutamide-induced breast events.
Journal: Expert review of anticancer therapy 20071201
Title: [Solitary oesophageal metastasis of breast cancer after 17 years latency].
Journal: Magyar sebeszet 20071201
Title: Reducing the risk of cancer treatment-associated bone loss in patients with breast cancer.
Journal: Seminars in oncology 20071201
Title: Management of arthralgias associated with aromatase inhibitor therapy.
Journal: Current oncology (Toronto, Ont.) 20071201
Title: Management of sexual dysfunction in postmenopausal breast cancer patients taking adjuvant aromatase inhibitor therapy.
Journal: Current oncology (Toronto, Ont.) 20071201
Title: Cancer therapy disparity: unequal access to breast cancer therapeutics and drug funding in Canada.
Journal: Current oncology (Toronto, Ont.) 20071201
Title: Managing bone loss in women with early-stage breast cancer receiving aromatase inhibitors.
Journal: Clinical breast cancer 20071201
Title: Novel therapeutic strategies combining antihormonal and biological targeted therapies in breast cancer: focus on clinical trials and perspectives.
Journal: Critical reviews in oncology/hematology 20071101
Title: The use of third-generation aromatase inhibitors and tamoxifen in the adjuvant treatment of postmenopausal patients with hormone-dependent breast cancer: evidence based review.
Journal: Current opinion in oncology 20071101
Title: Joint pain with aromatase inhibitors: abnormal frequency of Sjögren's syndrome.
Journal: The Journal of rheumatology 20071101
Title: Phase III, double-blind, controlled trial of atamestane plus toremifene compared with letrozole in postmenopausal women with advanced receptor-positive breast cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20071101
Title: Progression of endocrine therapies for breast cancer: where are we headed?
Journal: Expert review of anticancer therapy 20071101
Title: Effects of third generation aromatase inhibitors on bone health and other safety parameters: results of an open, randomised, multi-centre study of letrozole, exemestane and anastrozole in healthy postmenopausal women.
Journal: European journal of cancer (Oxford, England : 1990) 20071101
Title: Dual aromatase-sulfatase inhibitors based on the anastrozole template: synthesis, in vitro SAR, molecular modelling and in vivo activity.
Journal: Organic & biomolecular chemistry 20071021
Title: Letrozole in advanced breast cancer: the PO25 trial.
Journal: Breast cancer research and treatment 20071001
Title: Favorable outcome in patients with breast cancer in the presence of pathological response after neoadjuvant endocrine therapy.
Journal: Breast (Edinburgh, Scotland) 20071001
Title: Patients' knowledge and experience of adjuvant endocrine therapy for early breast cancer: a European study.
Journal: Breast (Edinburgh, Scotland) 20071001
Title: Severe disabling tendinopathy caused by anastrazole.
Journal: Rheumatology (Oxford, England) 20071001
Title: Aromatase inhibitor-induced bone mineral loss and its prevention by bisphosphonate administration in postmenopausal breast cancer patients.
Journal: The journal of obstetrics and gynaecology research 20071001
Title: Aromatase inhibitor and bone.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20071001
Title: The discovery and mechanism of action of letrozole.
Journal: Breast cancer research and treatment 20071001
Title: Letrozole in the neoadjuvant setting: the P024 trial.
Journal: Breast cancer research and treatment 20071001
Title: Letrozole in the extended adjuvant setting: MA.17.
Journal: Breast cancer research and treatment 20071001
Title: Letrozole as upfront endocrine therapy for postmenopausal women with hormone-sensitive breast cancer: BIG 1-98.
Journal: Breast cancer research and treatment 20071001
Title: A decade of letrozole: FACE.
Journal: Breast cancer research and treatment 20071001
Title: Safety of aromatase inhibitors in the adjuvant setting.
Journal: Breast cancer research and treatment 20071001
Title: The patient experience.
Journal: Breast cancer research and treatment 20071001
Title: Femara and the future: tailoring treatment and combination therapies with Femara.
Journal: Breast cancer research and treatment 20071001
Title: Anastrozole for malignant and benign conditions: present applications and future therapeutic integrations.
Journal: Expert opinion on pharmacotherapy 20071001
Title: [A case of recurrent breast cancer with multiple liver metastases responding to combination therapy of capecitabine and MPA].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20071001
Title: Effects of aromatase inhibitors letrozole and anastrazole on bone metabolism and steroid hormone levels in intact female rats.
Journal: Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20071001
Title: Resolution of endometrial hyperplasia with adjuvant anastrozole treatment in postmenopausal breast cancer: a case report.
Journal: The Journal of reproductive medicine 20071001
Title: Dual aromatase-sulfatase inhibitors based on the anastrozole template: synthesis, in vitro SAR, molecular modelling and in vivo activity.
Journal: Organic & biomolecular chemistry 20070921
Title: Antitumour and biological effects of letrozole and GnRH analogue as primary therapy in premenopausal women with ER and PgR positive locally advanced operable breast cancer.
Journal: British journal of cancer 20070911
Title: [Antiestrogen treatment in postmenopausal patients with metastatic breast cancer].
Journal: Ugeskrift for laeger 20070910
Title: Unusual macular degeneration following breast cancer.
Journal: Acta ophthalmologica Scandinavica 20070901
Title: Estrogen-dependent increase in bone turnover and bone loss in postmenopausal women with breast cancer treated with anastrozole. Prevention with bisphosphonates.
Journal: Bone 20070901
Title: Enhancement of the antitumor activity of tamoxifen and anastrozole by the farnesyltransferase inhibitor lonafarnib (SCH66336).
Journal: Anti-cancer drugs 20070901
Title: A phase II placebo-controlled trial of neoadjuvant anastrozole alone or with gefitinib in early breast cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070901
Title: A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20070901
Title: The effect of anastrazole on symptomatic uterine leiomyomata.
Journal: Obstetrics and gynecology 20070901
Title: Reducing the risk of late recurrence in hormone-responsive breast cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20070901
Title: Reducing the risk of early recurrence in hormone-responsive breast cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20070901
Title: Effect of estrogens on skin aging and the potential role of SERMs.
Journal: Clinical interventions in aging 20070901
Title: Nonsurgical treatment of male infertility: specific and empiric therapy.
Journal: Biologics : targets & therapy 20070901
Title: Nanomolar concentrations of anabolic-androgenic steroids amplify excitotoxic neuronal death in mixed mouse cortical cultures.
Journal: Brain research 20070824
Title: Health care costs for the treatment of breast cancer recurrent events: estimates from a UK-based patient-level analysis.
Journal: British journal of cancer 20070820
Title: Bone density in breast cancer: when to intervene?
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070801
Title: Metastatic uterine leiomyosarcoma regression using an aromatase inhibitor.
Journal: Obstetrics and gynecology 20070801
Title: Remission of porphyria cutanea tarda after anastrozole treatment of breast cancer.
Journal: Clinical breast cancer 20070801
Title: Reducing the risk for breast cancer recurrence after completion of tamoxifen treatment in postmenopausal women.
Journal: Clinical therapeutics 20070801
Title: Effects of hormonal therapy on cognitive functioning in breast cancer patients: a review of the literature.
Journal: Minerva ginecologica 20070801
Title: The ATAC trial: the vanguard trial for use of aromatase inhibitors in early breast cancer.
Journal: Expert review of anticancer therapy 20070801
Title: Cost-effectiveness analysis of anastrozole vs tamoxifen in adjuvant therapy for early stage breast cancer in the United Kingdom: the 5-year completed treatment analysis of the ATAC ('Arimidex', Tamoxifen alone or in combination) trial.
Journal: British journal of cancer 20070716
Title: Phase 2 randomized trial of primary endocrine therapy versus chemotherapy in postmenopausal patients with estrogen receptor-positive breast cancer.
Journal: Cancer 20070715
Title: Optimal use of aromatase inhibitors: to lead or to follow?
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070701
Title: Improved overall survival in postmenopausal women with early breast cancer after anastrozole initiated after treatment with tamoxifen compared with continued tamoxifen: the ARNO 95 Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070701
Title: Hormonal therapies for early breast cancer: systematic review and economic evaluation.
Journal: Health technology assessment (Winchester, England) 20070701
Title: Fulvestrant (Faslodex) -- how to make a good drug better.
Journal: The oncologist 20070701
Title: Adjuvant endocrine therapy for early breast cancer.
Journal: Cancer letters 20070618
Title: Changing pattern of the detection of locoregional relapse in breast cancer: the Edinburgh experience.
Journal: British journal of cancer 20070618
Title: Cost-utility of adjuvant hormone therapies with aromatase inhibitors in post-menopausal women with breast cancer: upfront anastrozole, sequential tamoxifen-exemestane and extended tamoxifen-letrozole.
Journal: Breast (Edinburgh, Scotland) 20070601
Title: Concomitant treatment of severe uterine adenomyosis in a premenopausal woman with an aromatase inhibitor and a gonadotropin-releasing hormone agonist.
Journal: Fertility and sterility 20070601
Title: Potential benefit of maintenance trastuzumab and anastrozole therapy in male advanced breast cancer.
Journal: Breast (Edinburgh, Scotland) 20070601
Title: Relative potencies of anastrozole and letrozole to suppress estradiol in breast cancer patients undergoing ovarian stimulation before in vitro fertilization.
Journal: The Journal of clinical endocrinology and metabolism 20070601
Title: Lumpectomy plus tamoxifen or anastrozole with or without whole breast irradiation in women with favorable early breast cancer.
Journal: International journal of radiation oncology, biology, physics 20070601
Title: New advances in ovulation induction.
Journal: Current opinion in obstetrics & gynecology 20070601
Title: The National Cancer Institute of Canada Clinical Trials Group MAP.3 trial: an international breast cancer prevention trial.
Journal: Current oncology (Toronto, Ont.) 20070601
Title: Aromatase inhibitors and musculoskeletal pain in patients with breast cancer.
Journal: Clinical journal of oncology nursing 20070601
Title: Efficacy of letrozole extended adjuvant therapy according to estrogen receptor and progesterone receptor status of the primary tumor: National Cancer Institute of Canada Clinical Trials Group MA.17.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070520
Title: Anastrozole quantification in human plasma by high-performance liquid chromatography coupled to photospray tandem mass spectrometry applied to pharmacokinetic studies.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070501
Title: A case of porphyria cutanea tarda resulting in digital amputation and improved by anastrazole.
Journal: Clinical and experimental dermatology 20070501
Title: The Breast International Group 1-98 trial: big results for women with hormone-sensitive early breast cancer.
Journal: Expert review of anticancer therapy 20070501
Title: Assessing the risk of bone fracture among postmenopausal women who are receiving adjuvant hormonal therapy for breast cancer.
Journal: Current medical research and opinion 20070501
Title: Novel retinoic acid metabolism blocking agents have potent inhibitory activities on human breast cancer cells and tumour growth.
Journal: British journal of cancer 20070423
Title: Towards optimal endocrine therapy for hormone-sensitive breast cancer: initial versus sequential adjuvant aromatase inhibition.
Journal: Cancer letters 20070418
Title: [Clinical study of aromatase inhibitors in advanced breast cancer].
Journal: Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences 20070418
Title: Impact of aromatase inhibitors on adhesion formation in a rat model.
Journal: Fertility and sterility 20070401
Title: [Advancement in endocrine therapy for breast cancer].
Journal: Ai zheng = Aizheng = Chinese journal of cancer 20070401
Title: Parotid gland metastasis of a breast cancer.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20070401
Title: Cost-effectiveness of letrozole, anastrozole and exemestane for early adjuvant breast cancer.
Journal: Expert review of pharmacoeconomics & outcomes research 20070401
Title: Switching to an aromatase inhibitor provides mortality benefit in early breast carcinoma: pooled analysis of 2 consecutive trials.
Journal: Cancer 20070315
Title: Cost-utility of adjuvant hormone therapies for breast cancer in post-menopausal women: sequential tamoxifen-exemestane and upfront anastrozole.
Journal: Breast cancer research and treatment 20070301
Title: Zoledronic acid prevents cancer treatment-induced bone loss in premenopausal women receiving adjuvant endocrine therapy for hormone-responsive breast cancer: a report from the Austrian Breast and Colorectal Cancer Study Group.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070301
Title: [A case of advanced breast cancer with multiple liver metastases resistant to chemotherapy responding to high-dose toremifene].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20070301
Title: Aromatase inhibitors: a safety comparison.
Journal: Expert opinion on drug safety 20070301
Title: Clinical evaluation of the use of exemestane as further hormonal therapy after nonsteroidal aromatase inhibitors in postmenopausal metastatic breast cancer patients.
Journal: Cancer investigation 20070301
Title: Trastuzumab in the management of early and advanced stage breast cancer.
Journal: Biologics : targets & therapy 20070301
Title: Modeling for cost-effective-adjuvant aromatase inhibitor strategies for postmenopausal women with breast cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20070201
Title: Striatal susceptibility to a dopaminergic neurotoxin is independent of sex hormone effects on cell survival and DAT expression but is exacerbated by central aromatase inhibition.
Journal: Journal of neurochemistry 20070201
Title: Do endocrine treatments for breast cancer have a negative impact on lipid profiles and cardiovascular risk in postmenopausal women?
Journal: American heart journal 20070201
Title: Pharmacogenetics and oncology treatment for breast cancer.
Journal: Expert opinion on pharmacotherapy 20070201
Title: Optimal treatment strategies in hormone-responsive early breast cancer: the role of aromatase inhibitors.
Journal: Onkologie 20070201
Title: The prevention and management of distant metastases in women with breast cancer.
Journal: Cancer investigation 20070201
Title: The FACE trial: letrozole or anastrozole as initial adjuvant therapy?
Journal: Cancer investigation 20070201
Title: A randomized comparison of ovulation induction and hormone profile between the aromatase inhibitor anastrozole and clomiphene citrate in women with infertility.
Journal: Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20070201
Title: Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women.
Journal: The Cochrane database of systematic reviews 20070124
Title: Prognostic value of Ki67 expression after short-term presurgical endocrine therapy for primary breast cancer.
Journal: Journal of the National Cancer Institute 20070117
Title: Severe acute hepatitis in a patient treated with anastrozole.
Journal: Lancet (London, England) 20070106
Title: Role of P450 aromatase in sex-specific astrocytic cell death.
Journal: Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 20070101
Title: Henoch-Schönlein purpura (HSP) during treatment with anastrozole.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20070101
Title: Development and evolution of therapies targeted to the estrogen receptor for the treatment and prevention of breast cancer.
Journal: Steroids 20070101
Title: Anastrozole had a better risk-benefit profile than tamoxifen as adjuvant treatment for breast cancer in postmenopausal women.
Journal: ACP journal club 20070101
Title: Aromatase inhibitors in the adjuvant treatment of postmenopausal women with early breast cancer: Putting safety issues into perspective.
Journal: The breast journal 20070101
Title: [Locally advanced breast cancer with a good response to sequential endocrine monotherapy--a case report].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20070101
Title: Economic evaluation of the prevention and treatment of breast cancer--present status and open issues.
Journal: Breast cancer (Tokyo, Japan) 20070101
Title: Effects of liarozole fumarate (R85246) in combination with tamoxifen on N-methyl-N-nitrosourea (MNU)-induced mammary carcinoma and uterus in the rat model.
Journal: BMC cancer 20070101
Title: Estrogen deprivation for breast cancer prevention.
Journal: Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer 20070101
Title: Systemic anticancer therapy in gynecological cancer patients with renal dysfunction.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20070101
Title: Optimizing endocrine therapy for premenopausal and postmenopausal women with breast cancer.
Journal: Oncology (Williston Park, N.Y.) 20070101
Title: Neoadjuvant use of endocrine therapy in breast cancer.
Journal: The breast journal 20070101
Title: Molecular response to aromatase inhibitor treatment in primary breast cancer.
Journal: Breast cancer research : BCR 20070101
Title: Quality of life issues in relation to the aromatase inhibitor.
Journal: The Journal of steroid biochemistry and molecular biology 20070101
Title: External influences and priority-setting for anti-cancer agents: a case study of media coverage in adjuvant trastuzumab for breast cancer.
Journal: BMC cancer 20070101
Title: Aromatase inhibitors in ovarian stimulation.
Journal: The Journal of steroid biochemistry and molecular biology 20070101
Title: DCIS and aromatase inhibitors.
Journal: The Journal of steroid biochemistry and molecular biology 20070101
Title: New experimental models for aromatase inhibitor resistance.
Journal: The Journal of steroid biochemistry and molecular biology 20070101
Title: Breast cancer metastasis to the stomach may mimic primary gastric cancer: report of two cases and review of literature.
Journal: World journal of surgical oncology 20070101
Title: EGFR associated expression profiles vary with breast tumor subtype.
Journal: BMC genomics 20070101
Title: Aromatase inhibitor therapy for uterine bleeding in a postmenopausal woman with leiomyomata.
Journal: Menopause (New York, N.Y.) 20070101
Title: Can a single model explain both breast cancer and prostate cancer?
Journal: Theoretical biology & medical modelling 20070101
Title: Effects of steroidal and nonsteroidal aromatase inhibitors on markers of bone turnover in healthy postmenopausal women.
Journal: Breast cancer research : BCR 20070101
Title: Memory impairments with adjuvant anastrozole versus tamoxifen in women with early-stage breast cancer.
Journal: Menopause (New York, N.Y.) 20070101
Title: A league of their own: demographics, motivations and patterns of use of 1,955 male adult non-medical anabolic steroid users in the United States.
Journal: Journal of the International Society of Sports Nutrition 20070101
Title: Effects of eight weeks of an alleged aromatase inhibiting nutritional supplement 6-OXO (androst-4-ene-3,6,17-trione) on serum hormone profiles and clinical safety markers in resistance-trained, eugonadal males.
Journal: Journal of the International Society of Sports Nutrition 20070101
Title: [Phase II clinical trial of neoadjuvant hormone therapy in comparison with chemotherapy of patients with breast cancer].
Journal: Voprosy onkologii 20070101
Title: Serum epidermal growth factor receptor and HER2 expression in primary and metastatic breast cancer patients.
Journal: Breast cancer research : BCR 20070101
Title: Live or let die: oestrogen regulation of survival signalling in endocrine response.
Journal: Breast cancer research : BCR 20070101
Title: Clinical trials update: endocrine and biological therapy combinations in the treatment of breast cancer.
Journal: Breast cancer research : BCR 20070101
Title: Overview of resistance to systemic therapy in patients with breast cancer.
Journal: Advances in experimental medicine and biology 20070101
Title: [Neoadjuvant endocrine therapy for locally advanced breast cancer].
Journal: La Clinica terapeutica 20070101
Title: Trastuzumab : in HER2 and hormone receptor co-positive metastatic breast cancer.
Journal: Drugs 20070101
Title: The effects of anastrozole on neonatal rat skin.
Journal: European journal of gynaecological oncology 20070101
Title: Anastrozole-associated sclerosing glomerulonephritis in a patient with breast cancer.
Journal: Oncology 20070101
Title: Breast cancer prevention in women with a BRCA1 or BRCA2 mutation.
Journal: Open medicine : a peer-reviewed, independent, open-access journal 20070101
Title: [Optimal adjuvant hormone therapy in postmenopausal women with hormone-sensitive mammary carcinoma: tamoxifen and the aromatase inhibitors anastrozole, exemestane and letrozole].
Journal: Nederlands tijdschrift voor geneeskunde 20061230
Title: Anastrozole improved testosterone-induced impairment acquisition of spatial learning and memory in the hippocampal CA1 region in adult male rats.
Journal: Behavioural brain research 20061215
Title: Liver toxicity after treatment with gefitinib and anastrozole: drug-drug interactions through cytochrome p450?
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20061210
Title: Photodynamic therapy for solitary retinal metastasis from breast carcinoma.
Journal: Eye (London, England) 20061201
Title: Quality of life of postmenopausal women in the ATAC ('Arimidex', tamoxifen, alone or in combination) trial after completion of 5 years' adjuvant treatment for early breast cancer.
Journal: Breast cancer research and treatment 20061201
Title: A prospective randomized trial comparing anastrozole and clomiphene citrate in an ovulation induction protocol using gonadotropins.
Journal: Fertility and sterility 20061201
Title: Co-expression of steroid receptors (estrogen receptor alpha and/or progesterone receptors) and Her-2/neu: Clinical implications.
Journal: The Journal of steroid biochemistry and molecular biology 20061201
Title: What do we know about the mechanisms of aromatase inhibitor resistance?
Journal: The Journal of steroid biochemistry and molecular biology 20061201
Title: Clinically occult cutaneous metastases.
Journal: Journal of the American Academy of Dermatology 20061201
Title: Effectiveness of switching from adjuvant tamoxifen to anastrozole in postmenopausal women with hormone-sensitive early-stage breast cancer: a meta-analysis.
Journal: The Lancet. Oncology 20061201
Title: Adjuvant therapy with aromatase inhibitors for postmenopausal women with early breast cancer: evidence and ongoing controversy.
Journal: Seminars in oncology 20061201
Title: Is estradiol mandatory for an adequate follicular and embryo development? A mouse model using aromatase inhibitor (anastrozole).
Journal: Journal of assisted reproduction and genetics 20061201
Title: Aromatase inhibitors in early breast cancer therapy: a variety of treatment strategies.
Journal: Expert opinion on pharmacotherapy 20061201
Title: Non-steroidal anti-estrogens in the treatment of breast cancer.
Journal: Current opinion in investigational drugs (London, England : 2000) 20061201
Title: Initial versus sequential adjuvant aromatase inhibitor therapy: a review of the current data.
Journal: Current medical research and opinion 20061201
Title: Aromatase inhibitors and bone health in women with breast cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20061120
Title: Plasma levels of tamoxifen, N-desmethyl tamoxifen and anastrozole in a patient with metastatic breast cancer and chronic hemodialysis.
Journal: Breast cancer research and treatment 20061101
Title: Correlates of use of different types of complementary and alternative medicine by breast cancer survivors in the nurses' health study.
Journal: Breast cancer research and treatment 20061101
Title: Anastrozole therapy in recurrent ovarian adult granulosa cell tumors: a report of 2 cases.
Journal: Gynecologic oncology 20061101
Title: Metastatic breast cancer: an updating.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20061101
Title: Optimal sequence of hormonotherapy in advanced breast cancer.
Journal: Current opinion in oncology 20061101
Title: Safety of adjuvant aromatase inhibitor therapy.
Journal: Cancer treatment reviews 20061101
Title: Anastrozole-induced hepatotoxicity.
Journal: European journal of gastroenterology & hepatology 20061101
Title: Aromatase destabilizer: novel action of exemestane, a food and drug administration-approved aromatase inhibitor.
Journal: Cancer research 20061101
Title: Adjuvant endocrine therapy in hormone receptor-positive postmenopausal breast cancer: evolution of NCCN, ASCO, and St Gallen recommendations.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN 20061101
Title: Effects of adjuvant aromatase inhibitor therapy on lipid profiles.
Journal: Expert review of anticancer therapy 20061101
Title: [Two patients having recurrent breast cancer with brain metastases well controlled with a gamma knife radio-surgery].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20061101
Title: Aromatase inhibitors: structural features and biochemical characterization.
Journal: Annals of the New York Academy of Sciences 20061101
Title: Postmenopausal advanced breast cancer: options for therapy after tamoxifen and aromatase inhibitors.
Journal: Breast (Edinburgh, Scotland) 20061001
Title: Acute bilateral pulmonary emboli occurring while on adjuvant aromatase inhibitor therapy with anastrozole: Case report and review of the literature.
Journal: Breast cancer research and treatment 20061001
Title: Pre-menopausal breast cancer and aromatase inhibitors: Treating a new generation of women.
Journal: Breast cancer research and treatment 20061001
Title: Update on the use of aromatase inhibitors in breast cancer.
Journal: Expert opinion on pharmacotherapy 20061001
Title: Aromatase inhibitors and bipolar mood disorder: a case report.
Journal: Bipolar disorders 20061001
Title: Refining the postmenopausal breast cancer treatment paradigm: the FACE trial.
Journal: Expert review of anticancer therapy 20061001
Title: Survival with aromatase inhibitors and inactivators versus standard hormonal therapy in advanced breast cancer: meta-analysis.
Journal: Journal of the National Cancer Institute 20060920
Title: Combination therapy with aromatase inhibitors: the next era of breast cancer treatment?
Journal: British journal of cancer 20060918
Title: Anastrozole is cost-effective vs tamoxifen as initial adjuvant therapy in early breast cancer: Canadian perspectives on the ATAC completed-treatment analysis.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20060901
Title: Treatment of familial male-limited precocious puberty with bicalutamide and anastrozole.
Journal: The Journal of pediatrics 20060901
Title: Combined ovarian ablation and aromatase inhibition as first-line therapy for hormone receptor-positive metastatic breast cancer in premenopausal women: report of three cases.
Journal: Anti-cancer drugs 20060901
Title: Pure oestrogen antagonists for the treatment of advanced breast cancer.
Journal: Endocrine-related cancer 20060901
Title: Formulation of anastrozole microparticles as biodegradable anticancer drug carriers.
Journal: AAPS PharmSciTech 20060901
Title: The 'Arimidex', Tamoxifen, Alone or in Combination (ATAC) Trial: a step forward in the treatment of early breast cancer.
Journal: Reviews on recent clinical trials 20060901
Title: The emerging role of aromatase inhibitors in the adjuvant management of breast cancer.
Journal: Reviews on recent clinical trials 20060901
Title: [Unclear about anastrozole and cancer treatment].
Journal: Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20060824
Title: Lobular carcinoma of the breast metastatic to the uterus in a patient under adjuvant anastrozole therapy.
Journal: Breast (Edinburgh, Scotland) 20060801
Title: A double-blind randomised trial to evaluate the effect of anastrozole for the treatment of non-toxic multinodular goitre.
Journal: International journal of clinical practice 20060801
Title: Information provision for patients by breast cancer teams about the side-effects of hormone treatments.
Journal: European journal of cancer (Oxford, England : 1990) 20060801
Title: Impact of chemotherapy regimens prior to endocrine therapy: Results from the ATAC (Anastrozole and Tamoxifen, Alone or in Combination) trial.
Journal: Cancer 20060801
Title: Effect of an aromatase inhibitor on bmd and bone turnover markers: 2-year results of the Anastrozole, Tamoxifen, Alone or in Combination (ATAC) trial (18233230).
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20060801
Title: Defining the role of aromatase inhibitors in the adjuvant endocrine treatment of early breast cancer.
Journal: Current medical research and opinion 20060801
Title: Incidence and management of side effects associated with aromatase inhibitors in the adjuvant treatment of breast cancer in postmenopausal women.
Journal: Current medical research and opinion 20060801
Title: Comprehensive side-effect profile of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: long-term safety analysis of the ATAC trial.
Journal: The Lancet. Oncology 20060801
Title: Estrogen receptors evolution in neoadjuvant aromatase inhibitor (AI) therapy for breast cancer in elderly women: stability of hormonal receptor expression during treatment.
Journal: American journal of clinical oncology 20060801
Title: Time to response: comparison of fulvestrant and oral endocrine agents.
Journal: Clinical breast cancer 20060801
Title: Aromatase inhibitors and bone loss.
Journal: Oncology (Williston Park, N.Y.) 20060801
Title: Use of aromatase inhibitors to increase final height.
Journal: Molecular and cellular endocrinology 20060725
Title: Leuprolide acetate plus aromatase inhibition for male breast cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060720
Title: Influence of adjuvant anastrozole on bone mineral density in Japanese postmenopausal breast cancer patients: is there a racial difference?
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20060701
Title: Pharmacoeconomic aspects of adjuvant anastrozole or tamoxifen in breast cancer: a Slovenian perspective.
Journal: Anti-cancer drugs 20060701
Title: Second- and third-generation aromatase inhibitors as first-line endocrine therapy in postmenopausal metastatic breast cancer patients: a pooled analysis of the randomised trials.
Journal: British journal of cancer 20060619
Title: Phase II study of gefitinib in combination with docetaxel as first-line therapy in metastatic breast cancer.
Journal: British journal of cancer 20060605
Title: Comparative assessment of lipid effects of endocrine therapy for breast cancer: implications for cardiovascular disease prevention in postmenopausal women.
Journal: Breast (Edinburgh, Scotland) 20060601
Title: Optimizing the use of aromatase inhibitors in adjuvant therapy for postmenopausal patients with hormone-responsive early breast cancer: current and future prospects.
Journal: Journal of cancer research and clinical oncology 20060601
Title: Adjuvant aromatase inhibitor therapy for early breast cancer: A review of the most recent data.
Journal: Journal of surgical oncology 20060601
Title: Adjuvant aromatase inhibitors for early breast cancer after chemotherapy-induced amenorrhoea: caution and suggested guidelines.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060601
Title: Switching to anastrozole versus continued tamoxifen treatment of early breast cancer. Updated results of the Italian tamoxifen anastrozole (ITA) trial.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20060601
Title: Anastrozole for breast cancer: recent advances and ongoing challenges.
Journal: Expert review of anticancer therapy 20060601
Title: [Introduction of new drug: letrozole, a new non-steroidal aromatase inhibitor for the treatment of postmenopausal women with breast cancer].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20060601
Title: Management of choroidal metastases from breast carcinomas using aromatase inhibitors.
Journal: Current opinion in ophthalmology 20060601
Title: Risk of cancer treatment-associated bone loss and fractures among women with breast cancer receiving aromatase inhibitors.
Journal: Clinical breast cancer 20060601
Title: A durable complete remission between two isolated presentations of metastatic breast cancer, the second with intracardiac disease.
Journal: Clinical breast cancer 20060601
Title: Optimising adjuvant endocrine treatment of breast cancer with aromatase inhibitors.
Journal: International journal of clinical practice 20060601
Title: t(8;16) AML developed subsequent to breast cancer therapy.
Journal: Hematology (Amsterdam, Netherlands) 20060601
Title: Comparison of anastrozole versus tamoxifen as preoperative therapy in postmenopausal women with hormone receptor-positive breast cancer: the Pre-Operative 'Arimidex' Compared to Tamoxifen (PROACT) trial.
Journal: Cancer 20060515
Title: Effects of third-generation aromatase inhibitors on bone.
Journal: European journal of cancer (Oxford, England : 1990) 20060501
Title: Pharmacoeconomic analysis of adjuvant therapy with exemestane, anastrozole, letrozole or tamoxifen in postmenopausal women with operable and estrogen receptor-positive breast cancer.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20060501
Title: Primary hormone treatment in postmenopausal women with breast cancer.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20060501
Title: Proliferation, steroid receptors and clinical/pathological response in breast cancer treated with letrozole.
Journal: British journal of cancer 20060410
Title: The effects of the aromatase inhibitor anastrozole on bone metabolism and cardiovascular risk indices in ovariectomized, androgen-treated female-to-male transsexuals.
Journal: European journal of endocrinology 20060401
Title: [Precocious puberty].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20060401
Title: [Clinical application of the gonadotropin--ovulation induction].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20060401
Title: The adjuvant endocrine treatment revolution: focus on anastrozole.
Journal: Expert opinion on drug metabolism & toxicology 20060401
Title: A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer.
Journal: British journal of cancer 20060327
Title: [Advances in the treatment of breast carcinoma. New therapy schedules with astonishing success quotas].
Journal: MMW Fortschritte der Medizin 20060323
Title: Regulation of sexual behaviour in male macaques by sex steroid modulation of the serotonergic system.
Journal: Experimental physiology 20060301
Title: Fulvestrant ('Faslodex'): current and future role in breast cancer management.
Journal: Critical reviews in oncology/hematology 20060301
Title: Aromatase inhibitors and breast cancer.
Journal: Minerva endocrinologica 20060301
Title: [The evolving role of endocrine therapy for breast cancer].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20060301
Title: Endocrine response after prior treatment with fulvestrant in postmenopausal women with advanced breast cancer: experience from a single centre.
Journal: Endocrine-related cancer 20060301
Title: Should aromatase inhibitors be used as initial adjuvant treatment or sequenced after tamoxifen?
Journal: British journal of cancer 20060227
Title: Anastrozole versus tamoxifen treatment in postmenopausal women with endocrine-responsive breast cancer and tamoxifen-induced endometrial pathology.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20060215
Title: Potent CYP19 (aromatase) 1-[(benzofuran-2-yl)(phenylmethyl)pyridine, -imidazole, and -triazole inhibitors: synthesis and biological evaluation.
Journal: Journal of medicinal chemistry 20060209
Title: The ATAC ('Arimidex', Tamoxifen, Alone or in Combination) adjuvant breast cancer trial: first results of the endometrial sub-protocol following 2 years of treatment.
Journal: Human reproduction (Oxford, England) 20060201
Title: Neoadjuvant endocrine therapy in breast cancer.
Journal: Breast (Edinburgh, Scotland) 20060201
Title: Fulvestrant, a new treatment option for advanced breast cancer: tolerability versus existing agents.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20060201
Title: Durable response of metastatic endometrial carcinoma to treatment with fulvestrant (Faslodex) after prior progestin and anastrozole therapy.
Journal: Gynecologic oncology 20060201
Title: Prepubertal gynecomastia in Peutz-Jeghers syndrome: incomplete penetrance in a familial case and management with an aromatase inhibitor.
Journal: European journal of endocrinology 20060201
Title: Proliferation and apoptosis as markers of benefit in neoadjuvant endocrine therapy of breast cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20060201
Title: Adjuvant endocrine therapy for postmenopausal women with early breast cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20060201
Title: Anastrozole as an adjuvant endocrine treatment for postmenopausal patients with breast cancer: emerging data.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20060201
Title: Is there a role for adjuvant tamoxifen in progesterone receptor-positive breast cancer? An in silico clinical trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20060201
Title: [A case of postoperative pulmonary metastasis of breast cancer treated with docetaxel and cyclophosphamide therapy].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20060201
Title: Review of the development of letrozole and its use in advanced breast cancer and in the neoadjuvant setting.
Journal: Breast (Edinburgh, Scotland) 20060201
Title: Improving bone health in patients with early breast cancer by adding bisphosphonates to letrozole: the Z-ZO-E-ZO-FAST program.
Journal: Breast (Edinburgh, Scotland) 20060201
Title: Latest studies hint at survival advantage with aromatase inhibitors in early breast cancer.
Journal: Journal of the National Cancer Institute 20060118
Title: Current management of treatment-induced bone loss in women with breast cancer treated in the United Kingdom.
Journal: British journal of cancer 20060116
Title: Hormonal therapy in epithelial ovarian cancer.
Journal: Expert review of anticancer therapy 20060101
Title: Improvement in dermatomyositis rash associated with the use of antiestrogen medication.
Journal: Archives of dermatology 20060101
Title: Role of anastrozole across the breast cancer continuum: from advanced to early disease and prevention.
Journal: Oncology 20060101
Title: Estrogen receptors as therapeutic targets in breast cancer.
Journal: Current topics in medicinal chemistry 20060101
Title: Metastasis to sigmoid colon mucosa and submucosa from serous borderline ovarian tumor: response to hormone therapy.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20060101
Title: Analysis of trastuzumab and chemotherapy in advanced breast cancer after the failure of at least one earlier combination: an observational study.
Journal: BMC cancer 20060101
Title: Does survival increase in metastatic breast cancer with recently available anticancer drugs?
Journal: Oncology research 20060101
Title: Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatment.
Journal: BMC cancer 20060101
Title: [Fulvestrant: a new agent in endocrine treatment for breast cancer].
Journal: Lijecnicki vjesnik 20060101
Title: Third-line hormonal treatment with exemestane in postmenopausal patients with advanced breast cancer progressing on letrozole or anastrozole. A phase II trial conducted by the Hellenic Group of Oncology (HELGO).
Journal: Tumori 20060101
Title: Letrozole: a pharmacoeconomic review of its use in postmenopausal women with breast cancer.
Journal: PharmacoEconomics 20060101
Title: Identification of the aromatase inhibitors anastrozole and exemestane in human urine using liquid chromatography/tandem mass spectrometry.
Journal: Rapid communications in mass spectrometry : RCM 20060101
Title: Estrogen receptors: role in breast cancer.
Journal: Critical reviews in clinical laboratory sciences 20060101
Title: [A cost-effectiveness study of first-line hormone therapy in post-menopausal patients with metastatic breast cancer on neoadjuvant treatment].
Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20060101
Title: Efficacy and tolerability of high dose 'ethinylestradiol' in post-menopausal advanced breast cancer patients heavily pre-treated with endocrine agents.
Journal: World journal of surgical oncology 20060101
Title: Influence of bicalutamide with or without tamoxifen or anastrozole on insulin-like growth factor 1 and binding proteins in prostate cancer patients.
Journal: The International journal of biological markers 20060101
Title: Joint symptoms: a practical problem of anastrozole.
Journal: Breast cancer (Tokyo, Japan) 20060101
Title: Cardiovascular safety profiles of aromatase inhibitors : a comparative review.
Journal: Drug safety 20060101
Title: Choroidal metastasis in a patient with disseminated breast cancer: hormonal therapy-induced regression.
Journal: The breast journal 20060101
Title: Effects of low-dose tamoxifen on breast cancer biomarkers Ki-67, estrogen and progesterone receptors.
Journal: International seminars in surgical oncology : ISSO 20060101
Title: Adjuvant endocrine therapy for postmenopausal breast cancer in the era of aromatase inhibitors: an update.
Journal: International seminars in surgical oncology : ISSO 20060101
Title: Endometrial safety of third generation aromatase inhibitors versus tamoxifen in breast cancer patients.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20060101
Title: Bone safety of aromatase inhibitors versus tamoxifen.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20060101
Title: Metastatic breast cancer: sequencing hormonal therapy and positioning of fulvestrant.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20060101
Title: Cost-effectiveness of anastrozole compared to tamoxifen in hormone receptor-positive early breast cancer. Analysis based on the ATAC trial.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20060101
Title: A fast liquid chromatographic/mass spectrometric screening method for the simultaneous detection of synthetic glucocorticoids, some stimulants, anti-oestrogen drugs and synthetic anabolic steroids.
Journal: Rapid communications in mass spectrometry : RCM 20060101
Title: Appraising adjuvant aromatase inhibitor therapy.
Journal: The oncologist 20060101
Title: Neoadjuvant use of hormonal therapy in elderly patients with early or locally advanced hormone receptor-positive breast cancer.
Journal: The oncologist 20060101
Title: The pathological findings of vasculitis simultaneously occurring with carcinoma, invasive breast carcinoma in a patient with Behçet's disease.
Journal: Breast cancer (Tokyo, Japan) 20060101
Title: Adjuvant therapy for patients who have node-positive breast cancer.
Journal: Advances in surgery 20060101
Title: Measuring proliferation in breast cancer: practicalities and applications.
Journal: Breast cancer research : BCR 20060101
Title: [Current status of breast cancer chemoprevention].
Journal: Revista da Associacao Medica Brasileira (1992) 20060101
Title: Treatment guidelines for adjuvant breast cancer are moving toward double standards: one for the rich and one for the poor.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051220
Title: Aromatase inhibitors in human lung cancer therapy.
Journal: Cancer research 20051215
Title: Effect of aromatase inhibition on bone metabolism in elderly hypogonadal men.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20051201
Title: Adjuvant endocrine therapy in postmenopausal breast cancer patients.
Journal: Breast (Edinburgh, Scotland) 20051201
Title: When to recommend and to pay for first-line adjuvant breast cancer treatment? A structured review of the literature.
Journal: Breast (Edinburgh, Scotland) 20051201
Title: The biology of steroid hormones and endocrine treatment of breast cancer.
Journal: Breast (Edinburgh, Scotland) 20051201
Title: Growth inhibition of estrogen receptor-positive and aromatase-positive human breast cancer cells in monolayer and spheroid cultures by letrozole, anastrozole, and tamoxifen.
Journal: The Journal of steroid biochemistry and molecular biology 20051201
Title: Direct analysis of pharmaceutical drug formulations using ion mobility spectrometry/quadrupole-time-of-flight mass spectrometry combined with desorption electrospray ionization.
Journal: Analytical chemistry 20051201
Title: Anal localization as first manifestation of metastatic ductal breast carcinoma.
Journal: Techniques in coloproctology 20051201
Title: Future perspectives in the medical treatment of endometriosis.
Journal: Obstetrical & gynecological survey 20051201
Title: Testotoxicosis: current viewpoint.
Journal: Pediatric endocrinology reviews : PER 20051201
Title: Anastrozole called breast cancer 'lifesaver'. Recipients showed a 40 percent decrease in relapse risk when switched to anastrazole after tamoxifen.
Journal: Health news (Waltham, Mass.) 20051201
Title: Effects of decreased estradiol-17beta on the serum and anterior pituitary IGF-I system in pigs.
Journal: The Journal of endocrinology 20051201
Title: [Advance and current status of exemestane and androstadienes in the treatment of breast cancer].
Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology] 20051201
Title: Case 24-2005: a woman with estrogen-receptor-positive breast cancer.
Journal: The New England journal of medicine 20051124
Title: New developments in the treatment of postmenopausal breast cancer.
Journal: Trends in endocrinology and metabolism: TEM 20051101
Title: The use of aromatase inhibitors in adjuvant therapy for early breast cancer.
Journal: Cancer chemotherapy and pharmacology 20051101
Title: Are all aromatase inhibitors the same? A review of controlled clinical trials in breast cancer.
Journal: Clinical therapeutics 20051101
Title: Anastrozole: a new gold standard of hormonal treatment for breast cancer?
Journal: Women's health (London, England) 20051101
Title: Retrospective analysis of time to recurrence in the ATAC trial according to hormone receptor status: an hypothesis-generating study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051020
Title: Exploratory study of drug plasma levels during bicalutamide 150 mg therapy co-administered with tamoxifen or anastrozole for prophylaxis of gynecomastia and breast pain in men with prostate cancer.
Journal: Cancer chemotherapy and pharmacology 20051001
Title: Comparative effects of anastrozole, tamoxifen alone and in combination on plasma lipids and bone-derived resorption during neoadjuvant therapy in the impact trial.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20051001
Title: New aromatase inhibitors as second-line endocrine therapy in postmenopausal patients with metastatic breast carcinoma: a pooled analysis of the randomized trials.
Journal: Cancer 20051001
Title: A step too far?
Journal: The Lancet. Oncology 20051001
Title: Do biomarker changes during neoadjuvant endocrine therapy reflect breast tumor receptor status?
Journal: Nature clinical practice. Oncology 20051001
Title: Role of the vaginally administered aromatase inhibitor anastrozole in women with rectovaginal endometriosis: a pilot study.
Journal: Fertility and sterility 20051001
Title: Defining the roles of aromatase inhibitors in the adjuvant treatment of early-stage breast cancer.
Journal: Clinical breast cancer 20051001
Title: Changing the gold standard in adjuvant therapy for breast cancer:from tamoxifen to aromatase inhibition.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20051001
Title: Recent advances in the use of aromatase inhibitors for women with postmenopausal breast cancer.
Journal: The journal of the British Menopause Society 20050901
Title: Promising switch to anastrozole for breast-cancer treatment.
Journal: The Lancet. Oncology 20050901
Title: [Neoadjuvant endocrine therapy with anastrozole significantly downstaged an elderly breast cancer woman with locally-advanced breast cancer which became operable].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20050901
Title: Radiotherapeutic prophylaxis of gynecomastia.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050820
Title: Case records of the Massachusetts General Hospital. Case 24-2005. A 58-year-old woman with early-stage estrogen-receptor-positive breast cancer.
Journal: The New England journal of medicine 20050811
Title: Novel males' capacity to disrupt early pregnancy in mice (Mus musculus) is attenuated via a chronic reduction of males' urinary 17beta-estradiol.
Journal: Psychoneuroendocrinology 20050801
Title: Selective oestrogen receptor modulators, aromatase inhibitors and the female breast.
Journal: Current opinion in obstetrics & gynecology 20050801
Title: Neoadjuvant treatment of postmenopausal breast cancer with anastrozole, tamoxifen, or both in combination: the Immediate Preoperative Anastrozole, Tamoxifen, or Combined with Tamoxifen (IMPACT) multicenter double-blind randomized trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050801
Title: Switching to anastrozole versus continued tamoxifen treatment of early breast cancer: preliminary results of the Italian Tamoxifen Anastrozole Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050801
Title: Adjuvant endocrine therapy in postmenopausal women with early breast cancer: where are we now?
Journal: European journal of cancer (Oxford, England : 1990) 20050801
Title: New approaches to reverse resistance to hormonal therapy in human breast cancer.
Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 20050801
Title: Adjuvant aromatase inhibitors for breast cancer.
Journal: Lancet (London, England) 20050801
Title: Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial.
Journal: Lancet (London, England) 20050801
Title: Anastrazole and oral contraceptives: a novel treatment for endometriosis.
Journal: Fertility and sterility 20050801
Title: Effects of aromatase inhibitors on proliferation and apoptosis in eutopic endometrial cell cultures from patients with endometriosis.
Journal: Fertility and sterility 20050801
Title: The role of aromatase inhibitors as adjuvant therapy for early breast cancer in postmenopausal women.
Journal: European journal of cancer (Oxford, England : 1990) 20050801
Title: Role of aromatase inhibitors in breast cancer.
Journal: British journal of cancer 20050801
Title: Potential use of COX-2-aromatase inhibitor combinations in breast cancer.
Journal: British journal of cancer 20050801
Title: Bone loss and the aromatase inhibitors.
Journal: British journal of cancer 20050801
Title: The effects of aromatase inhibitors on lipids and thrombosis.
Journal: British journal of cancer 20050801
Title: Sequencing of aromatase inhibitors.
Journal: British journal of cancer 20050801
Title: The evolving role of aromatase inhibitors in adjuvant breast cancer therapy.
Journal: Clinical breast cancer 20050801
Title: [Aromatase inhibitors in the treatment of breast cancer: current status and some problems].
Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology] 20050801
Title: Regression of tamoxifen-stimulated massive uterine fibroid after conversion to anastrozole.
Journal: Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology 20050801
Title: Fulvestrant versus anastrozole for the treatment of advanced breast carcinoma: a prospectively planned combined survival analysis of two multicenter trials.
Journal: Cancer 20050715
Title: The aromatase inhibitors in early breast cancer: who, when, and why?
Journal: The Medical journal of Australia 20050704
Title: Sperm analysis in growth hormone-deficient adolescents previously treated with an aromatase inhibitor: comparison with normal controls.
Journal: Fertility and sterility 20050701
Title: Activation of mitogen-activated protein kinase in xenografts and cells during prolonged treatment with aromatase inhibitor letrozole.
Journal: Cancer research 20050615
Title: A comparison of fulvestrant and the third-generation aromatase inhibitors in the second-line treatment of postmenopausal women with advanced breast cancer.
Journal: Cancer treatment reviews 20050601
Title: Regression of choroidal metastases from breast carcinoma using aromatase inhibitors.
Journal: The British journal of ophthalmology 20050601
Title: Preoperative gefitinib versus gefitinib and anastrozole in postmenopausal patients with oestrogen-receptor positive and epidermal-growth-factor-receptor-positive primary breast cancer: a double-blind placebo-controlled phase II randomised trial.
Journal: The Lancet. Oncology 20050601
Title: The aromatase inhibitor anastrozole is associated with favorable embryo development and implantation markers in mice ovarian stimulation cycles.
Journal: Fertility and sterility 20050601
Title: Selected highlights from the 27th San Antonio Breast Cancer Symposium. San Antonio, TX, USA, 8-11 December 2004.
Journal: Expert opinion on pharmacotherapy 20050601
Title: Adjuvant hormone therapy for breast cancer: alternatives to tamoxifen.
Journal: Prescrire international 20050601
Title: Fulvestrant in the treatment of postmenopausal women with advanced breast cancer.
Journal: Expert review of anticancer therapy 20050601
Title: Breast cancer and sex steroids: critical review of epidemiological, experimental and clinical investigations on etiopathogenesis, chemoprevention and endocrine treatment of breast cancer.
Journal: Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20050601
Title: Breast cancer (metastatic).
Journal: Clinical evidence 20050601
Title: Skeletal health in postmenopausal survivors of early breast cancer.
Journal: International journal of cancer 20050510
Title: Phase II study of sequential hormonal therapy with anastrozole/exemestane in advanced and metastatic breast cancer.
Journal: British journal of cancer 20050509
Title: Aromatase inhibitors in the treatment of breast cancer.
Journal: Endocrine reviews 20050501
Title: The role of growth factor receptor pathways in human breast cancer cells adapted to long-term estrogen deprivation.
Journal: Cancer research 20050501
Title: Alternative to tamoxifen effective for preventing breast cancer recurrence.
Journal: Mayo Clinic women's healthsource 20050501
Title: Vascular effects of aromatase inhibitors: data from clinical trials.
Journal: The Journal of steroid biochemistry and molecular biology 20050501
Title: Aromatase inhibitors for therapy of advanced breast cancer.
Journal: The Journal of steroid biochemistry and molecular biology 20050501
Title: Model systems: mechanisms involved in the loss of sensitivity to letrozole.
Journal: The Journal of steroid biochemistry and molecular biology 20050501
Title: Mechanisms of resistance to aromatase inhibitors.
Journal: The Journal of steroid biochemistry and molecular biology 20050501
Title: Aromatase inhibitors: cellular and molecular effects.
Journal: The Journal of steroid biochemistry and molecular biology 20050501
Title: Effects of anastrozole on the intratumoral gene expression in locally advanced breast cancer.
Journal: The Journal of steroid biochemistry and molecular biology 20050501
Title: Surgical issues surrounding use of aromatase inhibitors.
Journal: The Journal of steroid biochemistry and molecular biology 20050501
Title: Remission of macroglobulinemia during anastrozole treatment for breast cancer.
Journal: The New England journal of medicine 20050421
Title: Aromatase inhibition: translation into a successful therapeutic approach.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20050415
Title: Biomarker changes during neoadjuvant anastrozole, tamoxifen, or the combination: influence of hormonal status and HER-2 in breast cancer--a study from the IMPACT trialists.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050410
Title: ATAC trial update.
Journal: Lancet (London, England) 20050401
Title: ATAC trial update.
Journal: Lancet (London, England) 20050401
Title: Letrozole-, anastrozole-, and tamoxifen-responsive genes in MCF-7aro cells: a microarray approach.
Journal: Molecular cancer research : MCR 20050401
Title: [Three cases of advanced breast cancer successfully treated with a weekly dose of paclitaxel].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20050401
Title: Role of fulvestrant in sequential hormonal therapy for advanced, hormone receptor-positive breast cancer in postmenopausal women.
Journal: Clinical breast cancer 20050401
Title: Current and future perspectives on fulvestrant.
Journal: Clinical breast cancer 20050401
Title: Effectiveness and tolerability of fulvestrant in postmenopausal women with hormone receptor-positive breast cancer.
Journal: Clinical breast cancer 20050401
Title: Anastrozole: new indication. Adjuvant treatment of non metastatic breast cancer: useful for some patients.
Journal: Prescrire international 20050401
Title: Aromatase inhibitors for the treatment and prevention of breast cancer.
Journal: Clinical breast cancer 20050401
Title: Benzofuran- and furan-2-yl-(phenyl)-3-pyridylmethanols: synthesis and inhibition of P450 aromatase.
Journal: Journal of enzyme inhibition and medicinal chemistry 20050401
Title: Anastrozole.
Journal: Drugs of today (Barcelona, Spain : 1998) 20050401
Title: Phase II study of weekly vinorelbine and 24-h infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancer.
Journal: British journal of cancer 20050328
Title: Aromatase inhibitors in advanced breast cancer: there are efficacy differences.
Journal: British journal of cancer 20050328
Title: [Breast carcinoma: new, much promising trends. The cancer anxiety of women -- will be taken better care soon?].
Journal: MMW Fortschritte der Medizin 20050310
Title: [New strategies against breast carcinoma. To outwit the resistance tendency of tumor cells].
Journal: MMW Fortschritte der Medizin 20050310
Title: Clinical applications of hormonal therapy in ovarian cancer.
Journal: Current treatment options in oncology 20050301
Title: Innovations in antineoplastic therapy.
Journal: The Nursing clinics of North America 20050301
Title: [Weekly paclitaxel administration and intraabdominal CBDCA injection possibly beneficial treatment for recurrent breast cancer associated with metastatic ovarian cancer and peritoneal dissemination after operation--a case report].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20050301
Title: Zoledronic acid prevents cancer treatment-induced bone loss.
Journal: Oncology (Williston Park, N.Y.) 20050301
Title: Aromatase inhibitor anastrozole for treating endometrial hyperplasia in obese postmenopausal women.
Journal: European journal of obstetrics, gynecology, and reproductive biology 20050201
Title: Effect of aromatase inhibition on lipids and inflammatory markers of cardiovascular disease in elderly men with low testosterone levels.
Journal: Clinical endocrinology 20050201
Title: Evaluation of tamoxifen and anastrozole in the prevention of gynecomastia and breast pain induced by bicalutamide monotherapy of prostate cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050201
Title: Endocrine treatment options for advanced breast cancer--the role of fulvestrant.
Journal: European journal of cancer (Oxford, England : 1990) 20050201
Title: The choice of systemic adjuvant therapy in receptor-positive early breast cancer.
Journal: European journal of cancer (Oxford, England : 1990) 20050201
Title: Using aromatase inhibitors in the neoadjuvant setting: evolution or revolution?
Journal: Cancer treatment reviews 20050201
Title: Adjuvant use of aromatase inhibitors in postmenopausal women with breast cancer.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20050201
Title: Evaluating bone mass and bone quality in patients with breast cancer.
Journal: Clinical breast cancer 20050201
Title: Are aromatase inhibitors superior to antiestrogens?
Journal: The Journal of steroid biochemistry and molecular biology 20050201
Title: Reversal of tamoxifen resistant breast cancer by low dose estrogen therapy.
Journal: The Journal of steroid biochemistry and molecular biology 20050201
Title: Oestrogen-selective modulation of FSH and LH secretion by pituitary gland.
Journal: British journal of cancer 20050131
Title: The role of aromatization in testosterone supplementation: effects on cognition in older men.
Journal: Neurology 20050125
Title: Oral anti-oestrogens and medical adjuncts for subfertility associated with anovulation.
Journal: The Cochrane database of systematic reviews 20050125
Title: Anastrozole data show continued delay in relapse, but no clear survival advantage.
Journal: Journal of the National Cancer Institute 20050119
Title: Gene expression profiling of breast cancer in relation to estrogen receptor status and estrogen-metabolizing enzymes: clinical implications.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20050115
Title: Therapeutic observations in MCF-7 aromatase xenografts.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20050115
Title: Endocrine therapy trials of aromatase inhibitors for breast cancer in the adjuvant and prevention settings.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20050115
Title: Short-term changes in Ki-67 during neoadjuvant treatment of primary breast cancer with anastrozole or tamoxifen alone or combined correlate with recurrence-free survival.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20050115
Title: Prevention of hormone-related cancers: breast cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050110
Title: Short-term aromatase-enzyme blockade unmasks impaired feedback adaptations in luteinizing hormone and testosterone secretion in older men.
Journal: The Journal of clinical endocrinology and metabolism 20050101
Title: Dominant transmission of prepubertal gynecomastia due to serum estrone excess: hormonal, biochemical, and genetic analysis in a large kindred.
Journal: The Journal of clinical endocrinology and metabolism 20050101
Title: The ATAC ('Arimidex', Tamoxifen, Alone or in Combination) adjuvant breast cancer trial: baseline endometrial sub-protocol data on the effectiveness of transvaginal ultrasonography and diagnostic hysteroscopy.
Journal: Human reproduction (Oxford, England) 20050101
Title: How rapidly do oncologists respond to clinical trial data?
Journal: The oncologist 20050101
Title: Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer.
Journal: Lancet (London, England) 20050101
Title: Aromatase 2004, Edinburgh, UK, 6-8 September 2004.
Journal: Breast cancer research : BCR 20050101
Title: Deficits in plasma oestradiol measurement in studies and management of breast cancer.
Journal: Breast cancer research : BCR 20050101
Title: Interactions between antiretrovirals and antineoplastic drug therapy.
Journal: Clinical pharmacokinetics 20050101
Title: Endometriosis: new genetic approaches and therapy.
Journal: Annual review of medicine 20050101
Title: Prevention and management of bicalutamide-induced gynecomastia and breast pain: randomized endocrinologic and clinical studies with tamoxifen and anastrozole.
Journal: Prostate cancer and prostatic diseases 20050101
Title: Total mastectomy under local anesthesia: the tumescent technique.
Journal: The breast journal 20050101
Title: Clinical trial update: National Cancer Institute of Canada.
Journal: Breast cancer research : BCR 20050101
Title: Optimizing the treatment of metastatic breast cancer.
Journal: Breast cancer research and treatment 20050101
Title: Effect of anastrozole and tamoxifen on lipid metabolism in Japanese postmenopausal women with early breast cancer.
Journal: Acta oncologica (Stockholm, Sweden) 20050101
Title: Preclinical and clinical experience with fulvestrant (Faslodex) in postmenopausal women with hormone receptor-positive advanced breast cancer.
Journal: Cancer investigation 20050101
Title: Aromatase inhibitors in the treatment of early and advanced breast cancer.
Journal: Acta oncologica (Stockholm, Sweden) 20050101
Title: Endocrinology and hormone therapy in breast cancer: selective oestrogen receptor modulators and downregulators for breast cancer - have they lost their way?
Journal: Breast cancer research : BCR 20050101
Title: Mechanisms of ensemble failure of the male gonadal axis in aging.
Journal: Journal of endocrinological investigation 20050101
Title: Safety considerations of adjuvant therapy in early breast cancer in postmenopausal women.
Journal: Oncology 20050101
Title: Early stopping of clinical trials.
Journal: Breast cancer research : BCR 20050101
Title: Endocrinology and hormone therapy in breast cancer: new insight into estrogen receptor-alpha function and its implication for endocrine therapy resistance in breast cancer.
Journal: Breast cancer research : BCR 20050101
Title: The future of fulvestrant ('Faslodex').
Journal: Cancer treatment reviews 20050101
Title: The role of aromatase inhibitors in ameliorating deleterious effects of ovarian stimulation on outcome of infertility treatment.
Journal: Reproductive biology and endocrinology : RB&E 20050101
Title: Life following aromatase inhibitors--where now for endocrine sequencing?
Journal: Breast cancer research and treatment 20050101
Title: Selective estrogen receptor modulators inhibit growth and progression of premalignant lesions in a mouse model of ductal carcinoma in situ.
Journal: Breast cancer research : BCR 20050101
Title: Benefit with aromatase inhibitors in the adjuvant setting for postmenopausal women with breast cancer.
Journal: MedGenMed : Medscape general medicine 20050101
Title: Sequential treatment with exemestane and non-steroidal aromatase inhibitors in advanced breast cancer.
Journal: Oncology 20050101
Title: Aromatase inhibitors as adjuvant therapy for postmenopausal women: a therapeutic advance but many unresolved questions.
Journal: Breast cancer research : BCR 20050101
Title: Treatment of Postmenopausal Breast Cancer with Selective Estrogen Receptor Modulators (SERMs).
Journal: Breast disease 20050101
Title: Aromatase inhibitors: changing the face of endocrine therapy for breast cancer.
Journal: Breast disease 20050101
Title: State of the art of neoadjuvant chemotherapy in breast cancer: rationale, results and recent developments.
Journal: German medical science : GMS e-journal 20050101
Title: Arimidex inhibition on proliferation of human breast solid tumors measured by ATP bioluminescence.
Journal: Life sciences 20041231
Title: Selective oestrogen receptor modulators/new antioestrogens: a clinical perspective.
Journal: Cancer treatment reviews 20041201
Title: Recent advances in endocrine therapy for postmenopausal women with early breast cancer: implications for treatment and prevention.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20041201
Title: Fulvestrant - a new treatment for postmenopausal women with hormone-sensitive advanced breast cancer.
Journal: Expert opinion on pharmacotherapy 20041201
Title: Anastrozole demonstrates clinical and biological effectiveness in oestrogen receptor-positive breast cancers, irrespective of the erbB2 status.
Journal: European journal of cancer (Oxford, England : 1990) 20041201
Title: The responsiveness of a tumour to any kind of therapy is reflected by the objective response rate.
Journal: European journal of cancer (Oxford, England : 1990) 20041201
Title: Neoadjuvant endocrine therapy in primary breast cancer.
Journal: Clinical breast cancer 20041201
Title: Are all aromatase inhibitors the same? A review of the current evidence.
Journal: Breast (Edinburgh, Scotland) 20041201
Title: Long-term implications of bone loss in breast cancer.
Journal: Breast (Edinburgh, Scotland) 20041201
Title: A phase I study of the pharmacokinetics, pharmacodynamics, and safety of single- and multiple-dose anastrozole in healthy, premenopausal female volunteers.
Journal: Fertility and sterility 20041201
Title: Molecular markers in the endometrium at baseline of postmenopausal patients with early breast cancer in the ATAC (Arimidex, tamoxifen, alone, or in combination) trial.
Journal: American journal of obstetrics and gynecology 20041201
Title: Osteoprotegerin and osteopontin serum values in postmenopausal advanced breast cancer patients treated with anastrozole.
Journal: Endocrine-related cancer 20041201
Title: [Tamoxifen and aromatase inhibitors in the treatment of breast cancer in menopausal women: pharmacological and clinical aspects].
Journal: Bulletin du cancer 20041201
Title: Advances in endocrine therapy for breast cancer: considering efficacy, safety, and quality of life.
Journal: Clinical journal of oncology nursing 20041201
Title: An open label 12-month pilot trial on the effects of the aromatase inhibitor anastrozole in growth hormone (GH)-treated GH deficient adolescent boys.
Journal: Journal of pediatric endocrinology & metabolism : JPEM 20041201
Title: Aromatase inhibitors and breast cancer: time for a change?
Journal: International journal of clinical practice 20041201
Title: Aromatase inhibitors in advanced breast cancer.
Journal: Seminars in oncology 20041201
Title: Aromatase inhibitors in early breast cancer therapy.
Journal: Seminars in oncology 20041201
Title: Aromatase inhibitors in the management of early breast cancer: optimizing the clinical benefit.
Journal: Seminars in oncology 20041201
Title: [Aromatase inhibitors in adjuvant setting in breast cancer].
Journal: Bulletin du cancer 20041201
Title: Biochemical and biological characterization of a novel anti-aromatase coumarin derivative.
Journal: The Journal of biological chemistry 20041112
Title: Endocrine approaches for the treatment of early and advanced breast cancer in postmenopausal women.
Journal: The international journal of biochemistry & cell biology 20041101
Title: Steroid-free medium discloses oestrogenic effects of the bisphosphonate clodronate on breast cancer cells.
Journal: British journal of cancer 20041101
Title: Quality of life of postmenopausal women in the Arimidex, Tamoxifen, Alone or in Combination (ATAC) Adjuvant Breast Cancer Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20041101
Title: Response to fulvestrant in heavily pretreated postmenopausal women: a single-center experience.
Journal: Breast cancer research and treatment 20041101
Title: [Anastrozole-resistant breast cancer responsive to exemestane--a case report].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20041101
Title: Aromatase inhibitors: a new paradigm in breast cancer treatment.
Journal: Current medicinal chemistry. Anti-cancer agents 20041101
Title: Expression of estrogen receptors-alpha and -beta in primary breast neoplasms and tumors exposed to neoadjuvant hormonal therapy.
Journal: Bulletin of experimental biology and medicine 20041101
Title: Synthesis and evaluation of 4-triazolylflavans as new aromatase inhibitors.
Journal: Bioorganic & medicinal chemistry letters 20041018
Title: Concomitant use of tamoxifen with radiotherapy enhances subcutaneous breast fibrosis in hypersensitive patients.
Journal: British journal of cancer 20041004
Title: [Ulcus terebrans. Therapy options and their limits].
Journal: Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 20041001
Title: The role of aromatase inhibitors in the adjuvant treatment of breast carcinoma: the M. D. Anderson Cancer Center evidence-based approach.
Journal: Cancer 20041001
Title: Giving patients a choice improves quality of life: a multi-centre, investigator-blind, randomised, crossover study comparing letrozole with anastrozole.
Journal: Clinical oncology (Royal College of Radiologists (Great Britain)) 20041001
Title: [Therapeutic effects of Anastrozole in patients with advanced and recurrent breast cancer].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20041001
Title: [Combination therapy with Anastrozole and 5'-DFUR as a treatment for metastatic breast cancer].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20041001
Title: [Postoperative hormone (endocrine) therapy in endometrial carcinoma].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20041001
Title: Use of estrogen antagonists and aromatase inhibitors in breast cancer and hormonally sensitive tumors of the uterine body.
Journal: Current opinion in investigational drugs (London, England : 2000) 20041001
Title: [Survival of breast cancer patients treated with inhibitors of the aromatase vs tamoxifen].
Journal: Ginecologia y obstetricia de Mexico 20041001
Title: Benefit and projected cost-effectiveness of anastrozole versus tamoxifen as initial adjuvant therapy for patients with early-stage estrogen receptor-positive breast cancer.
Journal: Cancer 20040915
Title: Current developments in hormonal therapy of breast cancer.
Journal: Clinical breast cancer 20040901
Title: The ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial: an update.
Journal: Clinical breast cancer 20040901
Title: Switching trial of adjuvant tamoxifen with an aromatase inhibitor in postmenopausal patients with breast cancer.
Journal: Clinical breast cancer 20040901
Title: Adjuvant aromatase inhibitors following tamoxifen for early-stage breast cancer in postmenopausal women: what do we really know?
Journal: Clinical breast cancer 20040901
Title: Anastrozole, an aromatase inhibitor, and medroxyprogesterone acetate therapy in premenopausal obese women with endometrial cancer: a report of two cases successfully treated without hysterectomy.
Journal: Gynecologic oncology 20040901
Title: Safety and efficacy of anastrozole for the treatment of pubertal gynecomastia: a randomized, double-blind, placebo-controlled trial.
Journal: The Journal of clinical endocrinology and metabolism 20040901
Title: A review of adjuvant hormonal therapy in breast cancer.
Journal: Endocrine-related cancer 20040901
Title: Shifting paradigms in hormonal therapy for breast cancer.
Journal: Cancer biology & therapy 20040901
Title: Acute effects of tamoxifen and third-generation aromatase inhibitors on menopausal symptoms of breast cancer patients.
Journal: Anti-cancer drugs 20040901
Title: Cost utility and budget impact of third-generation aromatase inhibitors for advanced breast cancer: a literature-based model analysis of costs in the Italian National Health Service.
Journal: Clinical therapeutics 20040901
Title: Fulvestrant: a new type of estrogen receptor antagonist for the treatment of advanced breast cancer.
Journal: Drugs of today (Barcelona, Spain : 1998) 20040901
Title: Breast surgery in the 'Arimidex, Tamoxifen Alone or in Combination' (ATAC) trial: American women are more likely than women from the United Kingdom to undergo mastectomy.
Journal: Cancer 20040815
Title: The risk of venous thromboembolic disease associated with adjuvant hormone therapy for breast carcinoma: a systematic review.
Journal: Cancer 20040801
Title: An open randomised trial of second-line endocrine therapy in advanced breast cancer: comparison of the Aromatase inhibitors letrozole and anastrozole.
Journal: European journal of cancer (Oxford, England : 1990) 20040801
Title: Recurrence of prolactin-producing endometrial stromal sarcoma with sex-cord stromal component treated with progestin and aromatase inhibitor.
Journal: Gynecologic oncology 20040801
Title: Beating breast cancer.
Journal: Nursing standard (Royal College of Nursing (Great Britain) : 1987) 20040801
Title: Role of aromatase inhibitors in the treatment of breast cancer.
Journal: Clinical therapeutics 20040801
Title: Cost-effectiveness of letrozole in the treatment of advanced breast cancer.
Journal: Expert review of pharmacoeconomics & outcomes research 20040801
Title: Cost of managing women presenting with stage IV breast cancer in the United Kingdom.
Journal: British journal of cancer 20040705
Title: Hormonal manipulation of benign metastasizing leiomyomas: report of two cases and review of the literature.
Journal: The Journal of clinical endocrinology and metabolism 20040701
Title: [Tamoxifen-induced severe hypertriglyceridemia--report of 3 cases].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20040701
Title: The curability of breast cancer and the treatment of advanced disease.
Journal: European journal of nuclear medicine and molecular imaging 20040601
Title: Anastrozole ('Arimidex') versus tamoxifen as first-line therapy in postmenopausal women with advanced breast cancer: results of the double-blind cross-over SAKK trial 21/95--a sub-study of the TARGET (Tamoxifen or 'Arimidex' Randomized Group Efficacy and Tolerability) trial.
Journal: Breast cancer research and treatment 20040601
Title: Comparison of two aromatase inhibitors in women with clomiphene-resistant polycystic ovary syndrome.
Journal: International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 20040601
Title: Aromatase inhibitors in the adjuvant setting: bringing the gold to a standard?
Journal: Cancer treatment reviews 20040601
Title: Aromatase inhibitors in breast cancer.
Journal: Endocrine-related cancer 20040601
Title: [Adjuvant treatment of breast cancer by concomitant hormonotherapy and radiotherapy: state of the art].
Journal: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique 20040601
Title: [Aromatase inhibitors in the adjuvant therapy of breast carcinomas].
Journal: Therapeutische Umschau. Revue therapeutique 20040601
Title: Aromatase inhibition in the treatment of advanced breast cancer: is there a relationship between potency and clinical efficacy?
Journal: British journal of cancer 20040504
Title: Anastrozole is safer and may be more effective than tamoxifen in postmenopausal women with early-stage breast cancer.
Journal: Cancer treatment reviews 20040501
Title: Comment on 'Anastrozole (Arimidex) versus tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: survival analysis and updated safety results' by J.-M. Nabholtz et al.
Journal: European journal of cancer (Oxford, England : 1990) 20040501
Title: Successful treatment of severe endometriosis in two premenopausal women with an aromatase inhibitor.
Journal: Fertility and sterility 20040501
Title: The estrogen suppression after sequential treatment with formestane in advanced breast cancer patients.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20040501
Title: NCCN Guideline update: Breast Cancer Version 1.2004.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN 20040501
Title: 200 Sentinel lymph node biopsies without axillary lymph node dissection -- no axillary recurrences after a 3-year follow-up.
Journal: British journal of cancer 20040419
Title: Adjuvant use of anastrozole in breast cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040415
Title: Aromatase inhibitors: current indications and future prospects for treatment of postmenopausal breast cancer.
Journal: Journal of the American Geriatrics Society 20040401
Title: [Adjuvant treatment of breast cancer in 2004. A review of the 8th consensus conference of St. Gallen and new study results].
Journal: Gynakologisch-geburtshilfliche Rundschau 20040401
Title: Effect of estrogen deprivation on follicle/oocyte maturation and embryo development in mice.
Journal: Chinese medical journal 20040401
Title: In vivo models for endocrine-dependent breast carcinomas: special considerations of clinical relevance.
Journal: European journal of cancer (Oxford, England : 1990) 20040401
Title: Therapeutic strategies using the aromatase inhibitor letrozole and tamoxifen in a breast cancer model.
Journal: Journal of the National Cancer Institute 20040317
Title: [The uterine sarcoma, a new risk identified for tamoxifen].
Journal: Presse medicale (Paris, France : 1983) 20040313
Title: The use of selective estrogen receptor modulators and selective estrogen receptor down-regulators in breast cancer.
Journal: Best practice & research. Clinical endocrinology & metabolism 20040301
Title: Aromatase inhibitors for chemoprevention.
Journal: Best practice & research. Clinical endocrinology & metabolism 20040301
Title: Effects of aromatase inhibition in elderly men with low or borderline-low serum testosterone levels.
Journal: The Journal of clinical endocrinology and metabolism 20040301
Title: Fulvestrant: an oestrogen receptor antagonist with a novel mechanism of action.
Journal: British journal of cancer 20040301
Title: Fulvestrant: pharmacokinetics and pharmacology.
Journal: British journal of cancer 20040301
Title: Fulvestrant is an effective and well-tolerated endocrine therapy for postmenopausal women with advanced breast cancer: results from clinical trials.
Journal: British journal of cancer 20040301
Title: Fulvestrant and the sequential endocrine cascade for advanced breast cancer.
Journal: British journal of cancer 20040301
Title: Clinical and endocrine data for goserelin plus anastrozole as second-line endocrine therapy for premenopausal advanced breast cancer.
Journal: British journal of cancer 20040209
Title: Feasibility of sentinel node biopsy for breast cancer after neoadjuvant endocrine therapy: a pilot study.
Journal: Journal of surgical oncology 20040201
Title: Treatment of testosterone-induced gynecomastia with the aromatase inhibitor, anastrozole.
Journal: International journal of impotence research 20040201
Title: Anastrozole (Arimidex).
Journal: Clinical journal of oncology nursing 20040201
Title: [Controversies in endocrine therapy for breast cancer].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20040201
Title: Progress in chemoprevention of breast cancer.
Journal: Critical reviews in oncology/hematology 20040201
Title: Aromatase inhibitors: new endocrine treatment of breast cancer.
Journal: Seminars in reproductive medicine 20040201
Title: Dynamic contrast enhanced magnetic resonance imaging in monitoring bone metastases in breast cancer patients receiving bisphosphonates and endocrine therapy.
Journal: Acta radiologica (Stockholm, Sweden : 1987) 20040201
Title: First-line endocrine treatment of breast cancer: aromatase inhibitor or antioestrogen?
Journal: British journal of cancer 20040112
Title: Additive antitumour effect of the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib (Iressa, ZD1839) and the antioestrogen fulvestrant (Faslodex, ICI 182,780) in breast cancer cells.
Journal: British journal of cancer 20040112
Title: Spreading the word, but not too thinly.
Journal: Lancet (London, England) 20040110
Title: Advances in estrogen receptor biology: prospects for improvements in targeted breast cancer therapy.
Journal: Breast cancer research : BCR 20040101
Title: 8th Nottingham International Breast Cancer Conference, Nottingham, UK, 16-19 September 2003.
Journal: Breast cancer research : BCR 20040101
Title: The effects of post-surgical administration of goserelin plus anastrozole compared to goserelin alone in patients with severe endometriosis: a prospective randomized trial.
Journal: Human reproduction (Oxford, England) 20040101
Title: Estrogen and androgen receptors as comediators of breast cancer cell proliferation: providing a new therapeutic tool.
Journal: Archives of surgery (Chicago, Ill. : 1960) 20040101
Title: Data from the Arimidex, tamoxifen, alone or in combination (ATAC) trial: implications for use of aromatase inhibitors in 2003.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20040101
Title: Sequencing of endocrine therapy in postmenopausal women with advanced breast cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20040101
Title: Prevention strategies with aromatase inhibitors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20040101
Title: Does hormone therapy for the treatment of breast cancer have a detrimental effect on memory and cognition? A pilot study.
Journal: Psycho-oncology 20040101
Title: [Neoadjuvant endocrine therapy for breast cancer: an overview].
Journal: Bulletin du cancer 20040101
Title: 26th Annual San Antonio Breast Cancer Symposium, San Antonio, Texas, USA, 3-6 December 2003: update on clinical research.
Journal: Breast cancer research : BCR 20040101
Title: Hormonal therapy in early and advanced breast cancer.
Journal: The breast journal 20040101
Title: Fulvestrant: a review of its use in hormone receptor-positive metastatic breast cancer in postmenopausal women with disease progression following antiestrogen therapy.
Journal: Drugs 20040101
Title: Aromatase inhibitors for breast cancer in postmenopausal women.
Journal: The oncologist 20040101
Title: The impact of hormone receptor status on the clinical efficacy of the new-generation aromatase inhibitors: a review of data from first-line metastatic disease trials in postmenopausal women.
Journal: The breast journal 20040101
Title: Anastrozole as neoadjuvant therapy for patients with hormone-dependent, locally-advanced breast cancer.
Journal: Anticancer research 20040101
Title: Letrozole: a review of its use in postmenopausal women with breast cancer.
Journal: Drugs 20040101
Title: Pharmacokinetic profile of intramuscular fulvestrant in advanced breast cancer.
Journal: Clinical pharmacokinetics 20040101
Title: [The ATAC study on adjuvants in breast cancer].
Journal: I supplementi di Tumori : official journal of Societa italiana di cancerologia ... [et al.] 20040101
Title: [The ATAC study on adjuvants in breast cancer. What kind of repercussions will it have on clinical practice?].
Journal: I supplementi di Tumori : official journal of Societa italiana di cancerologia ... [et al.] 20040101
Title: Breast cancer research and the European Union Clinical Trials Directive.
Journal: Breast cancer research : BCR 20040101
Title: Report on the 4th European Breast Cancer Conference, Hamburg, Germany, 16-20 March 2004.
Journal: Breast cancer research : BCR 20040101
Title: Clinical trials update of the European Organization for Research and Treatment of Cancer Breast Cancer Group.
Journal: Breast cancer research : BCR 20040101
Title: Tamoxifen--what next?
Journal: The oncologist 20040101
Title: Treatment of pubertal gynecomastia with the specific aromatase inhibitor anastrozole.
Journal: Hormone research 20040101
Title: Current status of aromatase inhibitors in the management of breast cancer and critique of the NCIC MA-17 trial.
Journal: Cancer control : journal of the Moffitt Cancer Center 20040101
Title: Endocrinology and hormone therapy in breast cancer: aromatase inhibitors versus antioestrogens.
Journal: Breast cancer research : BCR 20040101
Title: Fulvestrant ('Faslodex')--a new hormonal treatment for advanced breast cancer.
Journal: European journal of oncology nursing : the official journal of European Oncology Nursing Society 20040101
Title: Biomarker investigations from the ATAC trial: the role of TA01.
Journal: Breast cancer research and treatment 20040101
Title: The scientific value of preoperative studies and how they can be used.
Journal: Breast cancer research and treatment 20040101
Title: Designing the future shape of breast cancer diagnosis, prognosis and treatment.
Journal: Breast cancer research and treatment 20040101
Title: Changes in endocrine therapy: anastrozole and advanced breast cancer in postmenopausal women.
Journal: The American journal of hospice & palliative care 20040101
Title: [AIOM Conference 2004. Endocrine therapy and management of patients with bone metastasis of breast cancer].
Journal: Tumori 20040101
Title: [New prevention strategies against breast cancer and cervical carcinoma. What can you advice to your patients].
Journal: MMW Fortschritte der Medizin 20031211
Title: [Interview with Prof. Dr. Wolfgang Eiermann. Which women need a medicamentous breast cancer prophylaxis?].
Journal: MMW Fortschritte der Medizin 20031211
Title: New findings about endocrine therapy for breast cancer.
Journal: Breast (Edinburgh, Scotland) 20031201
Title: Pharmacological prevention of breast cancer: quo vadis?
Journal: Breast (Edinburgh, Scotland) 20031201
Title: The best use of adjuvant endocrine treatments.
Journal: Breast (Edinburgh, Scotland) 20031201
Title: The ATAC adjuvant breast cancer trial in postmenopausal women: baseline endometrial subprotocol data.
Journal: BJOG : an international journal of obstetrics and gynaecology 20031201
Title: Phase II trial of anastrozole in women with asymptomatic müllerian cancer.
Journal: Gynecologic oncology 20031201
Title: A review of the efficacy of anastrozole in postmenopausal women with advanced breast cancer with visceral metastases.
Journal: Breast cancer research and treatment 20031201
Title: New developments in endocrine therapy: role of adjuvant therapy for early breast cancer.
Journal: Cancer nursing 20031201
Title: Clinical trials update: Medical management of advanced breast cancer.
Journal: Cancer nursing 20031201
Title: Breast cancer (metastatic).
Journal: Clinical evidence 20031201
Title: Endogenous estrogens influence endothelial function in young men.
Journal: Circulation research 20031128
Title: Effects of imatinib mesylate (STI571, Glivec) on the pharmacokinetics of simvastatin, a cytochrome p450 3A4 substrate, in patients with chronic myeloid leukaemia.
Journal: British journal of cancer 20031117
Title: Signaling pathways of apoptosis activated by aromatase inhibitors and antiestrogens.
Journal: Cancer research 20031115
Title: Economic evaluation of antiaromatase agents in the second-line treatment of metastatic breast cancer.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20031101
Title: Efficacy of tamoxifen following anastrozole ('Arimidex') compared with anastrozole following tamoxifen as first-line treatment for advanced breast cancer in postmenopausal women.
Journal: European journal of cancer (Oxford, England : 1990) 20031101
Title: An open randomised trial of second-line endocrine therapy in advanced breast cancer. comparison of the aromatase inhibitors letrozole and anastrozole.
Journal: European journal of cancer (Oxford, England : 1990) 20031101
Title: Adjuvant aromatase inhibitors: are we there yet?
Journal: Cancer 20031101
Title: Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer: results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety update analyses.
Journal: Cancer 20031101
Title: ATAC trial did not report interim results.
Journal: BMJ (Clinical research ed.) 20031101
Title: Aromatase inhibitors in breast cancer therapy.
Journal: Clinical breast cancer 20031101
Title: Cost-effectiveness of anastrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer.
Journal: Clinical therapeutics 20031101
Title: Doctors test drug to prevent cancer in high risk women.
Journal: BMJ (Clinical research ed.) 20031004
Title: Anastrozole and quinapril can be safely coadministered to elderly women with breast cancer and hypertension: a pharmacokinetic study.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20031001
Title: Fulvestrant in postmenopausal women with advanced breast cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20031001
Title: Fulvestrant: an estrogen receptor antagonist that downregulates the estrogen receptor.
Journal: Seminars in oncology 20031001
Title: Role of anastrozole in adjuvant therapy for postmenopausal patients.
Journal: Seminars in oncology 20031001
Title: The pharmacology of letrozole.
Journal: The Journal of steroid biochemistry and molecular biology 20031001
Title: An oncology perspective on the benefits and cost of combined androgen blockade in advanced prostate cancer.
Journal: The Canadian journal of urology 20031001
Title: Anastrozole for ductal carcinoma in situ.
Journal: Lancet (London, England) 20030906
Title: [Adjuvant endocrine treatment of breast cancer beyond St. Gallen 2003].
Journal: Zentralblatt fur Gynakologie 20030901
Title: Breast cancer tissue estrogens and their manipulation with aromatase inhibitors and inactivators.
Journal: The Journal of steroid biochemistry and molecular biology 20030901
Title: Neoadjuvant tamoxifen and aromatase inhibitors: comparisons and clinical outcomes.
Journal: The Journal of steroid biochemistry and molecular biology 20030901
Title: Neoadjuvant comparisons of aromatase inhibitors and tamoxifen: pretreatment determinants of response and on-treatment effect.
Journal: The Journal of steroid biochemistry and molecular biology 20030901
Title: Aromatase inhibitors as adjuvant therapies in patients with breast cancer.
Journal: The Journal of steroid biochemistry and molecular biology 20030901
Title: Aromatase inhibitors versus tamoxifen for management of postmenopausal breast cancer in the advanced disease and neoadjuvant settings.
Journal: The Journal of steroid biochemistry and molecular biology 20030901
Title: Advanced breast cancer updates on anastrozole versus tamoxifen.
Journal: The Journal of steroid biochemistry and molecular biology 20030901
Title: 'Arimidex' (anastrozole) versus tamoxifen as adjuvant therapy in postmenopausal women with early breast cancer--efficacy overview.
Journal: The Journal of steroid biochemistry and molecular biology 20030901
Title: The effects of hormone therapy on cognition in breast cancer.
Journal: The Journal of steroid biochemistry and molecular biology 20030901
Title: An integrated view of aromatase and its inhibition.
Journal: The Journal of steroid biochemistry and molecular biology 20030901
Title: Role of steroid sulfatase in local formation of estrogen in post-menopausal breast cancer patients.
Journal: The Journal of steroid biochemistry and molecular biology 20030901
Title: Breast cancer prevention--clinical trials strategies involving aromatase inhibitors.
Journal: The Journal of steroid biochemistry and molecular biology 20030901
Title: Bone metastases from breast carcinoma: histopathological - radiological correlations and prognostic features.
Journal: British journal of cancer 20030818
Title: The current status of aromatase inhibitors in the management of breast cancer.
Journal: The Surgical clinics of North America 20030801
Title: Anastrozole (Arimidex) versus tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: survival analysis and updated safety results.
Journal: European journal of cancer (Oxford, England : 1990) 20030801
Title: A comparison of the efficacy of aromatase inhibitors in second-line treatment of metastatic breast cancer.
Journal: American journal of clinical oncology 20030801
Title: Applicability of the intratumor aromatase preclinical model to predict clinical trial results with endocrine therapy.
Journal: American journal of clinical oncology 20030801
Title: Emerging role of aromatase inhibitors in the adjuvant setting.
Journal: American journal of clinical oncology 20030801
Title: Examining quality of life issues in relation to endocrine therapy for breast cancer.
Journal: American journal of clinical oncology 20030801
Title: Progress in systemic adjuvant therapy of early-stage breast cancer.
Journal: International journal of clinical oncology 20030801
Title: Should aromatase inhibitors replace tamoxifen?
Journal: Drug and therapeutics bulletin 20030801
Title: Aromatase inhibitors: mechanism of action and role in the treatment of breast cancer.
Journal: Seminars in oncology 20030801
Title: Aromatase inhibitor development and hormone therapy: a perspective.
Journal: Seminars in oncology 20030801
Title: Pharmacokinetics of third-generation aromatase inhibitors.
Journal: Seminars in oncology 20030801
Title: The role of aromatase inhibitors in the treatment of metastatic breast cancer.
Journal: Seminars in oncology 20030801
Title: Aromatase inhibitors in early breast cancer treatment.
Journal: Seminars in oncology 20030801
Title: Hormonal therapy: introduction.
Journal: Breast (Edinburgh, Scotland) 20030801
Title: Challenges in the endocrine management of breast cancer.
Journal: Breast (Edinburgh, Scotland) 20030801
Title: Biological response to hormonal manipulation in oestrogen receptor positive ductal carcinoma in situ of the breast.
Journal: British journal of cancer 20030721
Title: Fulvestrant versus anastrozole for the treatment of advanced breast carcinoma in postmenopausal women: a prospective combined analysis of two multicenter trials.
Journal: Cancer 20030715
Title: Oestrogen receptor downregulation: an opportunity for extending the window of endocrine therapy in advanced breast cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20030701
Title: Is there a benefit by the sequence anastrozole-formestane for postmenopausal metastatic breast cancer women?
Journal: The Journal of steroid biochemistry and molecular biology 20030701
Title: ATAC trial: reporting interim results is not helpful.
Journal: BMJ (Clinical research ed.) 20030614
Title: [Hormone therapy, chemotherapy and immunotherapy in breast carcinoma. The best strategy for your patient].
Journal: MMW Fortschritte der Medizin 20030612
Title: Is low-dose tamoxifen useful for the treatment and prevention of breast cancer?
Journal: Journal of the National Cancer Institute 20030604
Title: Fulvestrant (Faslodex) versus anastrozole for the second-line treatment of advanced breast cancer in subgroups of postmenopausal women with visceral and non-visceral metastases: combined results from two multicentre trials.
Journal: European journal of cancer (Oxford, England : 1990) 20030601
Title: Cost utility analysis of first-line hormonal therapy in advanced breast cancer: comparison of two aromatase inhibitors to tamoxifen.
Journal: American journal of clinical oncology 20030601
Title: Anastrozole versus tamoxifen as first-line therapy in postmenopausal patients with hormone-dependent advanced breast cancer: a prospective, randomized, phase III study.
Journal: American journal of clinical oncology 20030601
Title: Aromatase inhibition for the treatment of idiopathic hypogonadotropic hypogonadism in men with premature ejaculation.
Journal: Southern medical journal 20030601
Title: Anastrozole as a preventive agent in breast cancer.
Journal: Lancet (London, England) 20030531
Title: Estrogen excess associated with novel gain-of-function mutations affecting the aromatase gene.
Journal: The New England journal of medicine 20030508
Title: Could exemestane affect insulin-like growth factors, interleukin 6 and bone metabolism in postmenopausal advanced breast cancer patients after failure on aminoglutethimide, anastrozole or letrozole?
Journal: International journal of oncology 20030501
Title: The effect of high dehydroepiandrosterone sulfate levels on tamoxifen blockade and breast cancer progression.
Journal: American journal of surgery 20030501
Title: Long-term toxicities of selective estrogen-receptor modulators and antiaromatase agents.
Journal: Oncology (Williston Park, N.Y.) 20030501
Title: Postmenopausal women who progress on fulvestrant ('Faslodex') remain sensitive to further endocrine therapy.
Journal: Breast cancer research and treatment 20030501
Title: The role of aromatase inhibitors in early breast cancer.
Journal: Current treatment options in oncology 20030401
Title: Adjuvant systemic therapy of early stage breast cancer.
Journal: Current treatment options in oncology 20030401
Title: Update on the current use of hormonals as therapy in advanced breast cancer.
Journal: Anti-cancer drugs 20030401
Title: [Present and future of adjuvant hormone therapy in breast cancer: clinical evidence and clinical trials].
Journal: Revista clinica espanola 20030401
Title: Aromatase inhibitors for treatment of postmenopausal patients with breast cancer.
Journal: Expert review of anticancer therapy 20030401
Title: 21. The adjuvant treatment of breast cancer.
Journal: International journal of clinical practice 20030401
Title: Anastrozole as adjuvant therapy for early-stage breast cancer: implications of the ATAC trial.
Journal: Clinical breast cancer 20030401
Title: The aromatase inhibitors as adjuvant therapy for hormone receptor-positive breast cancer.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN 20030401
Title: Anastrozole (Arimidex) vs. tamoxifen for treatment of early breast cancer.
Journal: The Medical letter on drugs and therapeutics 20030317
Title: Is tamoxifen the Rosetta stone for breast cancer?
Journal: Journal of the National Cancer Institute 20030305
Title: The therapeutic potential of aromatase inhibitors.
Journal: Expert opinion on investigational drugs 20030301
Title: Aromatase inhibitors as adjuvant therapy in breast cancer.
Journal: Oncology (Williston Park, N.Y.) 20030301
Title: Inhibition of IL-6+IL-6 soluble receptor-stimulated aromatase activity by the IL-6 antagonist, Sant 7, in breast tissue-derived fibroblasts.
Journal: British journal of cancer 20030224
Title: Update on clinical role of tamoxifen.
Journal: Current opinion in obstetrics & gynecology 20030201
Title: Current and future status of adjuvant therapy for breast cancer.
Journal: Cancer 20030201
Title: Update on ATAC.
Journal: European journal of cancer (Oxford, England : 1990) 20030201
Title: Breast cancer prevention.
Journal: The British journal of general practice : the journal of the Royal College of General Practitioners 20030201
Title: [Summit meeting of breast cancer experts--many new ideas and practical progress. When the breast becomes malignant].
Journal: MMW Fortschritte der Medizin 20030123
Title: Differential effects of androgens and estrogens on bone turnover in normal men.
Journal: The Journal of clinical endocrinology and metabolism 20030101
Title: Predictions from a preclinical model: studies of aromatase inhibitors and antiestrogens.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20030101
Title: Pharmacology and pharmacokinetics of the newer generation aromatase inhibitors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20030101
Title: Clinical differences among the aromatase inhibitors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20030101
Title: Adjuvant endocrine therapy in postmenopausal breast cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20030101
Title: National surgical adjuvant breast and bowel project update: prevention trials and endocrine therapy of ductal carcinoma in situ.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20030101
Title: 25th Annual San Antonio Breast Cancer Symposium, San Antonio, Texas, USA, 10-14 December 2002 Update on clinical research.
Journal: Breast cancer research : BCR 20030101
Title: Treatment of breast cancer in countries with limited resources.
Journal: The breast journal 20030101
Title: Current status of endocrine therapy for breast cancer.
Journal: Breast cancer (Tokyo, Japan) 20030101
Title: Anastrozole-induced remission of diaphragmatic paralysis from metastatic breast cancer treated with multiple prior therapies.
Journal: Breast cancer (Tokyo, Japan) 20030101
Title: New options in the prevention and treatment of breast carcinoma.
Journal: Journal of the Medical Association of Georgia 20030101
Title: A roundtable discussion of aromatase inhibitors as therapy for breast cancer.
Journal: The breast journal 20030101
Title: Hormonal therapy in postmenopausal women with breast cancer.
Journal: Oncology 20030101
Title: Advances in endocrine treatments for postmenopausal women with metastatic and early breast cancer.
Journal: The oncologist 20030101
Title: Aromatase inhibitors in prevention--data from the ATAC (arimidex, tamoxifen alone or in combination) trial and the design of IBIS-II (the second International Breast Cancer Intervention Study).
Journal: Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer 20030101
Title: Safety issues surrounding the use of aromatase inhibitors in breast cancer.
Journal: Expert opinion on drug safety 20030101
Title: Advances in breast cancer treatment and prevention: preclinical studies on aromatase inhibitors and new selective estrogen receptor modulators (SERMs).
Journal: Breast cancer research : BCR 20030101
Title: 5th Milan Breast Cancer Conference, Milan, Italy, 11-13 June 2003.
Journal: Breast cancer research : BCR 20030101
Title: [Perspectives for the hormonal therapy of breast cancer].
Journal: Magyar onkologia 20030101
Title: [Aromatase inhibitors--theoretical concept and present experiences in the treatment of endometriosis].
Journal: Zentralblatt fur Gynakologie 20030101
Title: Three years' follow-up from the ATAC trial is sufficient to change clinical practice: a debate.
Journal: Breast cancer research and treatment 20030101
Title: Sequential hormonal therapy for metastatic breast cancer after adjuvant tamoxifen or anastrozole.
Journal: Breast cancer research and treatment 20030101
Title: Future directions in the endocrine therapy of breast cancer.
Journal: Breast cancer research and treatment 20030101
Title: Introducing a new section to Breast Cancer Research: endocrinology and hormone therapy.
Journal: Breast cancer research : BCR 20030101
Title: Focus on anastrozole and breast cancer.
Journal: Current medical research and opinion 20030101
Title: NCCN breast cancer clinical practice guidelines in oncology: an update.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN 20030101
Title: Questions about anastrozole for early breast cancer.
Journal: Lancet (London, England) 20021207
Title: Questions about anastrozole for early breast cancer.
Journal: Lancet (London, England) 20021207
Title: A phase I trial to assess the pharmacology of the new oestrogen receptor antagonist fulvestrant on the endometrium in healthy postmenopausal volunteers.
Journal: British journal of cancer 20021202
Title: Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor-positive advanced breast carcinoma.
Journal: Cancer 20021201
Title: New treatment option for postmenopausal women with early breast cancer.
Journal: Expert review of anticancer therapy 20021201
Title: Anastrozole (Arimidex) in clinical practice versus the old 'gold standard', tamoxifen.
Journal: Expert review of anticancer therapy 20021201
Title: [A case of recurrent breast cancer with carcinomatous pleurisy successfully treated with combined chemoendocrine-therapy of CTF (CPA, THP and 5-FU) and anastrozole following instillation therapy 12 years after radical mastectomy].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20021201
Title: Fulvestrant ('Faslodex')--a new treatment option for patients progressing on prior endocrine therapy.
Journal: Endocrine-related cancer 20021201
Title: From the Food and Drug Administration.
Journal: JAMA 20021106
Title: Expression and purification of a recombinant form of human aromatase from Escherichia coli.
Journal: Biochemical pharmacology 20021101
Title: An overview of the pharmacology and pharmacokinetics of the newer generation aromatase inhibitors anastrozole, letrozole, and exemestane.
Journal: Cancer 20021101
Title: Anastrozole versus progestins/tamoxifen.
Journal: European journal of cancer (Oxford, England : 1990) 20021101
Title: Fulvestrant versus anastrozole as second-line treatment of advanced breast cancer in postmenopausal women.
Journal: European journal of cancer (Oxford, England : 1990) 20021101
Title: Selective oestrogen receptor downregulator.
Journal: European journal of cancer (Oxford, England : 1990) 20021101
Title: Neoadjuvant endocrine therapy of breast cancer: a surgical perspective.
Journal: European journal of cancer (Oxford, England : 1990) 20021101
Title: Effects of anastrozole on lipid metabolism compared with tamoxifen in rats.
Journal: Breast cancer research and treatment 20021101
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20021101
Title: Anastrozole ('Arimidex') blocks oestrogen synthesis both peripherally and within the breast in postmenopausal women with large operable breast cancer.
Journal: British journal of cancer 20021021
Title: New generation aromatase inhibitors--from the advanced to the adjuvant setting.
Journal: Breast cancer research and treatment 20021001
Title: A new estrogen receptor antagonist--an overview of available data.
Journal: Breast cancer research and treatment 20021001
Title: Sequencing of endocrine therapies in breast cancer--integration of recent data.
Journal: Breast cancer research and treatment 20021001
Title: The novel use of very high doses of cabergoline and a combination of testosterone and an aromatase inhibitor in the treatment of a giant prolactinoma.
Journal: The Journal of clinical endocrinology and metabolism 20021001
Title: The ATAC (Arimidex, Tamoxifen, Alone or in Combination) adjuvant breast cancer trial in postmenopausal patients: factors influencing the success of patient recruitment.
Journal: European journal of cancer (Oxford, England : 1990) 20021001
Title: The evolving role of aromatase inhibitors in breast cancer.
Journal: International journal of clinical oncology 20021001
Title: Invasive lobular carcinoma of the breast presenting successively with colonic and gastric metastases.
Journal: International journal of clinical practice 20021001
Title: [Campaign against breast cancer. Are aromatase inhibitors the better choice? (interview by Dr. Dorothea Dlugosch)].
Journal: MMW Fortschritte der Medizin 20020919
Title: Anastrozole in the management of breast cancer.
Journal: Expert opinion on pharmacotherapy 20020901
Title: Anastrozole versus tamoxifen as first-line therapy for advanced breast cancer: methodologic issues.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020901
Title: Rapid determination of anastrozole in plasma by gas chromatography with electron capture detection and its application to an oral pharmacokinetic study in healthy volunteers.
Journal: Biomedical chromatography : BMC 20020901
Title: [Advanced breast cancer with lung and pleural metastases responsive to anastrozole--a case report].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20020901
Title: Double-blind, randomized trial comparing the efficacy and tolerability of fulvestrant versus anastrozole in postmenopausal women with advanced breast cancer progressing on prior endocrine therapy: results of a North American trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020815
Title: Fulvestrant, formerly ICI 182,780, is as effective as anastrozole in postmenopausal women with advanced breast cancer progressing after prior endocrine treatment.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020815
Title: American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for women with hormone receptor-positive breast cancer: status report 2002.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020801
Title: Effect of neoadjuvant treatment with anastrozole on tumour histology in postmenopausal women with large operable breast cancer.
Journal: British journal of cancer 20020729
Title: Endocrine effects of nonsteroidal aromatase inhibitors and their clinical impact.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020701
Title: The effect of second-line antiestrogen therapy on breast tumor growth after first-line treatment with the aromatase inhibitor letrozole: long-term studies using the intratumoral aromatase postmenopausal breast cancer model.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20020701
Title: Stick with tried-and-true breast cancer treatment.
Journal: Health news (Waltham, Mass.) 20020701
Title: New alternative to tamoxifen.
Journal: Harvard women's health watch 20020701
Title: Biological activity of anastrozole in postmenopausal patients with advanced breast cancer: effects on estrogens and bone metabolism.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20020701
Title: Aromatase inhibitors for the endocrine adjuvant treatment of breast cancer.
Journal: Lancet (London, England) 20020622
Title: Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial.
Journal: Lancet (London, England) 20020622
Title: Aromatase inhibition for ovarian stimulation: future avenues for infertility management.
Journal: Current opinion in obstetrics & gynecology 20020601
Title: Efficacy of anastrozole in male breast cancer.
Journal: American journal of clinical oncology 20020601
Title: [Antiestrogen therapy in the treatment of breast neoplasms].
Journal: Minerva ginecologica 20020601
Title: Letrozole for the management of breast cancer.
Journal: Expert review of anticancer therapy 20020601
Title: Recent advances in aromatase inhibitor therapy for breast cancer.
Journal: Seminars in oncology 20020601
Title: Concept evaluation: an assay for receptor-mediated and biochemical antiestrogens using pubertal rats.
Journal: Regulatory toxicology and pharmacology : RTP 20020601
Title: A better medication for treating breast cancer?
Journal: The Johns Hopkins medical letter health after 50 20020501
Title: Factors affecting progression-free survival in hormone-dependent metastatic breast cancer patients receiving high-dose chemotherapy and hematopoietic progenitor cell transplantation: role of maintenance endocrine therapy.
Journal: Bone marrow transplantation 20020501
Title: Effects of aromatase inhibition on in vitro follicle and oocyte development analyzed by early preantral mouse follicle culture.
Journal: Molecular reproduction and development 20020401
Title: New breast cancer drugs expand treatment options.
Journal: Harvard women's health watch 20020401
Title: Short-term effects of anastrozole treatment on insulin-like growth factor system in postmenopausal advanced breast cancer patients.
Journal: The Journal of steroid biochemistry and molecular biology 20020401
Title: Antiaromatase agents: evolving role in adjuvant therapy.
Journal: Clinical breast cancer 20020401
Title: [The role of aromatase inhibitors in the treatment of breast neoplasms. An evaluation of clinical efficacy and the tolerability profile].
Journal: Minerva ginecologica 20020401
Title: The oncology nurse's role in educating patients on endocrine therapy for metastatic breast cancer--focus on fulvestrant.
Journal: Cancer nursing 20020401
Title: Existing and emerging endocrine therapies for breast cancer.
Journal: Cancer nursing 20020401
Title: Gateways to Clinical Trials.
Journal: Methods and findings in experimental and clinical pharmacology 20020401
Title: Fulvestrant (Faslodex): current status in the therapy of breast cancer.
Journal: Expert review of anticancer therapy 20020401
Title: Aromatase inhibitors in breast cancer therapy.
Journal: Expert review of anticancer therapy 20020401
Title: Detection of aromatase inhibitors in vitro using rat ovary microsomes.
Journal: Toxicology letters 20020324
Title: Aromatase inhibitors in breast cancer.
Journal: Trends in endocrinology and metabolism: TEM 20020301
Title: Experience of hormonal therapy with anastrozole for previously treated metastatic breast cancer.
Journal: The Israel Medical Association journal : IMAJ 20020301
Title: Aromatase inhibitors for male infertility.
Journal: The Journal of urology 20020201
Title: Influence of letrozole and anastrozole on total body aromatization and plasma estrogen levels in postmenopausal breast cancer patients evaluated in a randomized, cross-over study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020201
Title: Fulvestrant.
Journal: Expert opinion on investigational drugs 20020201
Title: [Aromatase inhibitors of the 3rd generation. What can the 'pill against breast cancer' really do?].
Journal: MMW Fortschritte der Medizin 20020131
Title: World's largest breast cancer treatment trial supports anastrozole use.
Journal: Oncology (Williston Park, N.Y.) 20020101
Title: Hormones 'R' us.
Journal: Clinical breast cancer 20020101
Title: Estrogen receptor downregulators: new antihormonal therapy for advanced breast cancer.
Journal: Clinical therapeutics 20020101
Title: Aromatase inhibitors continue their ATAC on tamoxifen.
Journal: Trends in molecular medicine 20020101
Title: Tamoxifen resistant and refractory breast cancer: the value of aromatase inhibitors.
Journal: Drugs 20020101
Title: Anti-aromatase agents in the treatment and prevention of breast cancer.
Journal: Cancer control : journal of the Moffitt Cancer Center 20020101
Title: Endocrine and clinical endpoints of exemestane as neoadjuvant therapy.
Journal: Cancer control : journal of the Moffitt Cancer Center 20020101
Title: Recent advances in breast cancer (the Twenty-fourth San Antonio Breast Cancer Symposium, December, 2001).
Journal: Current medical research and opinion 20020101
Title: Estrogen as therapy for breast cancer.
Journal: Breast cancer research : BCR 20020101
Title: Finding the needle in the haystack: why high-throughput screening is good for your health.
Journal: Breast cancer research : BCR 20020101
Title: The impact of hormonal treatments on quality of life of patients with metastatic breast cancer.
Journal: Clinical therapeutics 20020101
Title: Evolving uses of hormonal agents for breast cancer therapy.
Journal: Clinical therapeutics 20020101
Title: Sequencing of hormonal therapy in postmenopausal women with metastatic breast cancer.
Journal: Clinical therapeutics 20020101
Title: Efficacy and economics of hormonal therapies for advanced breast cancer.
Journal: Drugs & aging 20020101
Title: McCune-Albright syndrome--the German experience.
Journal: Journal of pediatric endocrinology & metabolism : JPEM 20020101
Title: Effective aromatase inhibition by anastrozole in a patient with gonadotropin-independent precocious puberty in McCune-Albright syndrome.
Journal: Journal of pediatric endocrinology & metabolism : JPEM 20020101
Title: British Cancer Research Meeting, 30 June-3 July 2002, Glasgow.
Journal: Breast cancer research : BCR 20020101
Title: Tumour Fas ligand:Fas ratio greater than 1 is an independent marker of relative resistance to tamoxifen therapy in hormone receptor positive breast cancer.
Journal: Breast cancer research : BCR 20020101
Title: Anastrozole: in early breast cancer.
Journal: Drugs 20020101
Title: Breast cancer chemoprevention--an update.
Journal: Current medical research and opinion 20020101
Title: Current role of endocrine therapy in the management of breast cancer.
Journal: Breast cancer (Tokyo, Japan) 20020101
Title: Has tamoxifen had its day?
Journal: Breast cancer research : BCR 20020101
Title: A new day dawns: women without oestrogen or is a balance best?
Journal: Breast cancer research : BCR 20020101
Title: Advances in breast oncology: the 2002 ASCO meeting.
Journal: Current medical research and opinion 20020101
Title: FDA drug approval summaries: fulvestrant.
Journal: The oncologist 20020101
Title: Aromatase inhibitors in breast cancer: an update.
Journal: Cancer control : journal of the Moffitt Cancer Center 20020101
Title: Interactions of antioestrogens and aromatase inhibitors.
Journal: Forum (Genoa, Italy) 20020101
Title: HER-2 amplification impedes the antiproliferative effects of hormone therapy in estrogen receptor-positive primary breast cancer.
Journal: Cancer research 20011201
Title: High dehydroepiandrosterone-sulfate predicts breast cancer progression during new aromatase inhibitor therapy and stimulates breast cancer cell growth in tissue culture: a renewed role for adrenalectomy.
Journal: Surgery 20011201
Title: Comparative clinical pharmacology and pharmacokinetic interactions of aromatase inhibitors.
Journal: The Journal of steroid biochemistry and molecular biology 20011201
Title: Local endocrine effects of aromatase inhibitors within the breast.
Journal: The Journal of steroid biochemistry and molecular biology 20011201
Title: Biological and clinical effects of aromatase inhibitors in neoadjuvant therapy.
Journal: The Journal of steroid biochemistry and molecular biology 20011201
Title: A summary of second-line randomized studies of aromatase inhibitors.
Journal: The Journal of steroid biochemistry and molecular biology 20011201
Title: Adjuvant trials of aromatase inhibitors: determining the future landscape of adjuvant endocrine therapy.
Journal: The Journal of steroid biochemistry and molecular biology 20011201
Title: Faslodex (ICI 182, 780), a novel estrogen receptor downregulator--future possibilities in breast cancer.
Journal: The Journal of steroid biochemistry and molecular biology 20011201
Title: Where do selective estrogen receptor modulators (SERMs) and aromatase inhibitors (AIs) now fit into breast cancer treatment algorithms?
Journal: The Journal of steroid biochemistry and molecular biology 20011201
Title: The role of tamoxifen and aromatase inhibitors/inactivators in postmenopausal patients.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20011201
Title: Are differences in the available aromatase inhibitors and inactivators significant?
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20011201
Title: Preliminary experience with pure antiestrogens.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20011201
Title: Preliminary data from ongoing adjuvant aromatase inhibitor trials.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20011201
Title: Future use of selective estrogen receptor modulators and aromatase inhibitors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20011201
Title: Promising results for Arimidex and Femara.
Journal: Expert review of anticancer therapy 20011201
Title: Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinoma.
Journal: Cancer 20011101
Title: Formestane, a steroidal aromatase inhibitor after failure of non-steroidal aromatase inhibitors (anastrozole and letrozole): is a clinical benefit still achievable?
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20011101
Title: ICI 182,780 (Fulvestrant)--the first oestrogen receptor down-regulator--current clinical data.
Journal: British journal of cancer 20011101
Title: A vision for the future?
Journal: British journal of cancer 20011101
Title: Anastrozole (Arimidex)--an aromatase inhibitor for the adjuvant setting?
Journal: British journal of cancer 20011101
Title: Aromatase inhibitors and inactivators in breast cancer.
Journal: BMJ (Clinical research ed.) 20011020
Title: Use of the aromatase inhibitor anastrozole in the treatment of patients with advanced prostate carcinoma.
Journal: Cancer 20011015
Title: Role of anti-aromatase agents in postmenopausal advanced breast cancer.
Journal: Cancer chemotherapy and pharmacology 20011001
Title: Advances in aromatase inhibition: clinical efficacy and tolerability in the treatment of breast cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20010901
Title: Pharmacokinetics of anastrozole and tamoxifen alone, and in combination, during adjuvant endocrine therapy for early breast cancer in postmenopausal women: a sub-protocol of the 'Arimidex and tamoxifen alone or in combination' (ATAC) trial.
Journal: British journal of cancer 20010801
Title: Nonsteroidal and steroidal aromatase inhibitors in breast cancer.
Journal: Oncology (Williston Park, N.Y.) 20010801
Title: Exemestane: new preparation. No tangible advance in metastatic breast cancer after tamoxifen failure.
Journal: Prescrire international 20010801
Title: Anastrozole: pharmacological and clinical profile in postmenopausal women with breast cancer.
Journal: Expert review of anticancer therapy 20010801
Title: [Developments of hormonal agents for breast cancer].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20010701
Title: [Endocrine therapy for advanced or recurrent breast cancer].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20010701
Title: Aromatization mediates testosterone's short-term feedback restraint of 24-hour endogenously driven and acute exogenous gonadotropin-releasing hormone-stimulated luteinizing hormone and follicle-stimulating hormone secretion in young men.
Journal: The Journal of clinical endocrinology and metabolism 20010601
Title: The effect of aromatase inhibition on sex steroids, gonadotropins, and markers of bone turnover in older men.
Journal: The Journal of clinical endocrinology and metabolism 20010601
Title: Endocrine therapy in the treatment of metastatic breast cancer.
Journal: Seminars in oncology 20010601
Title: Anastrozole: licence extension. No advantage over tamoxifen in advanced-stage breast cancer.
Journal: Prescrire international 20010601
Title: Pharmacokinetics of anastrozole in Chinese male volunteers.
Journal: Acta pharmacologica Sinica 20010601
Title: Aromatase inhibitors and arthralgia.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010515
Title: Is anastrozole superior to tamoxifen as first-line therapy for advanced breast cancer?
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010501
Title: Is anastrozole superior to tamoxifen as first-line therapy for advanced breast cancer?
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010501
Title: Is anastrozole superior to tamoxifen as first-line therapy for advanced breast cancer?
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010501
Title: Is anastrozole superior to tamoxifen as first-line therapy for advanced breast cancer?
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010501
Title: Is anastrozole superior to tamoxifen as first-line therapy for advanced breast cancer?
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010501
Title: Influence of neoadjuvant anastrozole (Arimidex) on intratumoral estrogen levels and proliferation markers in patients with locally advanced breast cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20010501
Title: Aromatase inhibition and antiestrogen therapy in early breast cancer treatment and chemoprevention.
Journal: Oncology (Williston Park, N.Y.) 20010501
Title: [Aromatase inhibitors: anastrozole versus tamoxifen as first-ine therapy for advanced postmenopausal breast cancer].
Journal: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20010501
Title: The effect of anastrozole on the single-dose pharmacokinetics and anticoagulant activity of warfarin in healthy volunteers.
Journal: British journal of clinical pharmacology 20010501
Title: Estrogenic upregulation of DNA polymerase beta in oocytes of preovulatory ovine follicles.
Journal: Molecular reproduction and development 20010401
Title: [Development of a novel aromatase inhibitor, anastrozole (Arimidex)--its basic and clinical studies].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20010401
Title: Importance of local aromatase activity in hormone-dependent breast cancer: a review.
Journal: Breast (Edinburgh, Scotland) 20010401
Title: Aromatase inhibitors in the treatment and prevention of breast cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010201
Title: The uterotrophic activity of nonylphenol in the rat is not mediated by aromatase enzyme induction.
Journal: Toxicology letters 20010103
Title: Drug approval summaries: arsenic trioxide, tamoxifen citrate, anastrazole, paclitaxel, bexarotene.
Journal: The oncologist 20010101
Title: Differential regulation of gonadotropin secretion by testosterone in the human male: absence of a negative feedback effect of testosterone on follicle-stimulating hormone secretion.
Journal: The Journal of clinical endocrinology and metabolism 20010101
Title: [Endometriosis and aromatase inhibitor].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20010101
Title: Breast cancer chemoprevention: beyond tamoxifen.
Journal: Breast cancer research : BCR 20010101
Title: The Twenty-third Annual San Antonio Breast Cancer Symposium.
Journal: Current medical research and opinion 20010101
Title: Update on endocrine aspects of breast cancer: report from the 23rd San Antonio Breast Cancer Symposium, San Antonio, Texas, USA, 6-9 December 2000.
Journal: Breast cancer research : BCR 20010101
Title: [Modern approaches to hormone therapy of breast cancer as a reflection of pathogenesis of the disease].
Journal: Voprosy onkologii 20010101
Title: Intracellular aromatase and its relevance to the pharmacological efficacy of aromatase inhibitors.
Journal: The Journal of steroid biochemistry and molecular biology 20010101
Title: Fulvestrant.
Journal: Drugs 20010101
Title: [Evolvement of hormone therapy for breast cancer. Florence, March 14, 2001].
Journal: Tumori 20010101
Title: Aromatase, aromatase inhibitors, and breast cancer.
Journal: American journal of therapeutics 20010101
Title: New combinations with Herceptin in metastatic breast cancer.
Journal: Oncology 20010101
Title: Third-generation aromatase inhibitors in the treatment of advanced breast cancer.
Journal: Breast cancer (Tokyo, Japan) 20010101
Title: Aromatase and aromatase inhibitors.
Journal: Breast cancer (Tokyo, Japan) 20010101
Title: Tamoxifen vs the aromatase inhibitors: news from San Antonio, 2001.
Journal: Cancer control : journal of the Moffitt Cancer Center 20010101
Title: Aromatase inhibitors.
Journal: Current medical research and opinion 20010101
Title: Pure antiestrogens and breast cancer.
Journal: Current medical research and opinion 20010101
Title: Effect of chronic administration of an aromatase inhibitor to adult male rats on pituitary and testicular function and fertility.
Journal: The Journal of endocrinology 20000201
Title: A randomized, open, parallel-group trial to compare the endocrine effects of oral anastrozole (Arimidex) with intramuscular formestane in postmenopausal women with advanced breast cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 19991001
Title: Arimidex: a potent and selective fourth-generation aromatase inhibitor.
Journal: Breast cancer research and treatment 19940101
Title: Highly selective inhibition of estrogen biosynthesis by CGS 20267, a new non-steroidal aromatase inhibitor.
Journal: The Journal of steroid biochemistry and molecular biology 19901220
Title: Dukes M, et al. The preclinical pharmacology of "Arimidex" (anastrozole; ZD1033)--a potent, selective aromatase inhibitor. J Steroid Biochem Mol Biol. 1996 Jul;58(4):439-45.
